Publications

Publications from the Center for Cancer Biostatistics in conjunction with Cancer Center members.

 

In Press

  • Ben-Josef E, George A, Regine WF, Abrams R, Morgan M, Thomas D, Schaefer PL, DiPetrillo TA, Fromm M, Small W, Narayan S, Winter K, Griffith KA, Guha C, and Williams T: "Glycogen Synthase Kinase 3 beta predicts survival in adenocarcinoma of the pancreas."   Clin Can Res, in press, 2015.
  • Boonstra PS, Mukherjee B, Gruber SB, Ahn J, Schmit SL, Chatterjee N: "Tests for gene-environment interactions and joint effects with exposure misclassification".   In press, Am J Epid, 2015.
  • Boonstra PS, Mukherjee B and Taylor JMG: "Data-Adaptive Shrinkage via the Hyperpenalized EM Algorithm".  Statistics in Biosciences, in press, 2015.
  • Chatterjee M, Ben-Josef E, Thomas DG, Morgan MA, Zalupski MM, Khan G, Robinson CA, Griffith KA, Chen C, Ludwig T, Bekaii-Saab T, Chakravarti A, and Williams TM: "Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer."   Sci. Rep. in press, 2015.
  • Davis EJ, Griffith KA, Kim EJ, Ruch JM, McDonnell KJ, and Zalupski MM: "A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers."   Accepted, Am J Clin Oncol, 2015.
  • Foster JC, Nan B, Shen L, Kaciroti N, Taylor JMG: "Permutation Testing for Treatment-Covariate Interactions".  Statistics in Biosciences, in press, 2015.
  • Poorni M, Beesley L, Taylor JMG, Hesseltine, E, Haymart  M, Esfandiari N, Hanauer D, Worden F: "Retrospective Study of Sirolimus and Cyclophosphamide in Patients with Advanced Differentiated Thyroid Cancers".  J Thyroid Disorders & Therapy, in press, 2015.
  • Rizopoulos D, Taylor JMG, van Rosmalen J, Steyerberg EW, Takkenberg JJM: "Personalized Screening Intervals for Biomarkers Using Joint Models for Longitudinal and Survival Data."  Biostatistics, in press, 2015.
  • Virani S, Bellile E, Bradford CR, Carey TE, Colacino JC, Chepeha DB, Hellman J, McHugh JB, Peterson, L, Sartor MA, Taylor JMG, Walline HM, Wolf GT, Rozek LS: "NDN and CD1A are Novel Prognostic Methylation Markers and Differ by HPV Status in Patients with Head and Neck Squamous Carcinoma".  CEBP, in press, 2015.
  • Virani S, Bellile E, Peterson LA, Taylor JMG, McHugh J, Wolf GT: "Stability of Methylation Markers in Head and Neck Squamous Cell Cancinomas."   BMC Cancer, in press, 2015.
  • Walter JK, Griffith KA, and Jagsi R: "Oncologists' Experiences and Attitudes about Their Role in Philanthropy and Soliciting Donations from Grateful Patients."   J Clin Oncol, in press, 2015.
  • Xie CM, Wei D, Zhao L, Marchetto S, Mei L, Borg JP and Sun Y: " Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis, Accepted  J Cell Biology, 2015.
  • Zhao L, Feng D, Chen G, Taylor JMG: "A Unified Bayesian Semiparametric Approach to Assess Discrimination Ability in Survival Analysis."  Biometrics, in press, 2015.

  • Boonstra PS, Mukherjee B, Taylor JMG: "A Small-Sample Choice of the Tuning parameter in ridge regression." Statistica Sinica, in press, 2014.
  • Wolf G, Chepeha D, Bellile E, Nguyen A, Thomas D, Mchugh J: "Tumor Infiltrating Lymphocytes (TIL) and Prognosis in Oral Cavity Squamous Carcinoma: A Preliminary Study".  Oral Oncology, in press, 2014.

Published

  • Davis EJ,Griffith KA, Kim EJ, Ruch JM, McDonnell KJ, and Zalupski MM: "A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers." Am J Clin Oncol,41(2):128-132, 2018, PMC4854803.
  • Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt DE: "Erectile Function after Stereotactic Body Radiotherapy for Prostate Cancer: Comparison to Nerve-Sparing Prostatectomy and Conventional Radiotherapy." BJU Int, 121(1):61-68, 2018, PMID: 28710895.
  • Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling TH, Normolle D, Ten Haken RK, Lawrence TS: "Individualized Adaptive Sterotactic Body Radiotherapy (SBRT) for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial." JAMA Oncol, 4(1):40-47, 2018, PMC5766368.
  • Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG:"Individualized outcome prognostication for patients with laryngeal cancer."Cancer, 12494):706-716, 2018, PMC5800991.
  • Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N: "Current Challenges and Opportunities in Treating Glioblastoma." Pharmacological Reviews, 70:1-35, 2018.
  • Sehrawat A, Gao L, Wang Y, Bankhead A 3rd, McWeeney SK, King CJ, Schwartzman J, Urrutia J, Bisson WH, Coleman DJ, Joshi SK, Kim DH, Sampson DA, Weinmann S, Kallakury BVS, Berry DL, Haque R, Van Den Eeden SK, Sharma S, Bearss J, Beer TM, Thomas GV, Heiser LM, Alumkal JJ: "LSD1 activates a lethal prostate cancer gene network independently of its demethylase function." Proc Natl Sci USA, pii: 201719168. doi: 10.1073/pnas.1719168115. [Epub ahead of print], 2018, PMID: 29581250.
  • Spratt DE, Suresh K, Osawa T, Schipper M, Jackson WC, Abugharib A, Lebastchi A, Smith D, Montgomery JS, Palapattu GS, Priya Kunju L, Wu A, Lew M, Tomlins SA, Chinnaiyan AM, Weizer AZ, Hafez KS, Kaffenberger SD, Udager A, Mehra R: "Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections." Med Oncol, 5(3):21, 2018, PMID: 29387987.
  • Sun Y, Hawkins PG, Bi N, Tewari M, Hearn JWD, Hayman JA, Kalemkerian GP, Lawrence TS, Ten-Haken RK, Matuszak MM, Kong FM, Jolly S, Schipper MJ:"Serum MicroRNA Signature Predicts Response to High-dose Radiation Therapyin Locally Advanced Non-Small-Cell Lung Cancer." Int J Radiat Oncol Biol Phys, 100(1):107-114, 2018, PMC5736451.
  • Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Jackson W, Bazzi L, Ten Haken RK, Lawrence TS, Cuneo K, Feng M, Schipper MJ: "Using Indocyanine Green to Predict Liver Toxicity After Stereotactic Body Radiotherapy for Primary Hepatocellular Carcinoma." Int J Rad Oncol Biol Phys, 100(1):131-137, 2018, PMC5736416.
  • Tamura S, Wang Y, Veeneman B, Hovelson D, Bankhead A 3rd,Broses LJ, Lorenzatti Hiles G, Liebert M, Rubin JR, Day KC, Hussain M, Neamati N, Tomlins S, Palmbos PL, Grivas P, Day ML: "Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer." Bladder Cancer, 2018 Jan 20;4(1):77-90, 2018, PMC5798519.
  • Tran Q, Kidwell KM, Tsodikov A: "A joint model of cancer incidence, metastasis, and mortality" Lifetime Data Anal, 24(3):385-406, 2018, PMID 28871363.
  • Veenstra CM, Abrahamse P, Wagner TH, Hawley ST, Banerjee M, Morris AM: "Employment benefits and job retention: evidence among patients with colorectal cancer." Cancer Med, 7(3):736-745, 2018, PMC5852372.
  • Zhang Y,Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y1, Xiao L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish M, Shukla GC, Paulsen MT, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp CS, Freier SM, Watt AT, Guo S, Wei JT, Feng FY, Malik R, Chinnaiyan AM: "Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression." Nat Genet, 50(6):814-824, 2018, PMC5980762.
  • Zhao L, Wu W, Feng D, Jiang H, Nguyen X: "Bayesian Analysis of RNA-seq Data Using a Family of Negative Binomial Models." Bayesian Anal, 13(2)411-436, 2018.

  • Alva A, Nordquist L, Daignault S, George S, Ramos J, Albany C, Isharwal S, McDonald M, Campbell G, Danchaivijitr P, Yentz S, Anand A, Yu EY: "Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer." Prostate, 77(5):479-488, 2017, PMID 27990667.
  • Bear HD, Tang G, Rastogi P, Geyer CE Jr, Zoon CK, Kidwell KM, Robidoux A, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Paik S, Swain SM, Mamounas EP, Wolmark N: "The Effect on Surgical Compliacations of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40." Ann Surg Oncol,24(7):1853-1860, 2017, PMID 27864694.
  • Birkeland AC, Beesley L, Bellile E,Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME. "Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma." Head Neck, 39(12):2512-2518, 2017, PMC5686454.
  • Boonstra PS, Braun TM, Taylor JMG, Kidwell KM, Bellile EL, Daignault S, Zhao L, Griffith KA, Lawrence TS, Kalemkerian GP, Schipper MJ:"Statistical controversies in cancer research: Building the Bridge to Phase II: Efficacy Estimation in Dose Expansion Cohorts." Ann Oncol, 28(7):1427-1435,2017, PMID 28200082
  • Boonstra PS, Polk A, Brown N, Hristov AC, Bailey NG, Kaminiski MS, Phillips T, Devata S, Mayer T, Wilcox RA: "A Single Center Phase II Study of Ixazomib in Patients with Relapsed or Refractory Cutaneous or Peripheral T-cell Lymphomas." Am J Hematol, 92(12):1287-1294, 2017, PMID: 28842936.
  • Brockoff HC, Kim RY, Braun TM, Skouteris C, Helman JI, Ward BB: "Correlating the depth of invasion at specific anatomic locations with the risk for regional metastatic disease to lymph nodes in the neck for oral squamous cell carcinoma." Head Neck, 39(5):974-979, 2017, PMID 28236366.
  • Chen Y, Zhou Q, Li X, Wang F, Heist K, Kuick R, Owens SR, Wang TD:"Ultrasmall Paramagnetic Iron Oxide Nanoprobe Targeting Epidermal Growth Factor Receptor for In Vivo Magnetic Resonance Imaging of Hepatocellular Carcinoma."Bioconjug Chem, 28(11):2794-2803, 2017, PMID: 28972742.
  • Choksi P, Papaleontiou M, Guo C, Worden F, Banerjee M, Haymart M: "Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study.: J Clin Endocrinol Metab, 102(4):1254-1260, 2017, PMC5460727.
  • Conlon ASC, Taylor JMG, Elliott MR" Surrogacy Assessment Using Principal Stratification and a Gaussian Copula Model." Stat Methods Med Res, 26(1)1:88-107, 2017, PMC4272338.
  • Conlon A, Taylor J, Li Y, Diaz-Ordaz K, Elliott M:"Links between causal effects and causal association for surrogacy evaluation in a gaussian setting." Stat Med, 36(27):4243-4265, 2017, PMC5675829.
  • DaSilva AF, Nascimento TD, Jassar H, Heffernan J, Toback RL, Lucas S, DosSantos MF, Bellile EL, Boonstra PS, Taylor JMG, Casey KL, Koeppe RA, Smith YR, Zubieta JK:"Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo." Neurology, 88(17):1634-164, 2017, PMC5405765.
  • Day KC, Hiles GL, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, Daignault-Newton S, El-Sawy L, Wilson SJ, Chou A, Iganatoski KW, Keller E, Thomas D, Nagrath S, Morgan T, Day ML: "HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone, Cancer Res, 77(1):74-85, 2017, PMC5214538.
  • Dess RT, Sun Y, Matuszak MM, Sun G, Soni PD, Bazzi L, Murthy VL, Hearn JWD, Kong FM, Kalemkerian GP, Hayman JA, Ten Haken RK, Lawrence TS, Schipper MJ, Jolly S: "Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer." J Clin Oncol, 35(13):1395-1402, 2016, PMC5455464.
  • Dewaraja Y, Chun H, Devasia T, Srinivasa, Kaza, Cuneo, Majdalany, Novelli, Ljungberg, Schipper M, Fessler J: "Improved quantitative Y-90 bremsstrahlung SPECT/CTreconstruction with Monte Carlo Scatter Modeling." Med Phys, 44(12):6364-6376, 2017, PMC5734647.
  • Djuric Z, Aslam MN, Simon BR, Sen A, Jiang Y, Ren J, Chan R, Soni T, Rajendiran TM, Smith WL, Brenner DE: "Fatty acid and lipidomic data in normal and tumor colon tissues of rats fed diets with and without fish oil." Data Brief, 13:661-666, 2017, PMC5503825.
  • Djuric Z, Aslam MN, Simon BR, Sen A, Jiang Y, Ren J, Chan R, Soni T, Rajendiran TM, Smith WL, Brenner DE: "Effects of fish oil supplementation on prostaglandins in normal and tumor colon tissue: modulation by the lipogenic phenotype of colon tumors." J Nutr Biochem, 46:90-99, 2017, PMC5503762.
  • East E, Zhao L, Pang JC, Jorns JM: "Characteristics of a Breast Pathology Consultation Practice." Arch Pathol Lab Med, 141(4):578-584, 2017, PMID: 28353380.
  • Foy JJ, Marsh R, Ten-Haken RK, Younge KC, Schipper M, Sun Y, Owen D, Matuszak MM: "An analysis of knowledge-based planning for stereotactic body radiation therapy of the spine." Pract Radiat Oncol, 7(5):e355-e360, 2017, PMID: 28433524.
  • Friese CR, Hofer TP, Harrison JM, Janz NK, Jagsi R, Morrow M,Li Y, Hamilton A, Ward K, Kurian A, Katz S: "Treatment-Associated Toxicities Reported by Patients with Early-Stage Invasive Breast Cancer." Cancer, 123(11):1925-1934, 2017, PMC5444953.
  • Friese CR, Li Y, Bonarenko I, Hofer TP, Ward KC, Hamilton AS, Deapen D, Kurian AW, Katz SJ: "Chemotherapy decisions and patient experience with the recurrence sore assay for early stage breast cancer." Cancer, 123(1):43-51, 2017, PMC5161570
  • Gainor DL, Marchino E, Bellile E, Spector ME, Taylor JMG, Wolfe GT, Hogikyan ND, Prince ME, Bradford CR, Eisbruch A, Worden F, Shuman AG: "Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Lanryx." Otolaryngol Head Neck Surg, 1:194599817711374, 2017, PMC5624831.

  • Arthur AE, Bellile EL,Rozek LS, Peterson KE, Ren J, Harris E, Mueller C, Jolly S, Peterson LA, Wolf GT, Djuric Z, "Pretreatment serum xanthophyll concentrations as prediectors of head and neck cancer recurrence and survival" Head Neck, 38 Suppl 1:E1591-7, 2016, PMC4844799

  • Alva A, Friedlander T, Clark M, Huebner T, Daignault S, Hussain M, Lee C, Hafez K, Hollenbeck B, Weizer A, Premasekharan G, Tran T, Fu C, Ionescu-Zanetti C, Schwartz M, Fan A, Paris P: "Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer."   J Urol 194(3):790-8, 2015.
  • Boonstra PS, Shen J, Taylor JMG, Braun TM, Griffith KA, Daignault SD, Kalemkerian GP, Lawrence TS. Schipper MJ: "A statistical evaluation of dose expansion cohorts in phase I clinical trials".  JNCI, 107(1): 2015.
  • Chinn SB, Darr OA, Owen JH, Bellile E, Mchugh JB, Spector ME, Papagerakis SM, Chepeha DB, Bradford CR, Carey TE, Prince ME: "Cancer stem cells mediate tumorigenesis and metastasis in head and neck squamous cell carcinoma."  Head & Neck, 37(3):317-26, 2015, PMC4127160.
  • Chugh R, Griffith KA, Davis E, Thomas DG, Zavala J, Metko G, Brockstein B, Undevia S, Stadler W, and  Schuetze SM: "Doxorubicin plus the IGFR-1 Antibody Cixutumumab in Soft Tissue Sarcoma: A Phase 1 Study Using the TITE-CRM Model."   An Oncol 26(7):1459-64, 2015.
  • Conlon ASC, Taylor JMG, Sargent DJ: "Improving Efficiency in Clinical Trials Using Auxiliary Information; Application of a Multi-State Cure Model."  Biometrics, 71(2):460-8, 2015, PMC4480062.
  • Darr OA, Colacino JA, Tang AL, McHugh JB, Bellile EL, Bradford CR, Prince MP, Chepeha DB, Rozek LS, Moyer JS: "Epigenetic Alterations in Metastatic Cutaneous Carcinoma."  Head Neck, 37(7):994-1001, 2015, PMC4183742.
  • Elliott M, Conlon ASC, Li Y, Taylor JMG: "Surrogacy Marker Paradox Measures in Meta-Analytic Settings".  Biostatistics, 16(2):400-12, 2015, PMC4366594.
  • Elstrom RL, Ruan J, Christos PJ, Martin P, Lebovic D, Osborne J, Goldsmith S, Greenberg J, Furman RR, Avram A, Putman R, Chapman E, Mazumdar M, Griffith K, Coleman M, Leonard JP, and Kaminski MS: "Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin's lymphoma receiving radioimmunotherapy with 131I-tositumomab." Leukemia & Lymphoma: 56(2):342-6., 2015
  • Fernandes L, Taylor JMG, Murray S: "Adaptive Phase I Clinical Trial Design Using Markov Models for Conditional Probability of Toxicity."  J Biopharmaceutical Stat, epub ahead of print, 2015.
  • Fernandes L, Taylor JMG, Murray S: "Multivariate Markov models for the conditional probability of toxicity in phase II trials".  Biometrical Journal, epub ahead of print, 2015.
  • Foster J, Taylor JMG, Kaciroti N, Nan B: "Simple Subgroup Approximations to Optimal Treatment Regimes from Randomized Clinical Trial Data".  Biostatistics, 16(2):368-82, 2015, PMC in process.
  • Good NM, Suresh K, Young GP, Lockett TJ, Macrae FA, Taylor JMG: "A Prediction Model for Colon Cancer Surveillance Data."  Stat Med, 34(18):2662-75, 2015, PMC4494883
  • Hamstra D, Johnson S, Daignault S, Zikmund-Fisher B, Taylor JMG, Larkin K, Wood A, Fagerlin A: "The Impact of Numeracy on Verbatim Knowledge of the Longitudinal Risk for Prostate Cancer Recurrence following Radiation Therapy".  Med Decision Making, 35(1):27-36, 2015, PMC4567273.
  • Hou J, Seneviratne C, Su X, Taylor JMG, Johnson B,  Wang X, Zhang H, Kranzler H, Kang J, Liu L: "Subgroup identification in personalized treatment of alcohol dependence".  Alcoh Clin Exp Res, 39(7):1253-9, 2015, PMC4491003.
  • Hsu, CH, Taylor JMG, Hu, C: "Analysis of Accelerated Failure Time Data with Dependent Censoring Using Auxiliary Variables via Nonparametric Multiple Imputation."  Stat Med, 67(19):2768-80, 2015 PMC in process.
  • Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY: Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol,  Epub ahead of print 2015.
  • Jacobs BL, Daignault S, Lee CT, Hafez KS, Montgomery JS, Montie JE, Humrich JE, Hollenbeck BK, Wood DP Jr, Weizer AZ.  "Prostate Capsule Sparing versus Nerve Sparing Radical Cystectomy for Bladder Cancer: Results of a Randomized, Controlled Trial."  J Urol. 193(1):64-70, 2015, PMC4368062.
  • Jagsi R, Griffith KA, Kurian AW, Morrow M, Hamilton AS, Graff J, Katz SJ, and Hawley ST: "Racial/ethnic differences in breast cancer patients' preferences and experiences with genetic testing."  J Clin Oncol 33(14):1584-1591, 2015.
  • Jagsi R, Griffith KA, Moran M, Heimburger D, Boike T, Hayman J, and Pierce J: "Differences in the Acute Toxicity of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician and Patient-Reported Outcome in a Large, Prospective, Multicenter Cohort."  JAMA Oncol. 1(7):918-930, 2015.
  • Janz NK, Leinberger RL, Zikmund-Fisher BJ, Hawley ST, Griffith KA, and Jagsi R: "Provider perspectives on presenting risk information and managing worry about recurrence among breast cancer survivors."   Psycho-Oncology 24:592-600, 2015.
  • Luo Y, McShan D, Kong F, Schipper M, Haken RT. TH-AB-304-07: A Two-Stage Signature-Based Data Fusion Mechanism to Predict Radiation Pneumonitis in Patients with Non-Small-Cell Lung Cancer (NSCLC). Medical physics. 2015; 42(6):3702.
  • Paoletti C, Muniz MC, Thomas DG, Griffith KA, Kidwell K, Tokudome N, Brown ME, Aung K, Miller C, Blossom D, Schott AF, Henry NL, Rae JM, Connelly MC, Chianese DA, and Hayes DF: "Tumor Heterogeneity of Biomarker Expression in Circulating Tumor Cells (CTCs) in Estrogen Receptor Positive Metastatic Breast Cancer (MBC): Development of a CTC-Endocrine Therapy Index (CTC-ETI)."  Clin Can Res 21(11):2487-98, 2015.
  • Sabel MS, Kozminski D, Griffith KA, Chang AE, Johnson TM, and Wong S: "Sentinel lymph node biopsy use among melanoma patients 75 years of age and older."  An Surg Oncol 22(7):2112-9, 2015.
  • Sabolch A, Else T, Griffith KA, Ben-Josef E, Williams A, Miller BS, Worden F, Hammer GD, and Jolly S: "Adjuvant radiotherapy improves local control after surgical resection in patients with localized adrenocortical carcinoma: A retrospective cohort study."   Int J Radiation Oncol Biol Phys 92(2): 252-259, 2015.
  • Samuels SE, Vainshtein J, Spector ME, Ibrahim M, McHugh JB, Tao Y, Schipper M, Worden F, Eisbruch A Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.  Radiother Oncol, Epub ahead of print, 2015.
  • Schipper MJ, Wang G, Giles N, Ohrnberger J: Novel prostate cancer biomarkers derived from autoantibody signatures. Transl Oncol., ;8(2):106-11, 2015,  PMC4415116.
  • Shumway D, Griffith KA, Jagsi R, Williams G, Katz S, and Resnicow K: "Psychometric Properties of a Brief Measure of Autonomy Support in Breast Cancer Patients."  BMC Medical Informatics and Decision Making. 15:51, 2015.
  • Shumway DA, Griffith KA, Pierce LJ, Jagsi R, Feng M, Moran JM, Stenmark MH, Piotrowski T, and Hayman JA: "Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity Modulated Radiation Therapy (IMRT) Utilization in the State of Michigan."   JOP 11(3):e373-8, 2015.
  • Taylor JMG, Cheng W, Foster J: Reader Reaction to "A Robust Method for Estimating Optimal Treatment Regimes" by Zhang et al (2012).  Biometrics, 71(1):267-71, 2015.
  • Wiebel J, Banerjee M, Muenz DG, Worden F, Haymart MR: "Trends in Imaging after diagnosis of Thyroid Cancer".  Cancer, 121(9):1387-94 2015, PMC4409471.
  • Wolf G, Chepeha D, Bellile E, Nguyen A, Thomas D, Mchugh J: "Tumor Infiltrating Lymphocytes (TIL) and Prognosis in Oral Cavity Squamous Carcinoma: A Preliminary Study".  Oral Oncology, 51(1):90-5, 2015, PMC4268429.
  • Zhao SG, Jackson WC, Kothari V, Schipper MJ, Erho N, Evans JR, Speers C, Hamstra DA, Niknafs YS, Nguyen PL, Schaeffer EM, Ross AE, Den RB, Klein EA, Jenkins RB, Davicioni E, Feng FY: High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. Prostate Cancer Prostatic Dis. , Epub ahead of print , 2015.
  • Zhou J, Fang CX, Shen J, Schipper MJ, Zalupski MM, Minter RM, Simeone DM, Hart D, Eagle T, Kimmel GW, Vainshtein J, Lawrence TS, Feng M: Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. Am J Clin Oncol,  Epub ahead of print, 2015.
  • Zhao L, Feng D, Neelon B and Buyse M: "Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers." Stat Med, 34(10): 1733-1746, 2015, PMC in process.
  • Zhao L, Shi J, Shearon TH, and Li Y: "A Dirichlet process mixture model for survival outcome data: assessing nationwide kidney transplant centers." Stat Med, 34(8): 1404-1416, 2015, PMC in process
 

  • Alva A, Daignault S, Smith DC, Hussain M: "Phase II Trial of Combination Nab-Paclitaxel, Carboplatin and Gemcitabine in First Line Therapy of Advance Urothelial Carcinoma."  Invest New Drugs, 32(1):188-94, 2014, PMC in process.
  • Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG and Pang JC: "Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast".  An Surg Oncol, 21(13):4152-8, 2014.
  • Arthur AE, Peterson KE, Shen J, Djuric Z, Taylor JMG, Hebert JR, Duffy SA, Peterson LA, Bellile EL, Whitfield JR, Chepeha DB, Schipper MJ, Wolf GT, Rozek LS: "Diet, proinflammatory cytokine levels, and cachexia in head and neck squamous cell carcinoma."  Cancer, 120(17):2704-12, 2014, PMC4141000.
  • Banerjee M, Muenz DG, Chang JT, Papaleontiou M, Haymart MR: "Tree-Based Model for Thyroid Cancer Prognostication".  J Clin Endocrin Metabol, 99(10):3737-3745, 2014.
  • Banerjee M, Muenz DG, Worden F, Wong SL, Haymart MR: "Conditional Survival in Melanoma and Thyroid Cancer Patients". Thyroid, 24(12), 2014.
  • Berman MG, Askren MK, Jung MS, Therrien B, Peltier S, Noll DC, Zhang M, Hayes DF, Reuter-Lorenz PA, Cimprich B: "Pretreatment worry and neurocognitive responses in women with Breast cancer."  Health Psychology, 33(3):222-31, 2014.
  • Boonstra PS, Bondarenko I, Park SK, Vokonas PS, Mukherjee B: "Propensity score-based diagnostics for categorical response regression models."  Stat Med, 33(3):455-69, 2014, PMC3911784.
  • Boonstra PS, Taylor JMG, Mukherjee B: "Increasing Efficiency for Estimating Treatment-Biomarker Interactions with Historical Data".  Stat Methods Med Res, eprint, 2014.
  • Brown NA, Rolland DC, McHugh JB, Weigelin HC, Zhao L, Lim MS, Elenitoba-Johnson KS, Betz BL: "Activating FGFR2-RAS-BRAF mutations in ameloblastoma". Clin Cancer Res, 20(21):5517-26, 2014.
  • Choi SW, Braun T, Chang L, Ferrara JL, Pawarode A, Magenau JM, Hou G, Beumer JH, Levine JE, Goldstein S, Couriel DR, Stockerl-Goldstein K, Krijanovski O, Kitko C, Yanik GA, Lehmann MH, Tawara I, Sun Y, Paczesny S, Mapara MY, Dinarello CA, Dipersio JF, Reddy P: "Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial".  Lancet Oncol, 15(1):87-95, 2014, PMC in process.
  • Conlon ASC, Taylor JMG, Elliott MR: "Surrogacy Assessment Using Principal Stratification and a Gaussian Copula Model."  In press, Stat Meth Res, epub, 2014, PMC4273338.
  • Conlon ASC, Taylor JMG, Elliott MR: "Surrogacy Assessment Using Principal Stratification When Surrogate and Outcome Measures are Multivariate Normal."  Biostatistics, 15(2):266-83, 2014, PMC4023321..
  • Conlon ASC, Taylor JMG, Sargent DJ: "Multi-State Models for Colon Cancer Recurrence and Death with a Cured Fraction."  Stat Med, 33(10):1750-66, 2014, PMC3999912..
  • Cuneo KC, Chenevert TL, Ben-Josef E, Feng MU, Greenson JK, Hussain HK, Simeone DM, Schipper MJ, Anderson MA, Zalupski MM, Al-Hawary M, Galban CJ, Rehemtulla A, Feng FY, Lawrence TS, Ross BD:  A pilot study of diffusion weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer". Transl Oncol. 7(5): 644-9, 2014, PMC4225651.
  • DeCastro R, Sambuco D, Griffith KA, Ubel PA, Stewart A, Jagsi R: "Mentoring and the Career Satisfaction of Male and Female Academic Medical Faculty."  Acad Med, 89(2):301-11, 2014, PMC4341994.
  • Demiroz, C, Vainshtein JM, Koukourakis GV, Gutfeld O, Prince ME, Bradford CR, Wolf GT, McLean S, Worden FP, Chepeha DB, Schipper MJ, McHugh JB, Eisbruch A: "Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy."  Head & Neck, 36(11):1589-95, 2014, PMC4241546.
  • Dewaraja YK, Schipper MJ, Shen J, Smith LB, Murgic J, Savas H, Youssef E, Regan D, Wilderman SJ, Roberson PL, Kaminski MS, Avram AM.: Tumor-Absorbed Dose Predicts Progression-Free Survival Following 131I-Tositumomab Radioimmunotherapy. J Nucl Med 55(7): 1047-1053, 2014, PMC4237694
  • Dewyer NA, Wolf G, Light E, Worden F, Urba SG, Eisbruch A, Bradford CR, Chepeha DB, Prince ME, Moyer JS, Taylor JMG: "Circulating CD4-positive lymphocyte levels predict response to induction chemotherapy in patients with advanced laryngeal cancer."  Head and Neck, 36(1):9-14, 2014, PMC in process.
  • Grivas PD, Daignault S, Tagawa ST, Nanus DM, Stadler WM, Dreicer R, Kohli M, Hussain M: "Double-Blind, Randomized, Phase 2 Trial of Maintenance Sunitnib Versus Placebo After Response to Chemotherapy in Patients with Advanced Urothelial Carcinoma."  Cancer, 120(5):692-701, 2014.
  • Hamstra DA, Johnson SB, Daignault S, Zikmund-Fisher BJ, Taylor JMG, Larkin K, Wood A, Fagerlin A.  "The Impact of Numeracy on Verbatim Knowledge of the Longitudinal Risk for Prostate Cancer Recurrence following Radiation Therapy."  Med Decis Making. 2014
  • Henry NL, Conlon A, Clauw DJ, Williams DA, Hayes DF, Schott AF, Smerage JB, Ramirez G, Griffith KA, Kidwell K, Harte SE: "Effect of Estrogen Depletion on Pain Sensitivity in Aromatase Inhibitor-Treated Women".  J Pain, 15(5):468-75, 2014, PMC4063362.
  • Henry NL, Xia R, Schott AF, McConnell D, Banerjee M, Hayes DF: "Prediction of postchemotherapy ovarian function using markers of ovarian reserve".  Oncologist, 19(1):68-74, 2014, PMC in process.
  • Holden VI, Lenio S, Kuick R, Ramakrishnan SK, Shah YM, Bachman MA: "Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells".  Infect Immun, 82(9):3826-36, 2014, PMC4187820.
  • Hunter KU, Lee OE,  Lyden TH, Haxer MJ, Feng FY, Schipper MJ, Worden F,  Prince ME,  McLeanMA, Wolf GT,  Bradford CR, Chepeha DA and Eisbruch A. Aspiration Pneumonia after Chemo-IMRT of Oropharyngeal Carcinoma and its Clinical and Dysphagia-Related Predictors. Head and Neck, 36(1):120-5, 2014, PMC4144677.
  • Hussain M, Daignault S, Agarwal N, Grivas PD, Siefker-Radtke AO, Puzanov I, MacVicar GR, Levine EG, Srinivas S, Twardowski P, Eisenberger MA, Quinn DI, Vaishampayan UN, Yu EY, Dawsey S, Day KC, Day ML, Al-Hawary M, Smith DC.  "A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma."  Cancer. 120(17):2684-93, 2014, PMC4142676.
  • Jackson W, Alexander N, Schipper, MJ, Fig, L, Feng, F, Jolly S: "Characterization of Changes in Total ody Composition for Head and Neck Cancer Patients undergoing Chemoradiotherapy using Dual-Energy X-ray Absorptiometry (DEXA)."  Head & Neck, 36(9):1356-62, 2014.
  • Jagsi R, Griffith KA, Heimburger D, Walker EM, Grills IS, Boike T, Feng M, Moran J, Hayman J, and Pierce LJ on behalf of MROQC: "Choosing Wisely? Patterns and Correlates of the Use of Hypofractionated Whole Breast Radiotherapy in the State of Michigan."   Int J Radiation Oncol Biol Phys: 90(5): 1010-1016, 2014.
  • Jagsi R, Pottow JAE, Griffith KA, Bradley C, Hamilton AS, Graff J, Katz SJ, and Hawley ST: "The long-term financial burden of breast cancer. Experiences of a diverse cohort of survivors identified through population-based registries."   J Clin Oncol. 32(12):1269-1276, 2014.
  • Huang G, Griffith K, Hawley ST, Zikmund-Fisher B, Janz NK, Griggs JJ, Katz SJ, and Jagsi R: "Attitudes Towards and Use of Cancer Management Guidelines in a National Sample of Medical Oncologists and Surgeons."  J Natl Compr Canc Netw, 12(2):204-12, 2014.
  • Jakubowiak A, Griffith KA, Dyfeld D, Jasielec J, Daniel L, Vesole DH, Jagannath S, Al-Zoubi A, Anderson T, Detweiler Short K, Stockerl-Goldstein S, Asra A, Jobkar T, Durecki DE, McDonnell K, Mietzel M: "Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma."   Haematologica, 2014..
  • Jorns JM, Daignault S, Sabel MS, Wu AJ.  "Is intraoperative frozen section analysis of reexcision specimens of value in preventing reoperation in breast-conserving therapy?"  Am J Clin Pathol. 142(5):601-8, 2014.
  • Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies SR, Ellis MJ, Visscher DW.  "Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma."  Arch Pathol Lab Med. 138(11):1507-13, 2014.
  • Kiel MJ, Velusamy T, Rolland D, Sahasrabuddhe A, Chung F, Bailey N, Schrader A, Li B, Li J, Ozel A, Betz B, Miranda R, Medeiros LJ, Zhao L et al: "Integrated Genomic Sequencing Reveals Mutational Landscape of T-cell Prolymphocytic Leukemia".   Blood, 124(9):1460-72, 2014, PMC4148768.
  • Kim EJ, Sahai V, Abel EV, Griffith KA, Geenson JK, Takebe N, Khan GN, Blau JL, Creaig R, Balis UG, Zalupski MM, and Simeone DM: "Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastasis  Pancreatic Adenocarcinoma."  Clin Canc Res: 20(23): 5937-5945, 2014.
  • Kitko CL, Levine JE, Storer BE, Chai X, Fox DA, Braun TM, Couriel DR, Martin PJ, Flowers ME, Hansen JA, Chang L, Conlon M, Fiema BJ, Morgan R, Pongtornpipat P, Lamiman K, Ferrara JL, Lee SJ, Paczesny S: "Plasma CXCL9 elevations correlate with chronic GVHD diagnosis".  Blood, 123(5):786-93, 2014, PMC3907763.
  • Krishnamurthy S, Meyers K, Dong Z, Imai A, Ward B, Helman JI, Taichman R, Light E, McCauley L, Polverini PJ, Prince ME, Wicha MS, Nör JE: "Endothelial IL-6 defines the tumorigenic potential of human head and neck cancer stem-like cells."  Stem Cells, 32(11):2845-57, 2014.
  • Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E et al: "IL-22+CD4+ T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L". Immunity, 40(5):772-84, 2014, PMC4032366.
  • Kumar B, Bellile E, Lee J, Taylor JMG, D'Silva N, Cordell K, Urba S, Worden F, Eisbruch A, Wolf G, Teknos T, Prince M, Chepeha D, Hogikyan N, Moyer J, Carey T, Bradford C: "Biomarkers in Advanced Larynx Cancer:  Triological Society Thesis."  Laryngoscope, 124(1):179-87, 2014, PMC4123871.
  • Li H, Tan M, Jia L, Wei D, Zhao Y, Chen G, Xu J, Zhao L et al: "Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven tumorigenesis".  J Clin Investigation, 124(2):835-846, 2014
  • Li S, Mukherjee B, Wen X, Taylor JMG, Rice JD, Stringham HM, Boehnke M: "The Role of Covariate Heterogeneity in Meta-Analysis of Gene-Environment Interactions with Quantitative Traits."  Genet Epidemiol, 38(5):416-29, 2014, PMC4108593.
  • Liss AL, Ben-David MA, Jagsi R, Hayman JA, Griffith KA, Moran JM, Marsh RB, Pierce LJ: "Decline of Cosmetic Outcomes Following Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy: Results of a Single Institution Prospective Clinical Trial."   Int J Radiation Oncol Biol Phys. 89(1):96-102, 2014.
  • Lu JC, Connelly JA, Zhao L et al: "Strain measurement by cardiovascular magnetic resonance in pediatric cancer survivors: Validation of feature tracking against harmonic phase imaging". Pediatric Radiology, 44(9):1070-6, 2014.
  • Nadal E, Cheng, Prensner JR, Shiratsuchi H, Sam C, Zhao L, et al: "KRAS-G12C mutation is associated with poor outcome in surgically-resected lung adenocarcinomas". J Thoracic Oncol, 9(10):1513-22, 2014.
  • Papagerakis S, Bellile E, Peterson LA, Pliakas M, Balaskas K, Selman S, Hanauer D, Taylor JMG, Duffy S, Wolf G: "Proton Pump Inhibitors and Histamine 2 Blockers are Associated with Improved Overall Survival in Patients with Head and Neck Squamous Carcinoma."  Cancer Prev Res, 7(12):1258-69, 2014.
  • Park Y, Kalbfleisch JD, Taylor JMG: "Confidence Intervals under Order Restriction."  Statistica Sinica, 24:429-445, 2014, PMC3910006.
  • Presner JR, Zhao S, Erho N, Schipper MJ, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Karnes J, Mehra R, Sahu A, Davicioni E, Den RB, Dicker AP, Klein E, Jenkins RB, Chinnaiyan AM, Feng FY: RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncology 15(13): 1469-80, 2014.
  • Proust-Lima C, Sene M, Taylor JMG, Jacqmin-Gadda, H: "Joint latent class models of longitudinal and time-to-event data in the context of individual dynamic predictions."  Stat Meth Med Res, 23(1):74-90, 2014. PMC in process.
  • Roberson PL, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK: "Biological-Effect Modeling of Radioimmunotherapy for Non-Hodgkins Lymphoma: Determination of Model Parameters."  Cancer Biotherapy & Radiopharmaceuticals. 29(1): 26-33, 2014, PMC3869430.
  • Schipper MJ, Taylor JMG, Smith G and Jagsi R: "Comparing long-term treatment-associated toxicities in cancer patients: Approaches, caveats, and recommendations".   Int J Radiat Oncol Biol Phys 89(2):232-4, 2014, PMID 24837886.
  • Schipper MJ, Taylor JMG, TenHaken R, Matuzak M, Kong F, Lawrence TS: "Personalized dose selection in Radiation Therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariates."  Stats Med, 33(30):5330-9, 2014, PMC4367186.
  • Sene M, Taylor JMG, Dignam JJ, Jacqmin-Gadda H, Proust-Lima C: "Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: development and validation".  Stat Methods Med Res, epub, 2014.
  • Serrano PE, Herman JM, Griffith KA, Zalupski MM, Kim EJ, Bekaii-Saab TS, Ben-Josef E, Dawson LA, Ringash J, and Wei AC: "Quality of life in a prospective multi-center phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma."   Int J Radiation Oncol Biol Phys: 90(2):270-277, 2014.
  • Shukla S, Allam US, Ahsan A, Chen G, Krishnamurthy PM, Marsh K, Rumschlag  M, Shankar S, Whitehead C, Schipper MJ, Basrur V, Southworth DR, Chinnaiyan  AM. Rehemtulla A, Beer DG, Lawrence TS, Nyati MK, Ray D: "KRAS Protein Stability Is Regulated through SMURF2: UBCH5 Complex-Mediated β-TrCP1 Degradation".  Neoplasia, 16(2):115-128, 2014, PMC3978392.
  • Spector ME, Gallagher KK, Bellile E, Chinn SB, Ibrahim M, Byrd S, Chanowski EJ, Walline HM, Moyer JS, Prince ME, Wolf GT, Bradford CR, McHugh JB, Cordell K, Carey T, Worden FP, Eisbruch A, Chepeha DB: "Patterns of Nodal metastasis and Prognosis in Human Papillomavirus Postive Oropharyngeal Squamous Cell carcinoma."  Head and Neck, 36(9):1233-40, 2014, PMC4112024.
  • Stenmark  MH, Conlon A, Johnson S, Daignault S, Litzenberg D, Marsh R, Ritter T, Vance S, Kazzi N, Feng F, Sandler H, Sanda MG, Hamstra DA: "Dose to the inferior rectum is strongly associated with patient reported  bowel quality of life after radiation therapy for prostate cancer".  Radiation and Oncology, 110(2):291, 297, 2014.
  • Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY, Worden FP, Wolf GT, Chepeha DB, Prince ME, Bradford CR, Mukherji SK, Eisbruch A, Carey TE: "Nonendemic HPV-Positive Nasopharyngeal Carcinoma: Association with Poor Prognosis".  Intl J Radiat Oncol Biol Phys, 88(3):580-88, 2014, PMC3989890.
  • Stenzel Sl, Ahn J, Boonstra PS, Gruber SB, Mukherjee B: "The Impact of Exposure-Biased Sampling Designs on Detection of Gene-Environment Interactions in case-Control Studies with Potential Exposure Misclassification".  Eur J Epidemiol, eprint, 2014, PMC4256150.
  • Taylor JMG, Conlon ASC, Elliott MR: "Surrogacy Assessment Using Principal Stratification."  Clinical Trials, 15(2):266-83, 2014, PMC4023321.
  • Taylor JMG, Shen J, Kennedy EH, Wang L, Schaubel DE: "Comparison of Methods for Estimating the Effect of Salvage Therapy in Prostate Cancer when Treatment is given by Indication."  Stat Med, 33(2):257-74, 2014, PMC3865083.
  • Vainshtein JM, Griffith KA, Feng FY, Vineberg KA, Chepeha DB, and Eisbruch A: "Patient-Reported Voice and Speech Outcomes and their Clinical and Dosimetric Predictors after Chemo-IMRT of Oropharyngeal Cancer: Prospective Longitudinal Study."   Int J Radiation Oncol Biol Phys 89(5):973-80, 2014.
  • Vainshtein J, Schipper MJ, Vance S, FengF, Olson KB, Hamstra D: "Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-Specific Mortality in Patients Treated with External Beam Radiation Therapy".  Am J Clin Oncol, epub, 2014.
  • Walczak EM, Kuick R, Finco I, Bohin N, Hrycaj SM, Wellik DM, Hammer GD: "Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms".  Mol Endocrinol, 28(9):1471-86, 2014, PMC4154239.
  • Yuan ST, Brown RKJ, Zhao L, Ten Haken RK, Gross M, Cease KB, Schipper MJ, Stanton P, Yu J, Kong FS: "Timing and Intensity of Changes in FDG Uptake with Symptomatic Esophagitis During Radiotherapy or Chemotherapy".  Radiat Oncol, 9(37): 1-6, 2014, PMC3996188.
  • Zhou J, Prisciandaro J, Lee C, Schipper M, Eisbruch A, Jolly S: "Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?"  Practical Radiation Oncology, 4(1):20-6, 2014.
  • Zhao L, Feng D, Light E, Taylor JMG: "Bayesian Random Threshold Estimation in a Cox Proportional Hazards Cure Model."  Stat Med, 33(4):650-61, 2014, PMC4167617.
  • Zheng X, Schipper M, Kidwell K, Reddy R, Ren Y, Chang A, Lin J, Kong FM: "Survival Outcome after Stereotactic Body Radiation Therapy and Surgery for Stage I Non-Small Cell Lung Cancer: a Meta-Analysis."  Intl J Radiat Oncol Biol Phys, 90(3):603-11, 2014.

  • Ahn J, Mukherjee B, Gruber SB, Ghosh M: "Bayesian Semiparametric Analysis for Two-Phase Studies of Gene-Environment Interaction."  Anals of Applied Stat, 7(1):543-569, 2013.
  • Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD: "Trends in Breast Cancer Stage and Mortality in Michigan (1992–2009) by Race, Socioeconomic Status, and Area Healthcare Resources."  PLoS One, 8(4): e61879, 2013, PMC3639257.
  • Akinyemiju TF, Soliman AS, Johnson NJ, Altekruse SF, Welch K, Banerjee M, Schwartz K, Merajver S: "Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities."  J Cancer Epidemiol, epub, 2013, PMC3590635.
  • Andersson DA, Gentry C, Light E, Vastani N, Vallortigara J, Bierhaus A, Fleming T, Bevan S: "Methylglyoxal evokes pain by stimulating TRPA1".  PLoS One, 8(10):e77986, 2013, PMC3805573.
  • Arps DP, Healy P, Zhao L, Kleer CG and Pang JC:" Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast." Breast Cancer Res Treat, 138(3):719-26, 2013, PMC in process.
  • Arthur AE, Peterson KE, Hebert JR, Chepeha DB, Duffy SA, Bellile EL, Taylor JMG, Wolf GT, Rozek LS: "Characterization and stability of dietary patterns in the year following head and neck cancer diagnosis".  FASEB Journal, 27:372-8, 2013.
  • Arthur AE, Peterson KE, Rozek LS, Taylor JM, Light E, Chepeha DB, Hébert JR, Terrell JE, Wolf GT, Duffy SA. Pretreatment dietary patterns, weight status, and prognosis of head and neck squamous cell carcinoma." Am J Clin Nutr, 97(2):360-368, 2013, PMC3545683.
  • Boonstra PS, Mukherjee B, Taylor JMG: "Bayesian shrinkage methods for partially observed data with many predictors." Annals of Applied Statistics, 7(4):2272-92, 2013, PMC3891514.
  • Boonstra P, Taylor JMG, Mukherjee B: "Incorporating Auxiliary Information for Improved Prediction in High Dimensional Datasets: An Ensemble of Shrinkage Approaches".  Biostatistics, 14(2): 259-72, 2013, PMC3590922.
  • Braun TM, Jia N: "A Generalized Continual Reassessment Method for Two-Agent Phase I Trials."  Stat Biopharm Res, 5(2):105-115, 2013, PMC3891671.
  • Breslin TM, Banerjee M, Gust C, Birkmeyer N: "Trends in Advanced Imaging Use for Women Undergoing Breast Cancer Surgery. Cancer, 119:1251-1256, 2013.
  • Byrd K, Fox J, Bellile E, Wolf G, Danciu T: "Invasive Front Histology of Oral Squamous Cell Carcinoma Correlates With Overall Stage and Overall Survival".  Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116(6): e494, 2013.
  • Cao Y, Wang H, Johnson TD, Pan C, Hussain H, Balter JM, Normolle D, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M: "Prediction of Liver Function by Using Magnetic Resonance-based Portal Venous Perfusion Imaging."  Int J Radiat Oncol Biol Phys, 85(1):258-63, 2013.
  • Chapman CH, Nazem-Zadeh M, Lee OE, Schipper MJ, Tsien CI, Lawrence TS, Cao Y: "Regional Variation in Brain White Matter Diffusion Index Changes following Chemoradiotherapy: A Prospective Study Using Tract-Based Spatial Statistics."  PLoS One, 8(3): e57768, 2013, PMC3587621.
  • Chinn SB, Spector ME, Bellile EL, McHugh JB, Gernon TJ, Bradford CR, Wolf GT, Eisbruch A, Chepeha DB: "Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma."  Otolaryngol Head Neck Surg, 149(6):893-9, 2013, PMC in process.
  • Chung E, Corbett JR, Moran JM, Griffith KA, Marsh RB, Feng M, Jagsi R, Kessler ML, Ficaro EC, Pierce LJ: "Is there a dose-response relationship for heart disease with low-dose radiation therapy?"  Int J Radiat Oncol Biol Phys, 85(4): 959-64, 2013, Pub Med in process.
  • Chung E, Marsh RB, Griffith KA, Moran JM, Pierce LJ: "Quantifying dose to the reconstructed breast: Can we adequately treat?"  Med Dosim, 38(1):55-9, 2013.
  • Citronberg J, Bostick R, Ahearn T, Turgeon DK, Ruffin MT, Djuric Z, Sen A, Brenner DE, Zick SM: "Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial".  Cancer Prev Res, 6(4):271-81, 2013, PMC3618532.
  • Colacino J, Dolinoy DC, Duffy SA, Sartor MA, Chepeha DB, Bradford CR, McHugh JB, Patel DA, Virani S, Walline HM, Bellile E, Terrell JE, Stoerker JA, Taylor JMG, Carey TE, Wolf GT, Rozek LS: "Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics".  PLOS ONE, 8(1): e54742, 2013
  • Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Vatan L, Szeliga W, Mao Y, Thomas DG, Kotarski J, Tarkowski R, Wicha M, Cho K, Giordano T, Liu R, Zou W: "Myetoid-derived Supressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Supressing the Corepressor CTBP2."  Immunity, 39(3):611-621, 2013, PMC3831370.
  • Danhauer SC, Legault C, Bandos H, Kidwell K, Costantino J, Vaughan L, Avis NE, Rapp S, Coker LH, Naughton M, Naylor C, Terracciano A, Shumaker S: "Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Trial".  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 20(5):532-52, 2013, PMC3815441.
  • Dobrosotskaya IY, Bellile E, Spector ME, Kumar B, Feng F, Eisbruch A, Wolf GT, Prince ME, Moyer JS, Teknos T, Chepeha DB, Walline HM, McHugh JB, Cordell KG, Ward PD, Byrd S, Maxwell JH, Urba S, Bradford CR, Carey TE, Worden FP: "Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV positive and HPV negative locally advanced squamous cell carcinoma of the oropharynx (SCCOP)." Head Neck, Eprint, 2013, PMID: 23596055
  • Duffy SA, Teknos TN, Taylor JMG, Fowler K, Islam, Wolf G, McLean SA, Tghanem, Terrell JE: "Health Behaviors Predict Higher Interleukin-6 Levels Among Patients Newly Diagnosed with Head and Neck Squamous Cell Carcinoma."  Cancer Epidemiol Biomarkers & Prev, 22:374-381, 2013, PMC3596441.
  • Elliott MR, Li Y, Taylor JMG: "Accommodating Missingness When Assessing Surrogacy Via Principal Stratification."  J Clin Trials, 10(3):359-73, 2013, PMC4096330.
  • Engelke CG, Parsels LA, Qian Y, Zhang Q, Karnak D, Robertson JR, Tanska DM, Wei D, Davis MA, Parsels JD, Zhao L, Greenson JK, Lawrence TS, Maybaum J, Morgan MA: "Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776."  Clin Cancer Res, 19(16):4412-21, 2013, PMC3745540.
  • Esfandiari NH, Hughes DT, Yin H, Banerjee M, Haymart MR: "The Effect of Extent of Surgery and Number of Lymph Node Metastases on Overall Survival in Patients with Medullary Thyroid Cancer".  J Clin Endocrinol Metab, epub, 2013.
  • Foster J, Taylor JMG, Nan B: "Variable selection in monotone single-index models via the adaptive LASSO."  Stat Med, 32(22):3944-54, 2013, PMC3773259.
  • França MM, Ferraz-de-Souza B, Santos MG, Lerario AM, Fragoso MC, Latronico AC, Kuick RD, Hammer GD, Lotfi CF: "POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells."  Mol Cell Endocrinol, 371(1-2):140-7, 2013 PMC in process.
  • Friese CR, Pini TM, Li Y, Abrahamse PH, Gra JJ, Hamilton AS, Jagsi R, Janz NK, Hawley ST, Katz SJ, Griggs JJ: "Adjuvant Endocrine Therapy Initiation and persistence in a diverse sample of patients with breast cancer."  Breast Cancer Res Treat, 138(3):931-9, 2013, PMC3633703.
  • Goodsitt MM, Shenoy A, Shen J, Howard D, Schipper MJ, Wilderman S, Christodoulou E, Chun SY and Dewaraja YK: Evaluation of dual energy quantitative CT for determining the spatial distributions of red marrow and bone for dosimetry in internal emitter radiation therapy. Med. Phys. 41(5): 051901, 2013, PMC4000400.
  • Grivas PD, Hussain M, Hafez K, Daignault-Newton S, Wood D, Lee CT, Weizer A, Montie JE, Hollenbeck B, Montgomery JS, Alva A, Smith DC: "A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder."  Urology, 82(1): 111-7, 2013
  • Ha HT, Griffith KA, Zalupski MM, Schuetze SM, Thomas DG, Lucas DR, Baker LH, Chugh R: "Phase II trial of cetuximab in patients with metastatic or locally advanced soft tissue or bone sarcoma."  Am J Clin Oncol, 36(1): 77-82, 2013.
  • Hamstra DA, Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban DA, Wei JT, Sanda MG, Michalski JM; PROSTQA Consortium Study Group: "Multi-institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated With Patient-Reported Outcomes: The PROSTQA Experience."  Int J Radiat Oncol Biol Phys, 86(3):546-53, 2013.
  • Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, Daignault S, Thomas DG, Gudjonsson JE, Elder JT, Dlugosz AA, Johnson TM, Fullen DR, Bichakjian CK: "Distinct Gene Expression Profiles of Viral and Nonviral Associated Merkel Cell Carcinoma Revealed by Transcriptome Analysis." J Invest Dermatol, 133(4):936-45, 2013, PMC3597750.
  • Harris AC, Kitko CL, Couriel DR, Braun TM, Choi SW, Magenau J, Mineishi S, Pawarode A, Yanik G, Levine JE: "Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes."  Haematologica, 98(2):179-84, 2013, PMC3561423.
  • Haymart MR, Banerjee M, Yang D, Stewart AK, Doherty G, Koenig RJ, Griggs JJ: "The Relationship between Extent of Thyroid Cancer Surgery and Use of Radioactive Iodine."  Annals Surgery, 119(17):3133-39, 2013.
  • Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ: "The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer."  Cancer, 258(2):354-8, 2013. PMID: 22744940.
  • Haymart MR, Banerjee M, Yang D, Stewart AK, Sisson JC, Koenig RJ, Doherty G, Griggs JJ: "Variation in the management of thyroid cancer."  J Clin Endocrinology Metabolism, 98(5): 2001-8, 2013.
  • Haymart MR, Banerjee M, Yang D, Stewart AK, Griggs JJ, Sisson JC, Koenig RJ: "Referral patterns for patients with high-risk thyroid cancer."  Endocr Pract, 19(4):638-43, 2013, PMC3747229.
  • Haymart MR, Banerjee M, Yin H, Worden F, Griggs JJ: "Marginal treatment benefit in anaplastic thyroid cancer."  Cancer, 119(17):3133-9, 2013.
  • Haymart MR, Muenz DG, Stewart AK, Griggs JJ, Banerjee M: "Disease Severity and Radioactive Iodine Use for Thyroid Cancer."  J Clin Endocrin Metab, 98(2):678-86, 2013, PMC 3565122.
  • Hendren S, Fritze D, Banerjee M, Kubus J, Cleary RK, Englesbe MJ, Campbell DA Jr: "Antibiotic choice is independently associated with risk of surgical site infection after colectomy: a population-based cohort study."  Ann Surg, 257(3):469-75, 2013.
  • Henry NL, Skaar TC, Dantzer J, Li L, Kidwell K, Gersch C, Nguyen AT, Rae JM, Desta Z, Oesterreich S, Philips S, Carpenter JS, Storniolo AM, Stearns V, Hayes DF, Flockhart DA: "Genetic associations with toxicity related discontinuation of aromatase inhibitor therapy for breast cancer."  Breast Cancer Res Treat, 138(3):807-16, 2013, PMC3646626.
  • Henry NL, Xia R, Banerjee M, Gersch C, Dowsett M, McConnell D, Giacherio D, Schott AF, Pearlman M, Stearn V, Partridge A, Hayes DF: "Predictors of Recovery of Ovarian Function During Aromatase Inhibitor Therapy."  Annals of Oncology 24(8):2011-6, 2013, PMC3718506.
  • Herman JM, Narang AK, Griffith KA, Zalupski MM, Reese JB, Gearhart SL, Azad NS, Chan J, Olsen L, Efron JE, Lawrence TS, Ben-Josef E: "The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer".  Intl J Radiat Oncol Biol Phys, 85(1):e15-9, 2013, PMC3578309.
  • Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Merajver SD, Schwartz K: "A Comparison of Criteria to Identify Inflammatory Breast Cancer Cases from Medical Records and the Surveillance, Epidemiology and End Results Data base, 2007-2009".  Breast J, eprint, 2013.
  • Hirko KA, Soliman AS, Hablas A, Seifeldin IA, Ramadan M, Banerjee M, Harford JB, Chamberlain RM, Merajver SD: "Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999-2008)."  J Cancer Epidemiol, epub, 2013, PMC3824336.
  • Hoefling NL, McHugh JB, Light E, Kumar B, Walline H, Prince M, Bradford C, Carey TE, Mukherji SK: "Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma." Am J Neuroradiology, 34(5):1062-66, 2013.
  • Hoodin F, Zhao L, Carey J, Levine JE, Kitko C: "Impact of Psychological Screening on Routine Outpatient Care of Hematopoietic Cell Transplantation Survivors Biology of Blood and Marrow Transplantation".  Biology of Blood and Marrow Transplantation, 19(10):1493-1497, 2013.
  • Hu C, Tsodikov A: "Semiparametric Regression Analysis for time-to-event marked Endpoints in Cancer Studies".  Biometrics, 1-13, 2013.
  • Hung J, Hiniker SM, Ray M, McHugh J, Pierce L, Meirovitz A, Lucas DR, Thomas DG, Griffith KA, Baker LH, and Herman JM: "Sporadic Versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases."  Sarcoma, 798403, 2013, PMC3776386.
  • Hunter K, Fernandes L, Vineberg K, McShan D, Antonuk L, Cornwall C, Feng M, Schipper M,Balter J, Eisbruch A: "Parotid Glands Dose–Effect Relationships Based on Their Actually Delivered Doses: Implications for Adaptive Replanning in Radiation Therapy of Head-and-Neck Cancer." Int J Radiation Oncology Biology Physics 87(4): 676-682, 2013, PMC3805710.
  • Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch CA, Cornwall B, Lee CS, Chepeha DB, Eisbruch A: "Toxicities Affecting Quality of Life After Chemo-IMRT of Oropharyngeal Cancer: Prospective Study of Patient-Reported, Observer-Rated, and Objective Outcomes."  Int J Radiat Oncol Biol Phys, 85(4):935-40, 2013, PMC3556374.
  • Ithimakin S, Day KC, Malik F, Zen Q, Dawsey SJ, Bersano-Begey TF, Quraishi AA, Ignatoski KW, Daignault S, Davis A, Hall CL, Palanisamy N, Heath AN, Tawakkol N, Luther TK, Clouthier SG, Chadwick WA, Day ML, Kleer CG, Thomas DG, Hayes DF, Korkaya H, Wicha MS: "HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab."  Cancer Res, 73(5):1635-46, 2013, PMC3600586.
  • Jackson W, Alexander N, Schipper M, Fig L, Feng F, Jolly S: "Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy X-ray absorptiometry".  Head & Neck, epub, 1-7, 2013.
  • Jackson W, Johnson S, Li D, Foster C, Foster B, Song Y, Schipper M, Shilkrut M, Sandler H, Morgan T, Palapattu G, Hamstra D, Feng F: "A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy."  Radiat Oncol, 8(170): 1-8, 2013, PMC3718717.
  • Jagsi R, Griffith KA, Steward A, Sambuco D, DeCastro R, Ubel PA, Jagsi R: "Gender Differences in Salary in a Recent Cohort of Early-Career Physician-Researchers."  Acad Med, 88(11):1689-99, 2013.
  • Jiang Y, Turgeon DK, Wright BD, Sidahmed E, Ruffin MT, Brenner DE, Sen A, Zick SM: "Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer."  Eur J Cancer Prev, 22(5):455-60, 2013, PMC3720765.
  • Jo SY, Wanga  PI, Nör  JE, Bellile EL,  Zhang Z, Worden FP, Srinivasana A,  Mukherjia SK: "CT Perfusion Can Predict Overexpression of CXCL8 (Interleukin-8) in Head and Neck Squamous Cell Carcinoma."  Am J Neuroadiology, 34(12):2338-48, 2013.
  • Jorns JM, Healy P and Zhao L: "Review of Estrogen Receptor, Progesterone Receptor, and HER-2/neu Immunohistochemistry Impacts on Treatment for a Small Subset of Breast Cancer Patients Transferring." Arch Pathol Lab Med,137(11):1660-3, 2013, PMC in process
  • Jorns, J, Visscher D, Sabel M, Breslin T, Daignault-Newton S, Healy PN, Myers J, Wu A: "Intraoperative frozen section analysis of margins in breast conserving surgeries significantly decreases re-operative rates: one year experience at an outpatient surgery center."  Amer J Clin Path, 138(5):657-69, 2013.
  • Kidwell KM, Wahed AS: "Weighted log-rank Statistic to Compare Shared-Path Adaptive Treatment Strategies".  Biostatistics, 14(2):299-312, 2013.
  • Kim EJ, Ben-Josef E, Herman J, Bekaii-Saab T, Dawson L, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore M, Wei A, and Zalupski MM: "A Multi-Institutional Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin with Radiation Therapy in Patients with Pancreatic Cancer."  Cancer, 119(15):2692-2700, 2013.
  • Kwak M, Zebrack B, Meeske K, Embry L, Aguilar C, Block R, Hayes-Lattin B, Li Y, Butler M, Cole S: "Prevalence and predictors of post-traumatic stress symptoms in adolescent and young adult cancer survivors: A 1-year follow-up study."  Psychooncology, 22(8):1798-806, 2013, PMC in process.
  • Kwak M, Zebrack B, Meeske K, Embry L, Aguilar C, Block R, Hayes-Lattin B, Li Y, Butler M, Cole S: "Trajectories of psychological distress in adolescent and young adult cancer patients: A one-year longitudinal study."  J Clin Oncol, 31(17):2160-6, 2013.
  • Lao CD, Friedman J, Tsien CI, Normolle DP, Chapman C, Cao Y, Lee O, Schipper M, Van Poznak C, Hamstra D, Lawrence T, Hayman J, Redman BG: "Concurrent whole brain radiotherapy and bortezomib for brain metastasis."  Radiat Oncol, 8(1): 204, 2013, PMC3765365.
  • Lemasson B, Galbán CJ, Boes JL, Li Y, Zhu Y, Heist KA, Johnson TD, Chenevert TL, Galbán S, Rehemtulla A, Ross BD: "Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map Analysis."  Transl Oncol, 6(5):554-61, 2013, PMC3799198.
  • Levine JE, Harris AC, Taylor A, Braun TM, Magenau J, Ferrara JLM: "A Biomarker-Based Grading System At Onset Of GvHD Predicts NRM Better Than The Modified Glucksberg Grading System."  Blood, 122(21):145-, 2013.
  • Levine JE, Huber E, Hammer ST, Harris AC, Greenson JK, Braun TM, Ferrara JL, Holler E:"Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality".  Blood, 122(8):1505-9, 2013, PMC3750343.
  • Li S, Mukherjee B, Batterman S, Ghosh M: "Bayesian Analysis of Time-Series Data under Case-Crossover Designs: Posterior Equivalence and Inference."  Biometrics, 69(4):925-36, 2013, PMC in process.
  • Liu E, Stenmark M, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee O, Ben-Josef E, Lawrence TS, Feng M: "Stereotactic Body Radiation Therapy for Primary and Metastatic
  • Liver Tumors." Transl Oncol. 2013; 6(4): 442–446. PMC3730019
  • Long T, Matuszak M, Schipper M, Epelman M, Kong F, Ten Haken R, Romeijn E: "A Stochastic Optimization Approach to Adaptive Lung Radiation Therapy Treatment Planning."  Med. Phys, 40, 388, 2013.
  • Machtay M, Schipper M, Kong FM: "Oncology scan-thoracic cancers."  Int J Radiat Oncol Biol Phys, 85(3):571-4, 2013, PubMed - in process
  • Machtay M, Schipper MJ, Kong FM: "Shah et al. Induction Chemoradiation is not Supperior to Induction Chemotherapy Alsone in Stage IIA Lung Cancer. Annals Thoracic Surg."  Int J Radiat Oncol Biol Phys, 85(3):572-574, 2013.
  • Malyarenko D, Galbán CJ, Londy FJ, Meyer CR, Johnson TD, Rehemtulla A, Ross BD, Chenevert TL: "Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom."  J Magn Reson Imaging, 37(5):1238-46, 2013, PMC3548033.
  • Mason H, De Rubeis MB, Foster J, Taylor JMG, Worden F: "Outcomes Evaluation of a Weekly Nurse Practitioner-Managed Symptom Management Clinic for Head and Neck Cancer Patients Treated With Chemo-radiotherapy."  Oncol Nurs Forum, 40(6):581-6, 2013, PMC in process.
  • McShane LM, Cavenagh MM, Lively TG, Eberhard DA, Bigbee WL, Williams PM, Mesirov JP, Polley MYC, Kim KY, Tricoli JV, Taylor JMG, Shuman DJ, Simon RM, Doroshow JH,  Conley BA: "Criteria for the Use of Omics-Based Predictors In Clinical Trials:  Explanation & Elaboration."  BMC Medicine, 11:220, 2013, PMC3852338.
  • McShane LM, Cavenagh MM, Lively TG, Eberhard DA, Bigbee WL, Williams PM, Mesirov JP, Polley MYC, Kim KY, Tricoli JV, Taylor JMG, Shuman DJ, Simon RM, Doroshow JH, Conley BA: "Criteria for the Use of Omics-Based Predictors In Clinical Trials."  Nature, 502(7471):317-20, 2013, PMC4180668.
  • O'Malley M, Healy P, Daignault S, Ramnath N: "Cigarette Smoking and Gemcitabine-Induced Neutropenia in Advanced Solid tumors."  Oncology, 85(4):216-22, 2013.
  • Ouillette PD, Saiya-Cork K, Seymour E, Li C, Shedden K, Malek SN: "Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia."  Clin Cancer Res, 19(11):2893-904, 2013, PMC3674194.
  • Ouillette PD, Shedden K, Cheng L, Malek SN: "Analysis of Acquired Genomic Copy Number Aberrations and Regions of Loss of Heterozygosity in Acute Myelogenous Leukemia Genomes Using Affymetrix SNP 6.0 Arrays and Supporting Software Tools".  Methods in Molecular Biology, 973, 99-119, 2013.
  • Papaleontiou M, Banerjee M, Yang D, Sisson J, Koenig RJ, Haymart MR: "Factors that Influence Radioactive Iodine Use for Thyroid Cancer."  Thyroid, 23:219-224, 2013. PMID: 23134514
  • Park SI, Lee C, Sadler D, Koh AJ, Jones J, Seo JW, Soki FN, Cho SW, Daignault SD, McCauley LK: "Parathyrod Hormone-Related Protein Drives a CD11b+Gr1+ cell-mediated Positive Feedback Loop to Support Prostate Cancer Growth."  Can Res, 73(22):6574-83, 2013.
  • Parkin B, Ouillette P, Li Y, Keller J, Lam C, Roulston D, Li C, Shedden K, Malek SN: "Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia".  Blood, 121(2):369-77, 2013, PMC3653567.
  • Rakowski LA, Garagiola DD, Li CM, Decker M, Caruso S, Jones M, Kuick R, Cierpicki T, Maillard I, Chiang MY: "Convergence of the ZMIZ1 and NOTCH1 Pathways at C-MYC in Acute T Lymphoblastic Leukemias."  Cancer Res, 73(2):930-41, 2013 PMC3549029.
  • Ramnath N, Daignault-Newton S, Dy GK, Muindi JR, Adjei A, Elingrod VL, Kalemkerian GP, Cease KB, Stella PJ, Brenner DE, Troeschel S, Johnson CS, Trump DL: "A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer."  Cancer Chemother Pharmacol, 71(5):1173-82, 2013.
  • Raskin L, Fullen DR, Giordano TJ, Thomas DG, Frohm ML, Cha KB, Ahn J, Mukherjee B, Johnson TM, Gruber SB: "Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis."  J Invest Dermatol, 133(11):2585-92, 2013, PMC4267221.
  • Raymond VM, Mukherjee B, Wang F, Huang SC, Stoffel EM, Kastrinos F, Syngal S, Cooney KA, Gruber SB: "Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome."  JCO, 31(14):1713-18, 2013.
  • Revels SS, Banerjee M, Yin M, Sonnenday C, Birkmeyer JD: "Racial disparities in surgical resection and survival among patients with poor prognosis cancers."  J Am College Surgeons, 216:312-319, 2013.
  • Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton, Healy PN, Pienta KJ: "Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer."  PloS One, 8(10): e76773, 2013.
  • Russo N, Wang X, Liu M, Banerjee R, Goto M, Scanlon C, Metwally T, Inglehart RC, Tsodikov A, Duffy S, Van Tubergen E, Bradford C, Carey T, Wolf G, Chinnaiyan AM, D'Silva NJ: "A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature."  Oncogene, 32(42):5026-37, 2013.
  • Sabel MS, Terjimanian M, Conlon ASC, Griffith KA, Morris AM, Mulholland MW, Englesbe MJ, Holcombe S, Wang SC: "Analytic morphometric assessment of patients undergoing colectomy for colon cancer."  J Surg Oncol,108(3):169-175, 2013.
  • Schipper M, Vainshtein J*, Zalupski MM, Lawrence T, Abrams R, Francis IR, Khan G, Leslie W and Ben-Josef E. Prognostic Significance of CA 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated with Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full Dose Gemcitabine: Analysis of a Prospective Phase I/II Dose Escalation Study. Int J Radiation Oncology Biology Physics 86(1): 96-101, 2013, PMC3646633
  • Schott AF, Landis MD, Dontu G, Griffith KA, Layman RM, Krop I, Paskett LA, Wong H, Dobrolecki LE, Lewis MT, Froehlich AM, Paranilam J, Hayes DF, Wicha MS, Chang JC: "Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors."  Clin Cancer Res, 19(6):1512-24, 2013, PMC3602220.
  • Schuessler KM, Banerjee M, Yang D, Stewart AK, Doherty GM, Haymart MR: "Surgeon Training and Use of Radioactive Iodine in Stage I Thyroid Cancer Patients."  Annals of Surgical Oncology, 20:733-738, 2013, PMC3667416.
  • Schwartz JL, Bichakjian CK, Lowe L, Griffith KA, Frohm ML, Fullen DR, Hayman JA, Lao CD, Shah KS, McLean SA, Bradford CR, Johnson TM, and Wong SL: "Clinicopathologic features of primary Merkel cell carcinoma: A Large, contemporary, prospective, single-institution experience."  Dermatol Surg, 39(7):1009-1016, 2013
  • Sen A, Ren J, Ruffin MT, Turgeon DK, Brenner DE, Sidahmed E, Rapai ME, Cornellier ML, Djuric Z: "Relationships between serum and colon concentrations of carotenoids and fatty acids in randomized dietary intervention trial".  Cancer Prev Res, 6(6): 558-65, 2013.
  • Sheetz KH, Zhao L, Holcombe SA, Wang SC, Reddy RM, Lin MB, Orringer MB and Chang A: "Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer." Dis Esophagus, 26(7): 716-22, 2013.
  • Shenoy A, Goodsitt M, Shen J, Schipper MJ, Dewaraja J: "Investigation of Factors Affecting the Accuracy of a Dual Energy Quantitative CT Method for Estimating Regional Bone Marrow Cellularity."  Med Phys, 40:525, 2013.
  • Sottnik JL, Daignault-Newton S, Zhang X, Morrissey C, Hussain MH, Keller ET, Hall CL: "Integrin alpha2 beta 1 (α 2β 1) promotes prostate cancer skeletal metastasis."  Clin Exp Metastasis, 30(5): 569-78, 2013, PMC in process.
  • Spector ME, Gallagher KK, Bellile E, Chinn SB, Ibrahim M, Byrd S, Chanowski EJ, Walline HM, Moyer JS, Prince ME, Wolf GT, Bradford CR, McHugh JB, Cordell K, Carey T, Worden FP, Eisbruch A, Chepeha DB: "Patterns of Nodal Metastasis and Prognosis in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma."  Head and Neck, eprint, 2013.
  • Strong EA, DeCastro R, Sambuco D, Stewart A, Ubel PA, Griffith KA, Jagsi R: "Work-life Balance in Academic Medicine: Narratives of Physician-Researchers and Their Mentors."  J Gen Int Med, 28(12):1596-1603, 2013.
  • Sueyoshi R, Ignatoski KMW, Daignault S, Okawada M, Teitelbaum DH: "Angiotensin Converting Enzyme-Inhibitor Reduces Colitis Severity in an il-10 Knockout Model."  Digestive Diseases & Sci, 58(11):3165-77, 2013.
  • Taylor JMG, Park Y, Ankerst DP, Proust-Lima C, Williams S, Kestin L, Bae K, Pickles T, Sandler H: "Real-Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models."  Biometrics, 69(1): 206–213, 2013, PMC3622120.
  • Thall PF, Nguyen HQ, Braun TM, Qazilbash MH: "Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule-Dose Regimes."  Biometrics, 69(3):673-682, 2013.
  • Vainshtein JM, Schipper MJ, Zalupski MM, Lawrence TS, Abrams R, Francis IR, Khan G, Leslie W, Ben-Josef E: "Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study."  Int J Radiat Oncol Biol Phys, 86(1):96-101, 2013, PMC3646633.
  • Valdez CD, Kunju L, Daignault S, Wojno KJ, Day ML: "The E2F1/DNMT1 Axis is Associated with the Development of AR Negative Castration Resistant Prostate Cancer."  Prostate, 73(16):1776-85, 2013.
  • Van Tubergen EA, Banerjee R, Liu M, Vander Broek R, Light E, Kuo S, Feinberg SE, Willis AL, Wolf G, Carey T, Bradford C, Prince M, Worden FP, Kirkwood KL, D'Silva NJ: "Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6."  Clin Cancer Res, 19(5):1169-79, 2013, PMC3594656.
  • VanderVeen N, Paran C, Krasinkiewicz J, Zhao L et al: "Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a Phase I clinical trial for glioma". Hum Gene Ther Clin Dev, 24(3):116-26, 2013.
  • Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong CH, Wang H, Chin A, Gomez A, Harris AC, Levine JE, Choi SW, Couriel D, Reddy P, Ferrara JL, Paczesny S: "ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death".  N Engl J Med, 369(6):529-39, 2013.
  • Wang W, Xu Y, Schipper M, Matuszak MM, Ritter T, Cao Y, TenHaken R, Kong FM: " Effect of Normal Lung Definition on Lung Dosimetry and Lung Toxicity Prediction in Radiotherapy Treatment Planning."  Int J Radiat Oncol Biol Physics 86(5): 956-963, 2013, PMC4028143.
  • Walline H, Komarck C, McHugh J, Byrd S, Spector M, Hauff S, Graham M, Bellile E, Moyer J, Prince M, Wolf G, Chepeha D, Worden F, Stenmanrk M, Eisbruch A, Bradford C, Carey T: "High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and, oral cavity cancers: Comparison of multiple methods."   JAMA Otolaryngol Head Neck Surg, 139(12):1320-27, 2013.
  • Wei D, Parsels LA, Karnak D, Davis MA, Parsels JD, Marsh AC, Zhao L, Maybaum J, Lawrence TS, Sun Y, Morgan MA: "Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repair."  Clin Cancer Res, 19(16):4422-32, 2013, PMC3754450.
  • Westgate PM, Braun TM: "An improved quadratic inference function for parameter estimation in the analysis of correlated data".  Stat Med, 32(19):3260-73, 2013, PMC in process.
  • Yuan ST, Ellingrod VL, Schipper M, Stringer KA, Cai X, Hayman JA, Yu J, Lawrence TS, Kong FM: "Genetic Variations in TGFβ1, tPA, and ACE and Radiation-Induced Thoracic Toxicities in Patients with Non-Small-Cell Lung Cancer."  J Thorac Oncol, 8(2):208-13, 2013, PMC 3646090.
  • Zebrack B, Block R, Hayes-Lattin B, Embry L, Aguilar C, Meeske KA, Li Y, Butle M and Cole S: "Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients."  Cancer, 119(1):201-14, 2013.
  • Zhang J, Braun TM: "A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients".  J AM Stat Assoc, 108(503): 2013, PMC3821780.
  • Zhang J, Braun TM, Taylor JMG: "Adaptive Prior Variance Calibration in the Bayesian Continual Reassessment Method."  Stat Med, 32(13):2221-34, 2013, PMC3561509.
  • Zhang Q, Bhojani MS, Josef EB, Spalding AC, Kuick R: "Glycogen Synthase Kinase 3beta in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy."  J Carcinogene Mutagene 4(147): 2, 2013.
  • Zick SM, Sen A, Han-Markey TL, Harris RE: "Examination of the association of diet and persistent cancer-related fatigue: a pilot study."  Oncol Nurs Forum, 40(1):e41-9, 2013.
  • Zick SM, Zwickey H, Wood L, Foerster B, Khabir T, Wright B, Ichesco E, Sen A, Harris RE: "Preliminary differences in peripheral immune markers and brain metabolites between fatigued and non-fatigued breast cancer survivors: a pilot study."  Brain Imaging Behav, eprint 2013.
  • Zhou J, Griffith KA, Hawley ST, Zikmund-Fisher BJ, Janz NK, Sabel MS, Katz SJ, Jagsi R: "Surgeons' knowledge and practices regarding the role of radiation therapy in breast cancer management."  Int J Radiat Oncol Biol Phys. 87(5):1022-9, 2013, PMC in process.

  • Akinyemiju TF, Soliman AS, Yassine M, Banerjee M, Schwartz K, Merajver SD: "Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study."  Intl J Equity in Health, 11:16, 2012.
  • Alva A, Slovin S, Daignault S, Carducci M, Dipaola R, Pienta K, Agus D, Cooney K, Chen A, Smith DC, et al: "Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735.  A study by the DOD/PCF prostate cancer clinical trials consortium."  Invest New Drugs 30(2):749-57, 2012.PMC3175265.
  • Banerjee M, Ding Y, Noone AM: "Identifying Representative Trees from Ensembles."  Stat Med, 31:1601-1616, 2012
  • Ben-Josef E, Schipper M, Francis IR, Hadley S, Ten-Haken R, Lawrence T, Normolle D, Simeone DM, Sonnenday C, Abrams R, Leslie W, Khan G, Zalupski MM: "A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation with Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients with Unresectable Pancreatic Cancer."  Int J Radiat Oncol Biol Phys, 84(5):1166-7, 2012, PMC3421048.
  • Ben-Josef E, Taylor JMG, Lawrence TS: "Radiotherapy Improves Survival in Unresectable Pancreatic Cancer: Small Trial but Big (and Credible) Results."  J Clin Oncol 30(13): 1565-6, 2012, PMC in process.
  • Bhadra D,  Daniels,MJ, Kim S, Ghosh M, Mukherjee B: "A Bayesian Semiparametric Approach for Incorporating Longitudinal Information on Exposure History for Inference in Case–Control Studies."  Biometrics, 68, 361-370, 2012.
  • Boyd AD, Brown D, Henrickson C, Hampton J, Zhu B, Almani F, Ben-Josef E, Zalupski M, Simeone DM, Taylor JMG, Armitage R, Riba M: "Screening for depression, sleep-related disturbances, and anxiety in patients with adenocarcinoma of the pancreas: A preliminary study," Scientific World Journal, vol. 2012, Article ID 650707, 6 pages, 2012. PMC3366237.
  • Braun TM, Kang S, Taylor JMG: "A Phase I/II Trial Design when Response is Unobserved in Subjects with Dose-Limiting Toxicity."  Stat Meth Medical Research, eprint, 2012, PMC4096077.
  • Choi YH, Hu H, Tak S, Mukherjee B, Park SK: "Occupational noise exposure assessment using O*NET and its application to a study of hearing loss in the US general population."  Occup Environ Med 69(3):176-83, 2012, PMC3277688.
  • Choi SW, Stiff P, Cooke K, Ferrara JL, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE: "TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes".  Biol Blood Marrow Transplant. 18(10):1525-32, 2012, PMC3443302.
  • Colacino JA, Arthur AE, Dolinoy DC, Sartor MA, Duffy SA, Chepeha DB, Bradford CR, Walline HM, McHugh JB, D'Silva N, Carey TE, Wolf GT, Taylor JMG, Peterson KE, Rozek LS: "Dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas." Epigenetics 7(8): 883-891, 2012.
  • Djuric Z, Ren J, Brown PR, Ellsworth JS, Sen A: "Lifestyle factors associated with serum N-3 fatty acid levels in breast cancer patients."  Breast, 21(4):608-11, 2012, PMC3368994.
  • Djuric Z, Ruffin MT 4th, Rapai ME, Cornellier ML, Ren J, Ferreri TG, Askew LM, Sen A, Brenner DE, Turgeon DK: "A Mediterranean dietary intervention in persons at high risk of colon cancer: recruitment and retention to an intensive study requiring biopsies".  Contemp Clin Trials, 33(5):881-8, 2012, PMC3408796.
  • El-Zaatari M, Daignault S, Tessier A, Kelsey G, Travnikar LA, Cantu EF, Lee J, Plonka CM, Simeone DM, Anderson MA, et al: "Plasma shh levels reduced in pancreatic cancer patients."  Pancreas, 41(7): 1019-28, 2012, PMC3404255.
  • Erman AB, Collar RM, Griffith KA, Lowe L, Sabel MS, Bichakjian CK, Wong SL, McLean SA, Rees RS, Johnson TM, Bradford CR: "Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma".  Cancer, 118(4):1040-7, 2012.
  • Feng M, Normolle D, Pan CC, Dawson LA, Amarnath S, Ensminger WD, Lawrence TS, Ten Haken RK: "Dosimetric Analysis of Radiation-induced Gastric Bleeding."  Int J Radiat Oncol Biol Phys 84(1):e1-e6, 2012, PMC3423508.
  • Feng M. Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR,Chen J, Ensminger W, Lawrence TS: "A Phase I Clinical and Pharmacology Study Using Amifostine as a Radioprotector in Dose-escalated Whole Liver Radiation Therapy."  Int J Radiat Oncol Biol Phys, 83(5): 1441-7, 2012, PMC3383372.
  • Friese CR, Pini TM, Li Y, Abrahamse PH, Graff JJ, Hamilton AS, Jagsi R, Janz NK, Hawley ST, Katz SJ, Griggs JJ: "Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer."  Breast Cancer Research and Treatment, 138(3): 931-939, 2013.
  • Galbán CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, Galbán S, Rehemtulla A, Kazerooni EA, Martinez FJ, Ross BD: "Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression."  Nat Med, 18(11):1711-5, 2012, PMC3493851.
  • Galbán S, Lemasson B, Williams TM, Li F, Heist KA, Johnson TD, Leopold JS, Chenevert TL, Lawrence TS, Rehemtulla A, Mikkelsen T, Holland EC, Galban CJ, Ross BD: "DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma."  PLoS ONE 7(4): e35857, 2012, PMC3334987.
  • Ghosh D: "A causal framework for surrogate endpoints with semi-competing risks data."  Stat Probab Lett, 82(11):1898-1902, 2012, PMC3418330.
  • Ghosh D, Taylor JMG, Sargent DJ: "Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling."  Biometrics 68(1): 226-32, 2012, NIHMS #296716.
  • Ghosh M, Song J, Forster JJ, Mitra R, Mukherjee B: "On the equivalence of posterior inference based on retrospective and prospective likelihoods: application to a case-control study of colorectal cancer."  Stat Med 31, 2196, 2012.
  • Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, Daignault S, Thomas DG, Gudjonsson JE, Elder JT, Dlugosz AA, Johnson TM, Fullen DR, Bichakjian CK "Distinct Gene Expression Profiles of Viral- and Nonviral-Associated Merkel Cell Carcinoma Revealed by Transcriptome Analysis."  J Invest Dermatol. Epub, 2012.
  • Harris AC, Ferrara JL, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Landfried K, Akashi K, Vander Lugt M, Couriel DR, Reddy P, Paczesny S: "Plasma biomarkers of lower gastrointestinal and liver acute GVHD."  Blood, 119(12):2960-3, 2012, PMC3327467.
  • He S, Wang J, Kato K, Xie F, Varambally S, Mineishi S, Kuick R, Mochizuki K, Liu Y, Nieves E, Mani RS, Chinnaiyan AM, Marquez VE, Zhang Y: "Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells."  Blood, 119(5):1274-82, 2012.
  • Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP, et al: "Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin."  Am J Pathol, 181(3):1017-33, 2012, PMC3432433.
  • Hoff BA, Bhojani MS, Rudge J, Chenevert TL, Meyer CR, Galbán S, Johnson TD, Leopold JS, Rehemtulla A, Ross BD, Galbán CJ: "DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model."  NMR Biomed, 25(7):935-42, 2012.
  • Hu M, Zhu MY, Taylor JMG, Liu JS, Qin Z: "Using Poisson mixed-effects model to quantify exon-level gene expression in RNA-Seq."  Bioinformatics, 28(1): 63-68, 2012, PMC3244770.
  • Hunter KU, Feng FY, Griffith KA, Francis IR, Lawrence TS, Desai S, Murphy JD, Zalupski MM, Ben-Josef E: "Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer".  Intl J Radiat Oncol Biol Physics, 84(3):921-6, 2012.
  • Hunter KU, Vineberg KA, Schipper M, McShan DL, Antonuk AE, Cornwall C, Feng M, Balter JM, Eisbruch A: "The Effect of Differences in Planned and Delivered Parotid Doses on Salivary Output."  Intl J Radiat Oncol Biol Physics, 84(3): 2012
  • Imai A, Zeitlin BD, Visioli F, Dong Z, Zhang Z, Krishnamurthy S, Light E, Worden F, Wang S, Nör JE: "Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects."  Cancer Res, 72(3): 716-25, 2012
  • Jagsi R, Griffith KA, Stewart A, Sambuco D, DeCastro R, Ubel PA: "Gender Differences in Salaries of Physician Researchers."  JAMA, 307(22):2410-7, 2012.
  • Jakubowiak AJ, Dytfeld D, Griffith KA, Lebovic D, Vesole DH, Jagannath S, Al-Zoubi A, Anderson T, Nordgren B, Detweiler-Short K, Stockerl-Goldstein K, Ahmed A, Jobkar T, Durecki DE, McDonnell K, Mietzel M, Couriel D, Kaminski M, Vij R: "A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma".  Blood, 120(9):1801-9, 2012.
  • Johnson TD, Liu Z, Bartsch AJ, Nichols TE: "A Bayesian non-parametric Potts model with application to pre-surgical fMRI data."  Statistical Methods in Medical Research, early online, DOI:10.1177/0962280212448970, 2012.
  • Jorns JM, Visscher D, Sabel M, Breslin T, Healy P, Daignaut S, Myers JL, Wu AJ: "Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center."  Am J Clin Pathol, 138(5):657-69, 2012, PMC3988579.
  • Jung Y, Shiozawa Y, Wang J, McGregor N, Dai J, Park SI, Berry JE, Havens AM, Joseph J, Kim JK, Patel L, Carmeliet P, Daignault S, Keller ET, McCauley LK, Pienta KJ, Taichman RS: "Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment."  Neoplasia, (5):429-39, 2012, PMC3384430.
  • Kaciroti NA, Raghunathan TE, Taylor JMG, Julius S: "A Bayesian model for time-to-event data with informative censoring."  Biostatistics 13(2): 341-54, 2012, PMC3297827.
  • Kidwell KM, Yothers G, Ganz PA, Land SR, Ko CY, Cecchini RS, Kopec JA, Wolmark N: "Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01".  Cancer, 118(22):5614-22, 2012, PMC4131537.
  • Kiel MJ, Velusamy T, Betz  BL, Zhao L, Weigelin  HG , Chiang  MY et al. " Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma." J Exp Med 209(9) 1553-65, 2012, PMC3428949
  • Kim SH, Chen G, King AN, Jeon CK, Christensen PJ, Zhao L et al. "Characterization of Vitamin D Receptor (VDR) in Lung Adenocarcinama." Lung Cancer, 77(2):265-271, 2012, PMC3396768
  • Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarsky J, Wicha M,   Liu R, Zou W: "Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells."  Intl J Cancer, 130:29-39, 2012.
  • Lee F, Badalament RA, Chen H, Bousho I, Tsodikov A: Prostate Cancers Detected During 5α-Reductase Inhibitor Use Are Smaller, De-Differentiated, But Confined when Compared To Controls."  J Cancer, 3:122-8, 2012.
  • Lee O, Braun TM: "Permutation tests for random effects in linear mixed models."  Biometrics, 68:(2) 486-93, 2012, NIHMS539136.
  • Miller BS, Ignatoski KM, Daignault S, Lindland C, Doherty M, Gauger PG, Hammer GD, Wang SC, Doherty GM; University of Michigan Analytical Morphomics Group: "Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma."  World J Surg, 36(7):1509-16, 2012.
  • Mukherjee B, Ahn J, Gruber SB, Chatterjee N: "Testing gene-environment interaction in large-scale case-control association studies: possible choices and comparisons."  Am J Epidemiol, 175(3):177-90, 2012, PMC3286201.
  • Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB; GEM Study Investigators: "Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers."  J Natl Cancer Inst, 104(12):953-6, 2012, PMC3379723.
  • Ouillette P, Li J, Shaknovich R, Li Y, Melnick A, Shedden K, Malek SN: "Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia."  Genes Chromosomes Cancer 51(12): 1125-32, 2012, PMC3465492.
  • Pak D, Vineberg KA, Griffith KA, Sabolch A, Chugh R, Ben-Josef E, Biermann JS, Feng M: "Dose--effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity".  Intl J Radiat Oncol Biol Phys, 83(4):1257-63, 2012.
  • Pang J, Toy KA, Griffith KA, Awuah B, Quayson S, Newman LA, and Kleer CG: "Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression."  Breast Can Res Treat: 135:59-66, 2012, PMC3906643.
  • Park SI, Laio J, Berry JE, Li X, Koh AJ, Michalski ME, Eber MR, Soki FN, Sadler D, Sud S, Tisdelle S, Daignault SD, Nemeth JA, Snyder LA, Wronski TJ, Pienta KJ, McCauley LK: : "Cyclophosphamide Creates a receptive Microenvironment for Prostate Cancer Skeletal Metastasis."  Cancer Res, 72(10): 2522-32, 2012
  • Park Y, Taylor JMG and Kalbfleisch JD: "Constrained Nonparametric Maximum Likelihood Estimation of Stochastically Ordered Survivor Functions."  Canad J Statist, 40: 22-39, 2012.
  • Park, Y, Taylor JMG, Kalbfleisch J: "Pointwise Nonparametric Maximum Likelihood Estimator of Stochastically Ordered Survivor Functions".  Biometrika 99(2): 327-343, 2012 PMC3635706.
  • Park H, Wood D, Hussain H, Meyer CR, Shah RB, Johnson TD, Chenevert T, Piert M: "Introducing parametric PET/MR fusion imaging of primary prostate cancer."  J Nuclear Medicine 53(4), 546-551, 2012.
  • Pini M, Hawley S, Li Y, Katz S and Griggs J: "The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy."  Breast Cancer Research and Treatment, 134(2):867-74, 2012.
  • Poisson LM, Sreekumar A, Chinnaiyan AM, Ghosh D: "Pathway-directed weighted testing procedures for the integrative analysis of gene expression and metabolomic data."  Genomics, 99:(5), 265-74, 2012.
  • Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, Daignault S, Al-Mulla F, Keller E, Bonavida B, de la Serna I, Yeung KC: "Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer."  Cancer Res, 72(12):3091-104, 2012.
  • Roca H, Craig MJ, Ying C, Varsos ZS, Czarnieski P, Alva AS, Hernandez J, Fuller D, Daignault S, Healy PN, et al: "IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation."  J Cell Biochem, 113(5): 1569-80, 2012, PMC3337359.
  • Sabel MS, Rice JD, Griffith KA, Lowe L, Wong SL, Chang AE, Johnson TM, Taylor JMG: "Validation of Statistical Predictive Models Meant to Select Melanoma Patients for Sentinel Lymph Node Biopsy."  Annals of Surgical Oncology,19(1):287-293, 2012, PMC in process.
  • Sabolch A, Feng, M, Griffith KA, Rzasa C, Gadzala L,Feng F, Biermann JS, Chugh R, Ray M, Ben-Josef E: "Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity."  Am J Clin Oncol, 35(2): 151-7, 2012, PMC in process.
  • Sánchez BN, Kang S, Mukherjee B: "A latent variable approach to study gene-environment interactions in the presence of multiple correlated exposures."  Biometrics, 68(2):466-76, 2012.
  • Sarkar S, Johnson TD, Ma B, Park H, Bland P, Chenvert T, Ross B, Meyer C: "Evaluation of an image registration-based algorithm for measuring volume change in breast tumors."  Intl J Radiat Oncol Biol Physics, 83(3):1038-46, 2012
  • Schipper MJ, Koral KF, Avram AM, Kaminski MS, Dewaraja YK: "Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activity."  Cancer Biother Radiopharm, 27(7):403-11, 2012, PMC3432867.
  • Schiefelbein E, Zekri AR, Newton DW, Soliman GA, Banerjee M, Hung ChW, Seifeldin IA, Lo AC, Soliman AS: "Hepatitis C virus and other risk factors in hepatocellular carcinoma."  Acta Virol, 56(3):235-40, 2012.
  • Schlichting J, Soliman A, Schairer C, Banerjee M, Rozek L, Schottenfeld D, Harford J, Merajver S: "Association of Inflammatory and Non-Inflammatory Breast Cancer with Socioeconomic Characteristics in the Surveillance, Epidemiology, and End Results Database, 2000-2007."  Cancer Epidemiology, Biomarkers, and Prevention, 21:155-165, 2012.
  • Schneider BJ, Kalemkerian GP, Bradley D, Smith DC, Egorin MJ, Daignault S, Dunn R, Hussain M: "Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies."  Invest New Drugs, (1):249-57, 2012,
  • Schteingart DE, Sinsheimer JE, Benitez RS, Homan DF, Johnson TD, Counsell RE: "Structural requirements for Mitotane activity. Development of analogs for treatment
  • of adrenal cancer."  Anticancer Research 32 2711-2720, 2012.
  • Schuetze SM, Zhao L, Chugh R et al. "Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcoma." Eur J Cancer, 48(9):1347-53, 2012.
  • Shedden K, Li Y, Ouillette P, Malek SN: "Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34."  Leukemia 26(5): 1108-10, 2012, PMC in process.
  • Shuman AG, Shuman EK, Hauff SJ, Fernandes LL, Light E, Chenoweth CE, Bradford CR. "Preoperative topical antimicrobial decolonization in head and neck surgery."  Laryngoscope. 122(11):2454-60, 2012, PMC in process.
  • Shuman AG, Terrell JE, Light E, Wolf GT, Bradford CR, Chepeha D, Jiang Y, McLean S, Ghanem TA, Duffy SA: "Predictors of pain among patients with head and neck cancer."  Arch Otolaryngol Head Neck Surg, 138(12):1147-54, 2012.
  • Song L, Northouse L, Zhang L, Braun T, Cimprich B, Ronis D, Mood D: "Study of dyadic communication in couples managing prostate cancer: a longitudinal perspective."  Psychooncology, 21(1):72-81, 2012.
  • Soto DE, Passarelli MN, Daignault S, Sandler HM: "Concurrent Androgen Deprivation Therapy During Salvage Prostate Radiotherapy Improves Treatment Outcomes in High-Risk Patients."  Int J Radiat Oncol Biol Phys, 82(3): 1227-32, 2012, PMC3904219.
  • Sottnik JL, Daignault-Newton S, Zhang X, Morrissey C, Hussain MH, Keller ET, Hall CL. "Integrin alpha(2)beta(1) (α (2)β (1)) promotes prostate cancer skeletal metastasis."  Clin Exp Metastasis, 2012.
  • Spector ME, Gallagher KK, Light E, Ibrahim M,  Chanowski EJ,  Moyer JS, Prince ME, Wolf GT, Bradford CR, Cordell K,  McHugh JB, Carey T, Worden FP, Eisbruch A, Chepeha DB; University of Michigan Head Neck Specialized  Program of Research Excellence (SPORE) Program: "Matted Nodes: Poor Prognostic Marker in Oropharyngeal Squamous Cell Carcinoma Independent of HPV and EGFR Status."  Head Neck, 34(12): 1727-33, 2012, PMC3424373.
  • Stenmark MH, Cai X, Shedden K, Hayman JA, Yuan S, Ritter T, Ten Haken RK, Lawrence TS, Kong FMS: "Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy."  Int J Radiat Oncol Biol Phys, 84(2): e217-22, 2012.
  • Teman NR, Silski L, Zhao L, Kober M, Urba SC, Orringer MB, Chang AC, Lin J, Reddy RM: "Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes."  Ann Thorac Surg, 94(4):1118-25, 2012, PMC in process.
  • Tsien CI, Brown D, Normolle D, Schipper M, Morand P, Junck L, Heth JA, Gomez-Hassan D, Ten-Haken R, Chenevert TL, Cao Y, Lawrence TS: "Concurrent Temozolomide and Dose-Escalated Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma." Clin Cancer Res. 18(1):273-9, 2012, PMC3266840.
  • Vainshtein J, Abu-Isa E, Olson KB, Ray ME, Sandler HM, Normolle D, Litzenberg DW,Masi, K, Pan, C, Hamstra DA: "Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy."  Radiat Oncol 7(82):1-, 2012, PMC3408353
  • Venkatesha VA, Parsels LA, Parsels JD, Zhao L, Zabludoff SD, Simeone DM, Maybaum J, Lawrence TS, Morgan MA: "Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition."  Neoplasia, 14(6): 519-25, 2012.
  • Wang C, Sen A, Ruffin MT 4th, Nease DE Jr, Gramling R, Acheson LS, O'Neill SM, Rubinstein WS; Family Healthware™ Impact Trial (FHITr) Group: "Family history assessment: impact on disease risk perceptions".  Am J Prev Med, 43(4):392-8, 2012, PMC3448124.
  • Wansom D, Light E, Dafydd T, Worden F, Prince M, Urba S, Chepeha D, Kumar B, Eisbruch A, Taylor JMG, Moyer J, Wolf G: "Infiltrating lymphocytes and Human Papillomavirus-16 associated oropharyngeal cancer."  The Laryngoscope, 122:121-127, 2012, PMC3244770.
  • Westgate PM, Braun TM: "The effect of cluster size imbalance and covariates on the estimation performance of quadratic inference functions".  Stat Med, 31(20):2209-22, 2012.
  • Wu J, Johnson TD, Galban CJ, Chenevert TL, Meyer CR, Rehemtulla A, Hamstra DA, Ross BD: "Predicting treatment efficacy via quantitative MRI: a Bayesian Joint Model."  JRSSC 61(1), 83-98, 2012. NIHMS321498.
  • Yanik GA, Mineishi S, Levine JE, Kitko CL, White ES, Vander Lugt MT, Harris AC, Braun T, Cooke KR: "Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation."  Biol Blood Marrow Transplant, 18(7):1044-54, 2012.
  • Zhao L, M. Banerjee: "Bayesian piecewise mixture model for racial disparity in prostate cancer." CSDA, 56(2):362-369, 2012.
  • Zhao L, Taylor JMG, Schuetze SM: "Bayesian Decision Theoretic Two-Stage Design in Phase II Clinical Trials with Survival Endpoint."  Stat Med, 31(17): 1804-1820, 2012, PMC4167619.
  • Zick SM, Wyatt GK, Murphy SL, Arnedt JT, Sen A, Harris RE: "Acupressure persistent cancer-related fatigue in breast cancer survivors (AcuCrft): a study protocol for a randomized controlled trial".  BMC Complementary and Alternative Medicine, 12:132, 2012.

  • Abuzeid WM, Davis S, Tang AL, Saunders L, Brenner JC, Lin J, Fuchs JR, Light E, Bradford CR, Prince ME, Carey TE: "Sensitization of head and neck cancer to Cisplatin through the use of a novel curcumin analog." Arch otolaryngology--head & neck surg, 2011:137(5):499-507, PMC3298372
  • Ahn J, Mukherjee B, Gruber SB, Sinha S: "Missing exposure data in stereotype regression model: application to matched case-control study with disease subclassification." Biometrics 67(2): 546-58, 2011, PMC3119773
  • Arthur AE, Duffy SA, Sanchez GI, Gruber SB, Terrell JE, Hebert JR, Light E, Bradford CR, D'Silva NJ, Carey TE, Wolf GT, Peterson KE, Rozek LS: "Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysis." Nutr Cancer 63(5):734-42, 2011
  • Banerjee R, Henson BS, Russo N, Tsodikov A, D'Silva NJ: "Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma." Cellular signaling, 23(7):1110-8, 2011, PMC3090707
  • Bhojani S, Nyati M, Zhao L, Normolle D Lawrence T, Rehemtulla A: "Molecular imaging of Akt enables early prediction of molecularly targeted therapy response." Translational Oncology, 4(3): 122-5, 2011, PMC3104693
  • Boonstra PS, Mukherjee B, Taylor JMG, Nilbert M, Moreno VM, Gruber SB: "Bayesian Modeling for Genetic Anticipation in Presence of Mutational Heterogeneity: A Case Study in Lynch Syndrome." Biometrics 67(4): 1627-1637, 2011, PMC in process.
  • Bradley DA, Daignault S, Ryan CJ, Dipaola RS, Cooney KA, Smith DC, Small E, Mathew P, Gross ME, Stein MN, Chen A, Pienta KJ, Escara-Wilke J, Doyle G, Al-Hawary M, Keller ET, Hussain M: Erratum to: "Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium." Invest New Drugs 29(6):1432-40, 2011, PMC2917503
  • Braun TM, Alonzo TA: "Beyond the 3+3 method: expanded algorithms for dose escalation in Phase I oncology trials of two agents." Clin Trials 8(3):247-59, 2011, PMC in process.
  • Cai, XW: Shedden, KA: Yuan, SH: Davis, MA: Xu, LY: Xie, CY: Fu, XL: Lawrence, TS: Lubman, DM: Kong, FM Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer.
  • J Thorac Oncol 6(6):1073-8, 2011
  • Chen G, Kim SH, King AN, Zhao L, Simpson RU, Christensen PJ, Wang Z, Thomas DG, Giordano TJ, Lin L, Brenner DE, Beer DG, Ramnath N: "CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma." Clin Can Res, 17(4):817-26, 2011, PMC3058389.
  • Chen G, Kim S, Taylor JMG, Wang Z, Lee O, Ramnath N, Reddy RM, Lin J, Chang AC, Orringer MB, Beer DG: "Development and Validation of a qRT-PCR Classifier for Lung Cancer Prognosis." Journal of Thoracic Oncology, 6(9):1481-1487, PMC3167380.
  • Chenevert TL, Galbán CJ, Ivancevic MK, Rohrer SE, Londy FJ, Kwee TC, Meyer CR, Johnson TD, Rehemtulla A, Ross BD: "Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies." J Magn Reson Imaging, 34(4):983-7, 2011, PMC3177164
  • Conlon A, Taylor JMG, Sargent D, Yothers G: "Using Cure Models and Multiple Imputation to Utilize Recurrence as an Auxiliary Variable for Overall Survival." Clin Trials, 8(5): 581-90, 2011 PMCID: PMC3197975.
  • Davis SJ, Zhao L, Chang AC, Orringer MB: "Refractory cervical esophagogastric anastomotic strictures: management and outcomes." J thoracic and cardiovascular surg, 141(2):444-8, 2011
  • de Lima M, Giralt S, Thall PF, de Padua SL, Jones RB, Komanduri K, Braun TM, Nguyen HQ, Champlin R, Garcia-Manero G: "Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: A dose and schedule finding study." Cancer 116(23):5420-31, 2011, PMID 20672358
  • Dytfeld D, Griffith KA, Friedman J, Lebovic D, Harvey C, Kaminski MS, Jakubowiak AJ: "Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial." Leuk Lymphoma 52(7): 1271-80, 2011, PMC in process
  • Filson CP, Banerjee M, Wolf JS, Ye Z, Wei JT,Miller DC: "Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy." J Urol 2011:185(6):2072-7, PMC3093437.
  • Foster, JC, Taylor, JMG, and Ruberg, SJ: "Subgroup Identification from Randomized Clinical Trial Data." Stats in Med, 30(24): 2867-80, 2011.
  • Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck L, Sundgren PC, Johnson TD, Galbán S, Sebolt-Leopold JS, Rehemtulla A, Ross BD: "Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment." Clin Cancer Res, 17(14):4751-60, 2011, PMC3139775
  • Gilbert SF, Soliman AS, Iniesta M, Eissa M, Hablas A, Seifeldin IA, Strahley A, Banerjee M, Merajver SD" "Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients." Breast Cancer Res. Treat. 129, 5750 (2011)
  • Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR, Ben-Josef E: "Role of radiotherapy in the management of desmoid tumors." Intl J radiat oncol biol physics, 2011:80(3):787-92
  • Halverson S, Schipper M, Blas K, Lee V, Sabolch A, Olson K, Sandler HM, Feng FY, Hamstra DA : "The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse." Radiother Oncol, 101(3):513-20, 2011, PMID:21703711 PubMed - in process
  • Hipp J, Cheng J, Daignault S, Sica J, Dugan MC, Lucas D, Yagi Y, Hewitt S, Balis UJ: "Automated area calculation of histopathologic features using SIVQ." Anal Cell Pathol, 34(5):265-75, 2011
  • Jakubowiak AJ, Griffith KA, Reece DE, Hofmeister CC, Lonial S, Zimmerman TM, Campagnaro EL, Schlossman RL, Laubach JP, Raje NS, Anderson T, Mietzel MA, Harvey CK, Wear SM, Barrickman JC, Tendler CL, Esseltine DL, Kelley SL, Kaminski MS, Anderson KC, Richardson PG: "Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial." Blood 118(3):535-43, 2011, PMC3142898.
  • Jia N, Braun TM: "The Adaptive Accelerated Biased Coin Design for Phase I Clinical Trials." Journal of Applied Statistics, 12:2911-24, 2011.
  • Kennedy EH, Taylor JMG, Schaubel DE, Williams SG: "The effect of salvage therapy on survival in a longitudinal study with treatment by indication." Stats in Med, 29(25): 2569-2580, 2011, PMC2962719.
  • Lao CD, Johnson T, Sondak VK, Lowe L, Kim DSL, Zhao L, Naftanel M, Olsen S, Brenner DE: "Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model." J Amer Acad Dermatology 2011:64(6):1188-90, PMC3095910
  • Li Y, Taylor JMG, Little RJ: "A Shrinkage Approach for Estimating a Treatment Effect Using Surrogate Marker Data in Clinical Trials." Biostatistics, 67(4): 1434-41, 2011, PMC3365575.
  • Li Y, Taylor JMG, Elliot MR, Sargent D: ""Causal Assessment of Surrogacy in a Meta Analysis of Colorectal Cancer Trials" Biostatistics, 12(3):478-92, 2011.
  • Lin Z, Simeone DM, Anderson MA, Brand RE, Xie X, Shedden KA, Ruffin MT,Lubman DM: "Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer." J Proteome research 2011:10(5):2602-11, PMC3090531
  • Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch A: "Reducing Xerostomia After Chemo-IMRT for Head-and-Neck Cancer: Beyond Sparing the Parotid Glands." Int J Radiat Oncol Biol Phys. 83(3):1007-14, 2012, PMC3288420
  • Miller BS, Ignatoski KM, Daignault S, Lindland C, Gauger PG, Doherty GM, Wang SC; University of Michigan Analytical Morphomics Group: "A quantitative tool to assess degree of sarcopenia objectively in patients with hypercortisolism." Surgery, 150(6):1178-85, 2011.
  • Mukherjee B, Rennert G, Ahn J, Dishon S, Lejbkowicz F, Rennert HS, Shiovitz S, Moreno V, Gruber SB: "High Risk of Colorectal and Endometrial Cancer in Ashkenazi Families With the MSH2 A636P Founder Mutation." Gastroenterology 2011:140(7):1919-26
  • Murdoch-Kinch, CA, Russo N, Griffith S, Braun T, Eisbruch A, D'Silva NJ: "Recovery of salivary epidermal growth factor in parotid saliva following parotid sparing radiation therapy: A proof-of-principle study." Oral Surg, Oral Med, Oral Pathol, Oral Radiol, & Endodontology, 111(1): 64-70, 2011
  • Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, Talpaz M, Kaminski M, Li C, Shedden K, Malek SN: "Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia." Blood 118(11):3051-61, 2011, PMC3175782.
  • Ouillette P, Collins R, Shakhan S, Li J, Li C, Shedden K, Malek SN: "The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia." Clin Cancer Res 17: 677-80, 2011, PMC3207001
  • Parsels LA,Qian Y, Tanska DM, Gross M, Zhao L, Hassan MC, Arumugarajah S, Parsels JD, Hylander-Gans L, Simeone DM, Morosini D, Brown JL, Zabludoff SD, Maybaum J, Lawrence TS, Morgan MA: "Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition." Clinical can res, 2011:17(11):3706-15, PMC3107893.
  • Peng Y, Taylor JMG: "Mixture Cure Model with Random Effects for the Analysis of a Multi-Centre Tonsil Cancer Study." Stats in Med, 30(3): 211-23, 2011.
  • Poisson L, Taylor JMG, Ghosh D: ""Integrative set enrichment testing for multiple omics platforms." BMC Bioinformatics, 12:459, 2011.
  • Proust-Lima C, Taylor JMG, Secher S, Sandler H, Kestin L, Pickles T, Bae K, Allison R, Williams S: "Confirmation of a low alpha/beta ratio for prostate cancer treated by external beam radiation therapy monotherapy using a post-treatment repeated measures model for PSA dynamics." Int J Radiat Oncol Biol Phys, 79(1): 195-201, 2011.
  • Ray D, Ahsan A, Helman A, Chen G, Hegde A, Gurjar SR, Zhao L, Kiyokawa H, Beer DG, Lawrence TS, Nyati MK: "Regulation of EGFR Protein Stability by the HECT-type Ubiquitin Ligase SMURF2." Neoplasia 13(7):570-8, 2011, PMC3132843
  • Reka AK, Kuick R, Kurapati H, Standiford TJ, Omenn GS, Keshamouni VG: "Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach." J Thorac Oncol 6(11):1784-92, 2011, PMC3196823
  • Roberson PL, Amro H, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK: "Bio-effect model applied to (131) I radioimmunotherapy of refractory non-Hodgkin's lymphoma." European J nuclear medicine and molecular imaging, 38(5):874-83, 2011, PMC3312018.
  • Sabel MS, Liu Y, Griffith KA, He J, Xie X, Lubman DM: "Clinical utility of serum autoantibodies detected by protein microarray in melanoma." Int J Proteomics, 413742, 2011, PMC3199061.
  • Sabolch A, Feng FY, Daignault-Newton S, Halverson S, Blas K, Phelps L, Olson KB, Sandler HM, Hamstra DA: "Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation." Int J Radiat Oncol Biol Phys, 81(4):e351-60, 2011
  • Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, and Ben-Josef E: "Adjuvant and Definitive Radiotherapy for Adrenocortical Carcinoma." Intl J Radiat Oncol Biol Phys, 80(5): 1477-84, 2011.
  • Saiya-Cork K, Collins R, Parkin B, Ouillette P, Kuizon E, Kujawski L, Erba H, Campagnaro E, Shedden K, Kaminski M, Malek SN: "A pathobiological role of the insulin receptor in chronic Lymphocytic leukemia." Clinical cancer research : 2011:17(9):2679-92, PMC3086966.
  • Samadder NJ, Mukherjee B, Huang SC, Ahn J, Rennert HS, Greenson JK, Rennert G, Gruber SB: "Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use." Cancer 117(8):1640-8, 2011, PMC3117060
  • Samanatha D, Zhao L, Chang A Orringer M: "Refractory cervical esophagogastric anastomotic strictures: management and outcomes." J Thoracic and Cardiovascular Surgery, 141(2):444-8, 2011
  • Schinske KA, Nyati S, Khan AP, Williams TM, Johnson TD, Ross BD, Pérez Tomás, R, Rehemtulla A: "A Novel Kinase Inhibitor of FADD Phosphorylation Chemosensitizes through the Inhibition of NF-{kappa}B." Mol Cancer Ther (10): 1807-17, 2011, PMC3191281
  • Schneider BJ, Gadgeel SM, Ramnath N, Wozniak AJ, Dy GK, Daignault S, Kalemkerian GP: "Phase II trial of sunitinib maintenance therapy after platinum-based chemotherapy in patients with extensive-stage small cell lung cancer." J Thorac Oncol, 6(6):1117-20, 2012
  • Shuman AG, Light E, Olsen SH, Pynnonen MA, Taylor JMG, Johnson TM, Bradford CR: "Mucosal Melanoma of the Head and Neck." Arch Otolaryngol Head Neck Surg, 137(4):331-7, 2011.
  • Shuman AG, Yang Y, Taylor JMG, Prince ME: "End of Life Care Among Head and Neck Cancer Patients." Otolaryngology-Head and Neck Surgery, 144(5):733-739, 2011, PMID 21493350.
  • Simon RM, Subramanian J, Li MC, Menezes S: "Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data." Briefings in bioinformatics 2011:12(3):203-14, PMC3105299
  • Song L, Northouse, L, Braun TM, Zhang L, Cimprich B, Ronis D, Mood, D: "Assessing Longitudinal Quality of Life in Prostate Cancer Patients and Their Spouses: A Multilevel Modeling Approach." Quality of Life Research, 20(3): 371-81, 2011.
  • Spector ME, Wilson KF, Light E, McHugh JB, Bradford CR: "Clinical and pathologic predictors of recurrence and survival in spindle cell squamous cell carcinoma." Otolaryngol Head Neck Surg 145(2): 242-7, 2011.
  • Subramanian C, Jarzembowski JA, Halsey SM, Kuick R, Opipari AW, Castle VP, Kwok RPS: "CLU blocks HDACI-mediated killing of neuroblastoma." Tumour Biology, 32(2):285-94, 2011, PMC3041908.
  • Tan L, Kwok RP, Shukla A, Kshirsagar M, Zhao L, et al: "Trichostatin a restores Apaf-1 function in chemoresistant ovarian cancer cells." Cancer, 117(4):784-94, 2011, PMC3033976.
  • Taylor JMG: "Commentary on Random Survival Forests." J Thoracic Oncology, 6(12):1974-75, 2011.
  • Van Tubergen E, Vander Broek R, Lee J, Wolf G, Carey T, Bradford C, Prince M, Kirkwood KL, D'Silva NJ: "Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma." Cancer 2011:117(12):2677-89.
  • Wei DP, Li H, Yu J, Sebolt JT, Zhao L, Lawrence TS et al. "Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor." Cancer Res, 72(1): 282-93, 2011, PMC3251739
  • Wei J, Chan HP, Wu YT, Zhou C, Helvie MA, Tsodikov A, Lubomir M, Hadjiiski, Sahiner B: "Association of computerized mammographic parenchymal pattern measure with breast cancer risk: a pilot case-control study." Radiology 260(1): 42-9, 2011, PMC3135878.
  • Westgate P, Braun TM. Improving Small-Sample Inference in Group Randomized Trials with Binary Outcomes. Stat Med 30(3): 201-10, 2011.
  • Yang N, Feng S, Shedden K, Xie X, Liu Y, Rosser CJ, Lubman DM, Goodison S: "Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification." Clin can res, 2011:17(10):3349-59, PMC3096687.
  • Zhang Q, Taguchi A, Schliekelman M, Wong CH, Chin A, Kuick R, Misek DE, Hanash S: "Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines." Int J Proteomics, 145010, 2011.
  • Zhao L, Morgan MA, Parsels LA, Maybaum J, Lawrence TS, Normolle D: "Bayesian hierarchical changepoint methods in modeling the tumor growth profiles in xenograft experiments." Clin Cancer Res, 17(5):1057-64, 2011. PMC3048927
  • Zhao L, Morgan MA, Parsels LA, Maybaum J, Lawrence TS, Normolle DP: "Modeling the tumor growth profiles in xenograft experiments--response." Clin. Cancer Res 17, 4613-14, 2011.
  • Zhao L, Lee J, Mody R, Braun TM: "The superiority of the time-to-event continual reassessment method to the rolling six design in pediatric oncology Phase I trials." Clin Trials 8(4): 361-9, 2011.
  • Zheng N, Tsai HN, Zhang X, Shedden K, Rosania GR: "The subcellular distribution of small molecules: a meta-analysis." Mol. Pharm 8(5):1611-8, 2011, PMC3185174.
  • Zhu B, Song PX, Taylor JMG: "Stochastic Functional Data Analysis: A Diffusion Model-Based Approach." Biometrics, 67(4): 1295-304, 2011, PMC3128649.
  • Zhu B, Taylor JMG, Song PX: "Semiparametric Stochastic Modeling of the Rate Function in Longitudinal Studies." JASA, 106(496):1485-95, 2011, PMC3298426.

  • Ajrouch K, Reisine S, Light E, Sohn W, Ismail A: "Caregiver’s Social Relations and Children’s Oral Health in a Low-Income Urban Setting." Social Science and Dentistry, 1:77-87, 2010.
  • Anderson M, Brenner D, Scheiman J, Simeone D, Singh N, Sikora M, Zhao L, Mertens A: "Reliable gene expression measurements from endoscopic fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment." J Molecular Diagnostics, 12(5): 566-75, 2010, PMC2928420.
  • Bommer GT, Feng Y, Iura A, Giordano TJ, Kuick R, Kadikoy H, Sikorski D, Wu R, Cho KR, Fearon ER. IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. J Biol Chem, 15:285(3):1928-38, 2010
  • Boonstra PS, Gruber SB, Raymond VM, Huang SC, Timshel S, Nilbert M, Mukherjee B: "A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome." Genetic epidemiology, 34(7):756-68, 2010
  • Borràs E, Pineda M, Blanco I, Jewett EM, Wang F, Teulé A, Caldés T, Urioste M, Martínez-Bouzas C, Brunet J, Balmaña J, Torres A, Ramón y Cajal T, Sanz J, Pérez-Cabornero L, Castellví-Bel S, Alonso A, Lanas A, González S, Moreno V, Gruber S, Rosenberg NA, Mukherjee B, Lázaro C, Capellá G: "MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families." Cancer research 2010:70(19):7379-91
  • Braun TM, Wang S: "A hierarchical bayesian design for phase I trials of novel combinations of cancer therapeutic agents." Biometrics 2010:66(3):805-12
  • Bradley DA, Daignault S, Ryan CJ, Dipaola RS, Smith DC, Small E, Gross ME, Stein MN, Chen A, Hussain M. "Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium." Invest New Drugs, 2010
  • Bryant CM, Albertus DL, Kim S, Chen G, Brambilla C, Guedj M, Arima C, Travis WD, Yatabe Y, Takahashi T, Brambilla E, Beer DG: "Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study." PloS one 2010:5(7):e11712.
  • Cai XW, Shedden K, Ao X, Davis M, Fu XL, Lawrence TS, Lubman DM, Kong FM: "Plasma Proteomic Analysis May Identify New Markers for Radiation-Induced Lung Toxicity in Patients with Non-Small-Cell Lung Cancer." Intl J Radiat Oncol Biol Phys, 77(3): 867-76, 2010.
  • Cao Y, Li D, Shen Z, Normolle D: "Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters." Acad Radiol, 17(4):468-78, 2010, PMID: 20207317, NIHMS157346
  • Chang AC, Lee JS, Sawicki KT, Pickens A, Orringer MB: "Outcomes after esophagectomy in patients with prior antireflux or hiatal hernia surgery." Ann Thorac Surg 89(4):1015-21: discussion 1022-3, 2010, PMID 20338301 PMCID PMC2884381
  • Chepeha DB, Khariwala SS, Chanowski EJP, Zumsteg JW, Malloy KM, Moyer JS, Prince ME, Sacco AG, Lee JS: "Thoracodorsal artery scapular tip autogenous transplant: vascularized bone with a long pedicle and flexible soft tissue." Archives of otolaryngology--head & neck surgery 2010:136(10):958-64
  • Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, Berman MG, Hayes DF, Noll DC, Peltier S, Welsh RC: "Prechemotherapy alterations in brain function in women with breast cancer." J Clin Exp Neuropsychol, 32(3):324-31, 2010, PMID: 19642048
  • Dai L, Li C, Shedden K, Lee CJ, Li C, Quoc H, Simeone DM, Lubman DM: "Quantitative proteomic profiling studies of pancreatic cancer stem cells." J Proteome Research, 9(7):3394-402, 2010.
  • Dai L, Li C, Shedden KA, Misek DE, Lubman DM. "Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis." Electrophoresis, 30(7):1119-31, 2010, PMID: 19288585
  • Davis SJ, Zhao L, Chang AC, Orringer MB: "Refractory cervical esophagogastric anastomotic strictures: Management and outcomes." J Thorac Cardiovasc Surg, 14, 2010, PMID 21163501 PMCID
  • Dewaraja YK, Schipper MJ, Roberson PL, Wilderman SJ, Amro H, Regan DD, Koral KF, Kaminski MS, Avram AM: "131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling." J Nuclear medicine : official publication, Society of Nuclear Medicine, 51(7):1155-62, 2010.
  • Dey S, Soliman AS, Hablas A, Seifeldein IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD: "Urban-rural differences in breast cancer incidence in Egypt (1999-2006)." Breast (Edinburgh, Scotland) 2010:19(5):417-23.
  • Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt: A local phenomenon in a global pattern. Breast Can Res Treat 120:149-60, 2010.
  • Dey S, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD, Soliman AS. Urban-rural differences of gynaecological malignancies in Egypt (1999-2002). Br J Obstetrics and Gynaecology, 117:348-55, 2010.
  • Divi V, Worden FP, Prince ME, Eisbruch A, Lee JS, Bradford CR, Chepeha DB, Teknos TN, Hogikyan ND, Moyer JS, Tsien CI, Urba SG, Wolf GT: "Chemotherapy alone for organ preservation in advanced laryngeal cancer." Head & Neck, 32(8):1040-7, 2010.
  • Galb_an CJ, Bhojani M, Lee KC, Meyer CR, Van Dort M, Kuszpit KK, Koeppe R, Ranga R, Moffat BA, Johnson TD, Chenevert TL, Rehemtulla A, Ross BD: "Evaluation of Treatment Associated Inammatory Response on Diffusion Weighted-MRI and FDG-PET Imaging Biomarkers." Clinical Cancer Research 16, 1542-1552, 2010
  • Ghosh D, Elliott MR, Taylor JMG: "Links between analysis of surrogate endpoints and Endogeneity." Stats in Med, 29(28):2869-79, 2010, PMCID: PMC2997195.
  • Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR, and Ben-Josef E. (2010) The Role of Radiotherapy in the Management of Desmoid Tumors. Accepted by the Int. J. Radiation Oncology Biol. Phys. March 3rd, 2010. PMCID NOT NEEDED – NO FEDERAL FUNDING LISTED
  • Goto M, Mitra RS, Liu M, Lee J, Henson BS, Carey T, Bradford C, Prince M, Wang CY, Fearon ER, D’Silva NJ: "Rap1 Stabilizes –Catenin and Enhances –Catenin-Dependent Transcription and Invasion in Squamous Cell Carcinoma of the Head and Neck." Clin Cancer Res 16(1):65-76, 2010, PMID: 20028760, PMCID: PMC2844500
  • Ha Huan T, Lee JS, Urba S, Koenig RJ, Sisson J, Giordano T, Worden FP: "A Phase II Study of Imatinib in Patients with Advanced Anaplastic Thyroid Cancer." Thyroid: official journal of the American Thyroid Association, 20(9): 975-80, 2010.
  • Henry NL, Jacobson, JA, Banerjee M, Hayden J, Smerage JB, Poznak CV, Storniol AM, Stearns V, Hayes DF: "A Prospective Study of Aromatase Inhibitor-Associated Musculoskeletal Symptoms and Abnormalities on Serial High-Resolution Wrist Ultrasonography." Cancer, 116:4360-4367, 2010.
  • Hu M, Yu J, Taylor JM, Chinnaiyan AM, Qin ZS: "On the detection and refinement of transcription factor binding sites using ChIP-Seq data." Nucleic Acids Res 2010.
  • Hsu C, Taylor JMG: "A Robust Weighted Kaplan-Meier Approach with Dependent Censoring Using Linear Combinations of Prognostic Covariates." Stats in Med, 29(21):2215-23, 2010.
  • Huang W, Gonzalez M, Toy K, Banerjee M, Kleer C: "Blockade of CCN6 (WISP3) Activates Growth Factor-Independent Survival and Resistance to Anoikis in Human Mammary Epithelial Cells." Can Res, 70:3340-50, 2010.
  • Jacqmin-Gadda H, Proust-Lima C, Taylor JMG, Commenges D: "Score Test for Conditional Independence Between Longitudinal Outcome and Time-to-Event Given the Classes in the Joint Latent Class Model." Biometrics, 66(1): 11-19, 2010, PMID: 19432771
  • Jagsi R, Ben-David MA, Moran JM, Marsh R, Griffith KA, Hayman JA, and Pierce LJ: "Unacceptable Cosmesis in Protocol Investigating Intensity Modulated Radiotherapy with Active Breathing Control for Accelerated Partial Breast Irradiation."  Int. J. Radiat Oncol Biol Phys, 76(1):71-78, 2010.
  • Jagsi R, Moran J, Marsh R, Masi K, Griffith KA, Pierce LJ: "Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer." Intl J Radiat Oncol Biol Phys, 78(5):1594-603, 2010.
  • Jing X, Roh, M, Knoepp S, Zhao L, Michael C: "Minimizing the diagnosis of "follicular lesion of undetermined significance" and identifying predictive features for neoplasia." Diagn Cytopathology, 39(10):737-42, 2010.
  • Kato K, Cui S, Kuick R, Mineishi S, Hexner E, Ferrara JL, Emerson SG, Zhang Y: "Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease." Biol Blood Marrow Transplant, 16(6): 751-71, 2010, PMCID: PMC2913321
  • Kelly VR, Xu B, Kuick R, Koenig RJ, Hammer GD: "Dax1 Up-Regulates Oct4 Expression in Mouse Embryonic Stem Cells via LRH-1 and SRA." Molecular Endocrinology, 24(12):2281-91, 2010, PMC2999479
  • Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA: "Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver." J Magnetic Resonance Imaging : JMRI, 2010:32(2):360-6, PMID 20677263
  • Kwee TC, Galban CJ, Tsien C, Junck LR, Sundgren PC, Ivancevic MK, Johnson TD, Meyer CR, Rehemtulla A, Ross BD, Chenevert TL: "Comparison of apparent diffusion coeffcients (ADC) and distributed difusion coeficients (DDC) in high-grade gliomas." J Magnetic Resonance Imaging, 31, 531-537, 2010 PMC Journal, in Process.
  • Kwee TC, Galban CJ, Tsien C, Junck L, Sundgren PC, Ivancevic MK, Johnson TD, Meyer CR, Rehemtulla A, Ross BD, Chenevert TL: "Intravoxel water diusion heterogeneity imaging of human high-grade gliomas." NRM in Biomedicine, 23(2):179-87, 2010.
  • Li M, Anastassiades CP, Joshi B, Komarck CM, Piraka C, Elmunzer BJ, Turgeon DK, Johnson TD, Appelman H, Beer DG, Wang TD: "Affinity peptide for targeted detection of dysplasia in Barrett's esophagus." Gastroenterology, 139(5):1472-80, 2010.
  • Li Y, Taylor JMG, Elliott MR: "A bayesian approach to surrogacy assessment using principal stratification in clinical trials." Biometrics, 66(2):523-31, 2010, NIHMS #138770.
  • Li Y: Taylor JMG: "Predicting treatment effects using biomarker data in a meta-analysis of clinical trials." Stats in Med, 2010:29(18):1875-89
  • Li Z, Taylor JMG, Nan B: "Construction of Confidence Intervals and Regions for Ordered Binomial Probabilities." American Statistician, 64(4):291–298, 2010.
  • Loar P, Wahl H, Kshirsagar M, Gossner G, Griffith KA, and Liu JR. (2010) Inhibition of Glycolysis Enhances Cisplatin-Induced Apoptosis in Ovarian Cancer Cells. Am J Obstet Gynecol. 202:371.e1-8.
  • Long J, Parkin B, Ouillette P, Bixby D, Shedden K, Erba H, Wang S, Malek SN: "Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia. Blood, 116(1):71-80, 2010.
  • Magenau JM, Qin X, Tawara I, Rogers CE, Kitko C, Schlough M, Bickley D, Braun TM, Jang PS, Lowler KP, Jones DM, Choi SW, Reddy P, Mineishi Shin, Levine JE, Ferrara JLM, Paczesny S: "Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease." Biology of blood and marrow transplantation: J Am Soc Blood and Marrow Transplantation 2010:16(7):907-14
  • Maxwell JH, Kumar B, Feng FY, Worden FP, Lee JS, Eisbruch A, Wolf GT, Prince ME, Moyer JS, Teknos TN, Chepeha DB, McHugh JB, Urba SG, Stoerker J, Walline HM, Kurnit DM, Cordell KG, Davis SJ, Ward PD, Bradford CR, Carey TE: "Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence." Clin Cancer Res, 16(4):1226-35, 2010, PMID 20145161 PMCID PMC2822887
  • Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, Hassan MC, Arumugarajah S, Hylander-Gans L, Morosini D, Simeone DM, Canman CE, Normolle DP, Zabludoff SD, Maybaum J, Lawrence TS: "Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair." Cancer Res 70(12):4972-81, 2010, PMC2889008.
  • Mukherjee B, Ahn J, Gruber SB, Ghosh M, Chatterjee N: "Case-control studies of gene-environment interaction: bayesian design and analysis." Biometrics 2010:66(3):934-48
  • Ning W. and Zhao L. A moment-based test for the mixture distributions with small sample sizes and its application." Far East J Theoretical Statistics, 33(1), 23-39, 2010
  • Normolle D, Pan C, Ben-Josef E, Lawrence T: "Adaptive trial of personalized radiotherapy for intrahepatic cancer." Per Med, 7(2):197-204, 2010, PMID: 20448804, PMC2862493
  • Ouillette P, Fossum S, Parkin B, Ding L, Bockenstedt P, Al-Zoubi A, Shedden K, Malek SN: "Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks." Clin Can Res., (3):835-47, 2010, PMID: 20086003
  • Pai D, Willat JM, Korobkin M, Cohan RH, Ellis JH, Francis IR, Wolf JS, Schipper MJ: "CT appearances following laparoscopic partial nephrectomy for renal cell carcinoma using a rolled cellulose bolster." Cancer Imaging, 10:161-8, 2010.
  • Parkin B, Erba H, Ouillette P, Roulston D, Purkayastha A, Karp J, Talpaz M, Kujawski L, Shakhan S, Li C, Shedden K, Malek S: "Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia." Blood, 116(23):4958-67, 2010
  • Parkin B, Ouillette P, Wang Y, Liu Y, Wright W, Roulston D, Purkayastha A, Dressel A, Karp J, Bockenstedt P, Al-Zoubi A, Talpaz M, Kujawski L, Liu Yang, Shedden K, Shakhan S, Li C, Erba H, Malek SN: "NF1 Inactivation in Adult Acute Myelogenous Leukemia." Clin Can Res : An official journal of the American Association for Cancer Research 2010:16(16):4135-47
  • Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V, Pitteri S, Zhang Q, Chin A, Kitko C, Mineishi S, Yanik G, Peres E, Hanauer D, Wang Y, Reddy P, Hanash S, Ferrara JL: "Elafin is a biomarker of graft-versus-host disease of the skin." Sci Transl, 2(13):13ra2, 2010, PMID 20371463 PMCID PMC2895410
  • Pierce LJ, Phillips KA, Griffith KA, Buys S, Gaffney DK, Moran MS, Haffty BG, Ben-David M, Kaufman B, Garber JE, Merajver SD, Balmana J, Meirovitz A, and Domchek SM (2010). Local Therapy in BRCA1 and BRCA2 Mutation Carriers with Operable Breast Cancer Comparison of Breast Conservation and Mastectomy. Breast Cancer Res Treat 121:389–398.
  • Proust-Lima C, Taylor JMG, Secher S, Sandler H, Kestin L, Pickles T, Bae K, Allison R, Williams S: "Confirmation of a low alpha/beta ratio for prostate cancer treated by external beam radiation therapy monotherapy using a post-treatment repeated measures model for PSA dynamics." Intl J Radiat Oncol Biol Phys, 79(1): 195-201, 2011, PMID 20381268.
  • Qin ZS, Yu J, Shen J, Maher CA, Hu Ming, Kalyana-Sundaram S, Yu J, Chinnaiyan AM: "HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data." BMC bioinformatics 2010:11():369
  • Resnicow, K., Strecher, V., Couper, M., Chua, H., Little, R., Nair, V., Polk, T., & Atienza, A: "Methodological and Design Issues in Patient-Centered Ehealth Research." Am J Prev Med, 38(1):98-102, 2010, PMID 20117564, NIHMS168101.
  • Sabel MS, Su G, Griffith KA, Chang AE: "Intratumoral Delivery of Encapsulated IL-18 and TNF –α in a Model of Metastatic Breast Cancer." Breast Cancer Res Treat, 122:325-36, 2010.
  • Sabel MS, Su G, Griffith KA, Chang AE: "Rate of Freeze Alters the Immunologic Response After Cryoablation of Breast Cancer." Ann Surg Oncol. 17:1187-1193, 2010.
  • Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, Karnovsky A, Kuick R, Jagadish HV, Mirel B, Weymouth T, Athey B, Omenn GS. ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics, 26(4):456-63, 2010, PMCID: PMC2852214
  • Shedden K, Rosania GR: "Chemical address tags of uorescent bioimaging probes." Cytometry A. 77(5):429-38, 2010, PMID:20104576, PMC2907078
  • Shuman AG, Entezamil P, Chernin AS, Wallace NE, Taylor JMG, Hogikyan ND: "Demographics and Efficacy of Head and Neck Cancer Screening." Otolaryngology-Head and Neck Surgery, 143: 353-360, 2010.
  • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han Bo, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: "Re: florian jentzmik, carsten stephan, kurt miller, et Al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours." Eur urol 2010:58:12-8., European urology 2010:58(3):e29-30
  • Srinivasan A, Galban CJ, Johnson TD, Chenevert TL, Mukherji SK: "Utility of K-Means clustering algorithm in dierentiating apparent diusion coecient values between benign and malignant neck pathologies". Am J Neuroradiology, 31(4): 736-40, 2010
  • Stanbery L, D'Silva NJ, Lee JS, Bradford CR, Carey TE, Prince ME, Wolf GT, Worden FP, Cordell KG, Petty EM: "High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma." Translational oncology 2010:3 (4):239-45
  • Taylor JMG: "Discussion of Predictive Comparison of Joint Longitudinal-Survival Modeling: A Case Study Illustrating Competing Approaches'', by Hanson, Branscum and Johnson." Lifetime Data Analysis, DOI 10.1007/s10985-010-9168-7, 2010.
  • Tsien C, Galb_an CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck LR, Meyer CR, Rehemtulla A, Lawrence TS, Ross BD: "Parametric Response Map as an Imaging Biomarker to Distinguish Progression from Pseudoprogression in High Grade Gliomas." J Clin Oncol, 28(13):2293-99, 2010.
  • Vilar E, Bartnik CM,Stenzel SL, Raskin L, Ahn J, Moreno V, Mukherjee B, Iniesta MD,Morgan MA, Rennert G, Gruber SB: "MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Can res 2011:71(7):2632-42
  • Wahl H, Daudi S, Kshirsagar M, Griffith KA, Tan L, Rhode J, Liu JR: "Expression of Metabolically Targeted Biomarkers in Endometrial Carcinoma." Gynecol Oncol. 116:21-27, 2010.
  • Wansom D, Light E, Worden F, Prince M, Urba S, Chepeha DB, Cordell K, Eisbruch A, Taylor JMG, D’Silva N, Moyer J, Bradford CR, Kurnit D, Kumar B, Carey TE, Wolf GT: "Correlation of Cellular Immunity with Human Papillomavirus 16 Status and Outcome in Patients with Advanced Oropharyngeal Cancer." Arch Otolaryngol Head Neck Surg, 136(12):1267-73, 2010, PMC3342998
  • Wasco MJ, Daignault S, Bradley D, Shah RB. "Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases." Hum Pathol, 41(2):163-71, 2010, PMID 19800100
  • Ye W, Taylor JMG, Lin X: "Simulating Pseudo Data for a Two-stage Approach in Joint Modeling of Longitudinal Measurements and Time-to-Event Data." Biometrics 2010:66(3):987-91.
  • Zhang X, Johnson TD, Little RJA, Cao Y: "A Bayesian image analysis of the change in tumor/brain contrast uptake ratio induced by radiation via reversible jump Markov chain Monte Carlo." Bayesian Analysis 5, 189-212, 2010, PMCID: PMC2864505
  • Zhang X, Johnson TD, Little RJ, Cao Y: "Longitudinal Image Analysis of Tumor/Brain Change in Contrast Uptake Induced by Radiation." Journal of the Royal Statistical Society, Ser. C, 59, 821-838, 2010, PMC2995925.
  • Zick SM, Ruffin MT, Djuric Z, Normolle D, Brenner DE: "Quantitation of 6-, 8- and 10-Gingerols and 6-Shogaol in Human Plasma by High-Performance Liquid Chromatography with Electrochemical Detection." Int J Biomed Sci, 6(3):233-240, 2010, PMID: 21072137, PMC2975369

  • Abdullah NM, Rosania GR, Shedden K: "Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors." PLoS One, 4(2): e4470, 2009, PMID: 19214225
  • Agarwal P, Patel S, Corbett J, Jung JI, Barber K, Schipper MJ, and Kazerooni EA. Left ventricular functional analysis with 16 and 64-row multidetector CT: comparison with gated SPECT. Journal of Computer Assisted Tomography 2009: 33(1): 8-14.
  • Ahn J., Mukherjee B., Banerjee M., Cooney K. Bayesian Inference for the Stereotype Regression Model: Application to a Case-Control Study of Prostate Cancer.Stats in Med, 28:3139–3157, 2009.
  • Barlaskar FM, Spalding AC, Heaton JH, Kuick R, Kim AC, Thomas DG, Giordano TJ, Ben-Josef E, Hammer GD: "Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma." J Clin Endocrinol Metab. 94(1):204-12, 2009. PMCID: PMC2630877
  • Breslin TM, Morris AM, Gu N, Wong S, Finlayson EV, Banerjee M, Birkmeyer JD: Hospital Factors and Racial Disparities in Late Mortality after Surgery for Breast and Colon Cancer." J Clin Oncol, 27:3945-50, 2009.
  • Cao Y, Tsien CI, Sundgren PC, Nagesh V, Normolle D, Buchtel H, Junck L, Lawrence TS: "Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction." Clin Cancer Res, 15(5):1747-54, 2009, PMID: 19223506, PMC2699596
  • Caoili EM, Cohan RH, Ellis JH, Dillman J, Schipper MJ, Francis IR: "Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspective." Arch Intern Med 169(11):1069-71, 2009.
  • Chamdin A, Jarzembowski JA, Subramanian C, Kuick R, Lee JS, Kwok RP, Castle VP, Opipari AW. Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome. Transl Oncol, 18:2(3):128-37, 2009, PMCID: PMC2730138
  • Chang AC, Lee JS: "Resection for esophageal cancer in the elderly." Thorac Surg Clin (3):333-43, 2009, PMID 20066945 PMCID PMC2855305
  • Comstock KE, Hall CL, Daignault S, Mandlebaum SA, Yu C, Keller ET. "A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo." In Vivo. 2009 Sep-Oct: 23(5):661-8, PMID 19779098.
  • Contessa JN, Griffith KA, Wolff W, Ensminger W, Zalupski MM, Lawrence TS, and Ben-Josef E: "Radiation Therapy for Pancreastic Neuroendocrine Tumors." Intl J Radiat Oncol Biol Phys, 75(4): 1196-1200, 2009, PMID 19327905.
  • Cooke DT, Lin GC, Lau CL, Zhang L, Si MS, Lee J, Chang AC, Pickens A, Orringer MB: "Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: risk factors, presentation, and detection." Ann Thorac Surg, 88(1):177-84: discussion 184-5, 2009, PMID 19559221 PMCID
  • Corbier F, Commenges D, Taylor JMG, Joly P: "A Penalized Likelihood Approach for Mixture Cure Models." Stats in Med, 28: 510-24, 2009.
  • Dai L, Li C, Shedden KA, Misek DE, Lubman DM: "Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis." Electrophoresis. 30(7):1119-31, 2009, PMID:19288585, PMC2674123.
  • Desai S, Ben-Josef E, Griffith KA, Simeone D, Greenson J, Francis I, Hampton J, Coletti L, Chang A, Lawrence TS, and Zalupski MM: "Gemcitabine-Based Combination Chemotherapy followed by Radiation with Capecitabine as Adjuvant Therapy for Resected Pancreas Cancer." Int. J. Radiat Oncol Biol Phys, 75(5): 1450-55, 2009
  • Else T, Trovato A, Kim AC, Wu Y, Ferguson DO, Kuick RD, Lucas PC, Hammer GD: "Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis." Cancer Cell, 2:15(6):465-76, 2009. PMCID: PMC2703790
  • Feng M, Balter JM, Normolle D, Adusumilli S, Cao Y, Chenevert TL, Ben-Josef E: "Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution." Int J Radiat Oncol Biol Phys, 74(3):884-91, 2009, PMID: 19395190, PMC2691867
  • Gajdos C, Griffith KA, Wong SL, Johnson TM, Sondak VK, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, and Sabel MS. (2009): "Is there a benefit to sentinel lymph node (SLN) biopsy in patients with T4 melanoma?" Cancer. 115(24):5752-5760.
  • Galb_an CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, Junck LR, Sundgren P, Johnson TD, Ross DJ, Rehemtulla A, Ross BD: "The parametric response map is an imaging biomarker for early cancer treatment outcome." Nature Medicine (5): 572-576, 2009, NIHMSID: NIHMS168273
  • Galb_an CJ, Mukherji SK, Chenevert TL, Meyer CR, Hamstra DA, Bland PH, Johnson TD, Moffat BA, Rehemtulla A, Eisbruch A, Ross BD: "A Feasibility Study of Parametric Response Map Analysis of Di_usion-Weighted Magnetic Resonance Imaging Scans of Head and Neck Cancer Patients for Providing Early Detection of Therapeutic E_cacy." Translational Oncology 2, 184-190, 2009, PMCID: PMC2730136
  • Gartner EM, Griffith KA, Pan Q, Brewer GJ, Henja GF, Merajver SD, and Zalupski MM: "A pilot trial of the anti-angiogenic copper lower agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer." Invest. New Drugs, 27: 159-65, 2009
  • Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G, Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res, 15:15(2):668-76, 2009. PMCID: PMC2629378
  • Gonzalez M., Li X., Toy K., DuPrie M., Ventura A., Banerjee M., Ljugman M., Merajver S., Kleer C: "Down-regulation of EZH2 decreases growth of estrogen receptor negative invasive breast carcinoma and requires BRCA1." Oncogene, 28:843-853, 2009.
  • Goodsitt MM, Chan HP, Way TW, Schipper MJ, Larson SC and Christodoulou EG: "Quantitative CT of lung nodules: dependence of calibration on patient body size, lung size and calibration nodule size for single- and dual-energy techniques." Medical Physics, 36(7): 3107-3121, 2009.
  • Gruber SB, Mukherjee B: "Genetic anticipation in Lynch syndrome: Still awaiting for the answer." J Clin Oncol, 27, 326-327, 2009.
  • Hu M, Yu J, Taylor JMG, Chinnaiyan A, Qin Z: "On the Detection and Refinement of Transcription Factor Binding Sites Using ChIP-Seq Data." Nucleic Acids Research, 1-14, 2009.
  • Hsu, C, Taylor, JMG: "Nonparametric Comparison of Two Survival Functions with Dependent Censoring Via Nonparametric Multiple Imputation." Stats in Med, 28:462-75, 2009.
  • Hsu, C, Taylor, JMG, Long, Q, Alberts, D: "Analysis of Colorectal Adenoma Recurrence Data Subject to Informative Censoring." Cancer Epidemiology, Biomarkers & Prevention, 18(3): 712-7, 2009.
  • Jagsi R, Motomura AR, Griffith KA, Rangarajan S, and Ubel PA. (2009) Sex Difference in Attainment of Independent Funding by Career Development Awardees. Ann Intern Med. 151:804-811.
  • Jakubowiak AJ, Kendall T, Al-Zoubi A, Khaled Y, Mineishi S, Ahmed A, Campagnaro E, Brozo C, Braun T, Talpaz M, Kaminski MS. Phase II Trial of Combination Therapy with Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone (VDD) in Patients with Newly Diagnosed Myeloma. Journal of Clinical Oncology (27): 5015:5022, 2009.
  • Johnson TD, Piert M: "A Bayesian analysis of dual autoradiographic images." Computational Statistics and Data Analysis 53, 4570-4583, 2009
  • Johnson JC, Soliman AS, Tadgerson D, Copeland G, Seefeld DA, Pingatore NL, Haverkate R, Jim M, Espey DK, Banerjee M, Roubidoux MA: "Tribal Linkage and Race Data Quality for American Indians in a State Cancer Registry." Am J Prev Med, 36:549-554, 2009, PMID 19356888.
  • Kastrinos F, Mukherjee B, Tayob N, Sparr, Raymond VM, Wang F, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S: "The Risk of Pancreatic Cancer in Lynch Syndrome." JAMA, 302(16):1790-1795, 2009, PMID 19861671.
  • Keshamouni VG, Jagtap P, Michailidis G, Strahler JR, Kuick R, Reka AK, Papoulias P, Krishnapuram R, Srirangam A, Standiford TJ, Andrews PC, Omenn GS. Temporal Quantitative Proteomics by iTRAQ 2D-LC-MS/MS and Corresponding mRNA Expression Analysis Identify Post-Transcriptional Modulation of Actin-Cytoskeleton Regulators During TGF-beta-Induced Epithelial-Mesenchymal Transition. J Proteome Res. 2:8(1):35-47, 2009.
  • Kim A, Giordano TJ, Kuick R, Serecky K, Hammer GD. Wnt/betacatenin signaling in adrenocortical stem/progenitor cells: Implications for adrenocortical carcinoma. Ann Endocrinol (Paris). 2009.
  • Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW: "Lymphoma after Solid Organ Transplantation: Risk, Response to Therapy and Survival in a Transplant Registry Population." J Clin Oncol, 27(20): 3354-62, 2009, PMID 19451438.
  • Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W: "Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments." Blood,114:1141–1149, 2009.
  • Lee MC, Rogers K, Griffith KA, Kiehl KA, Breslin TM, Cimmino VM, Chang AE, Newman LA, and Sabel MS: "Determinants of Breast Conservation Rates: Reasons for Mastectomy at a Comprehensive Cancer Center." The Breast Journal, 15(1):34-40, 2009
  • Li C, Simeone DM, Brenner DE, Anderson MA, Shedden KA, Ruffin MT, Lubman DM: "Pancreatic cancer serum detection using a lectin/glyco-antibody array method." J Proteome Res., 8(2):483-92, 2009, PMID: 19072160
  • Little, RJ, Long, Q, Lin, X: "A Comparison of Methods for Estimating the Causal Effect of a
  • Treatment in Randomized Clinical Trials Subject to Noncompliance." Biometrics, 65(2): 640-9,
  • Liu CA, Braun TM. Identifying Optimal Treatment Schedules via Parametric Non-Mixture Cure Models. Journal of the Royal Statistical Society, Series C: Applied Statistics (58): 225-236, 2009.
  • Liu Y, Kuick R, Hanash S, Richardson B: "DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors." Clin Immunol. 130(2):213-24, 2009. PMCID: PMC2655730
  • Lo AC, Georgopoulos A, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Omar HG, Douglas JA, Merajver SD, Soliman AS: "Molecular Differences between Inflammatory and Non-Inflammatory Breast Cancers in Egyptian Patients." Breast, 18:55-9, 2009.
  • Luo S, Mukherjee B, Chen J, Chatterjee N: "Shrinkage estimation for robust and efficient screening of HWE in genomewide association studies." Genet Epidemiol. 33(8):740-50, 2009, PMID 19434716, NIHMS141800.
  • Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M: "Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma." Gastroenterology, 137(1):110-8, 2009, PMID: 19362088, PMC2704256
  • Miller DC, Saigal CS, Warren JL, Leventhal M, Deapen D, Banerjee M, Lai J, Hanley J,Litwin MS: "External Validation of a Claims-Based Algorithm for Classifying Kidney Cancer Surgeries." BMC Health Services Research, 9:92-98, 2009.
  • Moran JM, Ben-David MA, March RB, Balter JM, Griffith KA, Hayman JA, and Pierce LJ: "Partial Breast Irradiation (PBI): What is the impact of conformal and IMRT techniques with and without Active Breathing Control?" Int. J. Radiat Oncol Biol. Phys, 75(1): 294-301, 2009, NIHMS125402
  • Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL: "Two thousand transhiatal esophagectomies: changing trends, lessons learned." Ann Surg, 246(3):363-72: discussion 372-4, 2009, PMID 17717440 PMCID PMC1959358
  • Paczesny S, Krijanovski O, Braun TM, Choi S, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A, Bickley D, Jones D, Whitfield J, Reddy P, Levine JE, Hanash SM, Ferrara JLM: "A biomarker panel for acute graft versus host disease." Blood (113): 273-278, 2009.
  • Paczesny S, Levine J, Braun TM, Ferrara, JLM.: "Plasma Biomarkers in GVHD: A New Era?" Biology of Blood and Marrow Transplantation (15): 33-38, 2009, PMID 19147075 PMC2644447.
  • Park J, Rosania GR, Shedden KA, Nguyen M, Lyu N, Saitou K: "Automated extraction of chemical structure information from digital raster images." Chem Cent J, 3(1):4, 2009, PMID:19196483, PMC2648963.
  • Piert M, Park H, Khan A, Sddiqui J, Hussain HK, Chenevert TL, Wood D, Johnson TD, Shah RB, Meyer CR: "Detection of aggressive primary prostate cancer with 11C-Choline PET/CT utilizing multi-modality fusion techniques." J Nuclear Med, 50, 2009, 15851593 NIHMSID: NIHMS170399
  • Proust-Lima C, Taylor JM. Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of prosttreatment PSA: a joint modeling approach. Biostatistics, 10(3):535-49, 2009, PMCID: PMC2697347.
  • Sabel MS, Rogers K, Griffith KA, Jagsi R, Kleer CG, Diehl KA, Breslin TM, Cimmino VM, Chang AE, and Newman LA: "Residual Disease After Re-excision Lumpectomy for Close Margins." J. Surg. Oncol, 99:99-103, 2009, PMID 19065638
  • Sargent D, Taylor, JMG: "Current Issues in Oncology Drug Development, with a Focus on Phase II Trials." J Biopharm Stat, 19(3): 556-62, 2009, 19384696.
  • Schneider BJ, Worden FP, Gadgeel SM, Parchment RE, Hodges CM, Zwiebel J, Dunn RL, Wozniak AJ, Kraut MJ, Kalemkerian GP: "Phase II Trial of Fenretinide (NSC 374551) in Patients with Recurrent Small Cell Lung Cancer." Investigational New Drugs, 27(6): 571-78, 2009.
  • Scisney-Matlock M, Grand A, Steigerwalt SP, Normolle D: "Reliability and reproducibility of clinic and home blood pressure measurements in hypertensive women according to age and ethnicity." Blood Press Monit, 14(2):49-57, 2009, PMID: 19305185
  • Shen RL, Taylor JMG, Ghosh D: "Reconstructing Tumor-wise Protein Expression in Tissue Microarray Studies Using a Bayesian Cell Mixture Model." Bioinformatics, 24(24): 2880-6, 2009
  • Soliman AS, Banerjee M, Ismail K, Hablas A, Seifeldin IA, Ramadan M, El-Hamzawy H, Fokuda A, Lo AC, Harford JB, Merajver SD: "High Proportion of Inflammatory Breast Cancer in the Population-Based Cancer Registry of Gharbiah, Egypt." The Breast Journal, 15:432-34, 2009.
  • Soto, DE, Andridge, R, Pan, CC, Williams, S, Taylor, JMG, Sandler, HM: "Determining if Pretreatment PSA Doubling Time Predicts PSA Trajectories After Radiation Therapy for Localized Prostate Cancer: A Linear Mixed Model Analysis." Radiotherapy and Oncology, 90(3): 389-94, 2009
  • Soto DE, Daignault S, Sandler H, Ray M. "No Effect of Statins on Biochemical Outcomes after Radiation Therapy for Localized Prostate Cancer." Urology, 73(1): 158-62, 2009.
  • Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB: "Risk of Colorectal and Endometrial Cancer in Lynch Syndrome." Gastroenterology, 137,1621-27, 2009.
  • Strecher V, McClure J, Alexander G, Chakraborty, B, Nair V, Konkel J, Greene S, Couper M, Carlier C, Wiese C, Little R, Pomerleau C, Pomerleau O: "The Role of Engagement in a Tailored Web-Based Smoking Cessation Program: Results of a Randomized Trial." J Medical Internet Research, 10(5): e36, 2009, PMCID: PMC2630833.
  • Strope SA, Daignault S, Hollingsworth JM, Ye Z, Wei JT, Hollenbeck BK. "Physician ownership of ambulatory surgery centers and practice patterns for urological surgery: evidence from the state of Florida." Med Care. 47(4):403-10, 2009. PMCID: PMC2743534.
  • Vilar E, Mukherjee B, Kuick R, Raskin L, Misek D, Taylor JMG, Giordano T, Hanash S, Fearon ER, Rennert G, Gruber S: "Gene Expression Patters in Mismathc Repart-D Eficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Pl3K-AKT-mTOR Pathway." Clinical Cancer Research, 15(8): 2829-39, 2009
  • Wang, R., Morris, D., Tomlins, S., Lonigro, R., Tsodikov, A., Mehra, R., Giordano, T., Kunju, L.P., Lee, C., Weizer, A., Chinnaiyan, A. (2009) Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non-Muscle-Invasive Bladder Cancer, Can Res, Vol. 69(9), 3810-3818, PMCID: PMC2713755.
  • Wang Y, Wu R, Cho KR, Thomas DG, Gossner G, Liu JR, Giordano TJ, Shedden KA, Misek DE, Lubman DM: "Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage." J Proteome Res., (3):1452-63, 2009, PMID: 19159301
  • Weizer AZ, Wasco MJ, Wang R, Daignault S, Lee CT, Shah RB. "Multiple adverse histological features increase the odds of under staging T1 bladder cancer." J Urol, 182(1):59-65, 2009, PMID 19447443.
  • Worden FP, Moyer J, Lee JS, Taylor JMG, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Hogikyan N, Lassig AA, Emerick K, Mukherji S, Hadjiyski L, Tsien CI, Miller TH, Wallace NE, Mason HL, Bradford CR, Wolf GT: "Chemo-selection as a Strategy for Organ Preservation in Patients with T4 Laryngeal Squamous Cell Carcinomawith Cartilage Invasion." Laryngoscope, 119(8): 1510-17, 2009, PMCID: PMC2739984.
  • Yan B, Noone AM, Yee C, Banerjee M, Schwartz K, Simon MS: "Racial Differences in Colorectal Cancer Survival in the Detroit Metropolitan Area." Cancer, 115:3791-3800, 2009.
  • Zhang L, Mukherjee B, Hu B, Moreno V, Cooney K: "Semiparametric Bayesian modeling of random genetic effects in family based association studies." Stats in Med, 28, 113-139, 2009.
  • Zick S, Ruffin M, Lee J, Normolle D, Siden R, Alrawi S, Brenner D: "Phase II Trial of Encapsulated Ginger as a Treatment for Chemotherapy-Induced Nausea and Vomiting." Supportive Care in Cancer 17(5): 563-72., 2009, PMID: 19005687.
  • Zhao L, Woodworth G, Bayesian Decision-Theoretic Group Sequential Analysis with Survival Endpoints, Stat Med, 28:1339–1352, 2009

 
  • Banerjee M, Noone A.M. Tree-Based Methods for Survival Data. Statistical Advances in Biomedical Sciences: State of the Art and Future Directions (Eds. M. Segal, S. Datta, J. Fine). 265-285, 2008.
  • Braun TM, Alonzo TA: "A Modified Sign Test for the Comparison of Paired ROC Curves." Biostatistics, (9):364-72, 2008.
  • Brown, M, Tsodikov, A, Bauer, KR, Parise, CA, Caggiano, V: "The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor‐negative, invasive breast cancer: The California Cancer Registry, 1999–2004." Cancer, 112(4):737-47, 2008.
  • Cao, Y., Pan, C., Balter, J., Platt, J., Francis, I., Knol, J., Normolle, D., Ben-Josef, E., Ten Haken, R., Lawrence, T: "Liver Function After Irradiation Based Upon Computed Tomographic Portal Vein Perfusion Imaging" Intl J Radiat Oncol Biol Phys, 70(1):154-160, 2008, PMC2714771.
  • Chen W, Ghosh D, Raghunathan TE, Sargent DJ: "A false-discovery-rate-based loss framework for selection of interactions." Stat Med 27:204-21, 2008.
  • Chepeha DB, Fung K, Sacco AG, Jones L, Bradford CR, Lee JS, Moyer JS, Teknos TN, Shargorodsky J, Nussenbaum B, Eisbruch A, Prince ME, Wolf GT: "Lateral Oromandibular Defect: When is it a ppropriate to use a bridging reconstruction plate combined wth a soirt-tissue revascularized flap." Head and Neck, 30(6): 709-17, 2008
  • Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki
  • J, Clarke MF: "Isolation and Molecular Characterization of Cancer Stem Cells in MMTV-Wnt-1 Murine Breast Tumors." Stem Cells, 26(2):364-71, 2008.
  • Choi H, Ghosh D: "A comparison of meta-analysis methods of gene expression data." Statistical Advances in the Biomedical Sciences, 325-339, 2008.
  • Choi H, Ghosh D, Nesvizhskii AI: "Statistical validation of Peptide identifications in large-scale proteomics using the target-decoy database search strategy and flexible mixture modeling." J Proteome Res, 7(1):286-92, 2008.
  • Choi SW, Kitko CL, Braun T, Paczesny S, Yanik G, Mineishi S, Krijanovski O, Jones D, Whitfield J, Cooke K, Hutchinson RJ, Ferrara JLM, Levine JE: "Change in Plasma Tumor Necrosis Factor Receptor 1 Levels in the First Week Post-Myeloablative Allogeneic Transplant Correlates with Severity and Incidence of GVHD and Survival." Blood (112): 1539-1542, 2008.
  • Cooper S, Shedden K: "Microarray and the Relationship of mRNA Variation to Protein Variation during the Cell Cycle." J Theor Biol, 249(3): 574-81, 2007.
  • Dillman JR, Caoili EM, Cohan RH, Ellis JH, Francis IR, Schipper MJ. Detection of upper tract urothelial neoplasms: Sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography. Abdominal Imaging 2008: 33(6):707-16.
  • Duffy, S, Taylor, JMG, Terrell, J, Islam, M, Yuan, Z, Fowler, K, Wolf, G, Teknos, T: "IL-6 Predicts Recurrence Among Head and Neck Cancer Patients." Cancer, 113(4): 750-7, 2008.
  • Ehrlich M, Sanchez C, Shao C, Nishiyama R, Kehrl J, Kuick R, Kubota T, Hanash SM: "ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation.: Autoimmunity, 41(4):253-71, 2008.
  • Etzioni, R, Tsodikov, A, Mariotto, A, Szabo, A, Falcon, S, Wegelin, J, diTommaso, D, Karnofski, K, Gulati, R, Penson, D, Feuer, E: "Quantifying the role of PSA screening in the US prostate cancer mortality decline" Cancer Causes and Control, 19(2): 175-81, 2008, PMC18027095.
  • Felix A.S., Soliman A.S., Khaled H., Zaghloul M.S., Banerjee M., El-Baradie M., El-Kalawy M., Awny A., Ismail K., Hablas A., Seifeldin I.A., Ramadan M., Wilson M.L: "The Changing Patterns of Bladder Cancer in Egypt over the Past 26 Years." Cancer Causes and Control, 19:421-29, 2008.
  • Frankel TL, Griffith KA, Lowe L, Wong SL, Bichakjian DK, Chang AE, Cimmino VM, Bradford CR, Rees RS, Johnson TM, and Sabel MS: "Do micromorphometric features of metastatic deposits within sentinel nodes predict non-sentinel lymph node involvement in melanoma?" Ann Surg Oncol, 15(9):2403-2411, 2008
  • Gilbert SM, Daignault S, Weizer AZ, Wei JT, Hollenbeck BK. "The use of tumor markers in testis cancer in the United States: a potential quality issue." Urol Oncol, 26(2):153-7, 2008.
  • Gilbert SM, Dunn RL, Miller DC, Daignault S, Ye Z, Hollenbeck BK. "Mortality After Urologic Cancer Surgery: Impact of Non-index Case Volume." Urology. 71(5):906-10, 2008.
  • Ghosh D: "Semiparametric inference for surrogate endpoints with bivariate censored data." Biometrics, 64(1):149-56, 2008.
  • Ghosh, D., Banerjee, M. and Biswas, P: "Inference for constrained estimation of tumor size distributions." Biometrics, 64(4): 1009-17, 2008
  • Gu WJ, Choi HW, Ghosh D: "Global associations between copy number and transcript mRNA expression: an empirical study." Cancer Informatics 4:7-23, 2008.
  • Hall C, Daignault S, Shah R, Pienta K, Keller E: "Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis." Prostate, 68(13): 1396-404, 2008.
  • Hamstra, DA, Galb, CJ, Meyer, CR, Johnson, TD, Sundgren, PC, Tsien, C, Lawrence, TS, Junck, L, Rehemtulla, A, Ross, BD, Chenevert, TL: "The functional diusion map (fDM) as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival." J Clin Oncol 46:3387-3394, 2008.
  • He H, Gu Q., Zheng M., Normolle D., Sun Y: "SAG/ROC2/RBX2 E3 Ligase Promotes UVB-Induced Skin Hyperplasia, But Not Skin Tumors, By Simultaneously Targeting c-Jun/AP-1 And p27" Carcinogenesis, 29(4): 858-65, 2008.
  • Herman JM, Pierce LJ, Sandler HM, Griffith KA, Jabbari S, Hiniker SM and Johnson TM: "Radiotherapy is effective for treatment of Bowen’s Disease." Radiotherapy and Oncology, 88(3): 398-402, 2008
  • Ignatoski KM, Escara-Wilke JF, Dai JL, Lui A, Dougall W, Daignault S, Yao Z, Zhang J, Day ML, Sargent EE, Keller ET. "RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model." Prostate, 68(8):820-9, 2008.
  • Khan MK, Minc LD, Nigavekar SS, Kariapper MST, Nair BM, Schipper MJ, Cook AC, Lesniak WG and Balogh LP. Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine: Nanotechnology, Biology, and Medicine 2008: 4(1): 57-69.
  • Kim H, Wu R, Cho KR, Thomas DG, Gossner G, Liu JR, Giordano TJ, Shedden KA, Misek DE, Lubman DM: "Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas." Proteomics Clin Appl, 2(4):571-584, 2008, PMID 20523764 PMCID PMC2879670
  • Kim SP, Sarmast Z, Daignault S, Faerber GJ, McGuire EJ, Latini JM. "Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan." J Urol, 179(5):1912-6, 2008.
  • Kitko CL, Paczensny S, Yanik G, Braun T, Jones D, Whitfield J, Choi S, Hutchinson RJ, Ferrara JLM, Levine JE: "Early Elevations of TNFR1 at Day 7 Post Allogeneic Transplant Correlate with Severity of GVHD and Overall Survival in Pediatric Patients." Biology of Blood and Marrow Transplantation (14): 759-765, 2008.
  • Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha
  • DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JMG, D’Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR, Carey TE: "EGFR, p16, HPV Titer, Bcl-xL and p53, Sex and Smoking as Indicators of Response to Therapy and Survival in Oropharyngeal Cancer." J Clin Oncol, 26(19): 3128-37, 2008.
  • Kujawski L, Ouillette P, Erba H, Saddler C, Jakubowiak A, Kaminski M, Shedden K, Malek S: "Genomic Complexity Identifies Patients with Aggressive Chronic Lymphocytic Leukemia". Blood, 112(5): 1993-2003, 2008.
  • Lakshmi K. You L, Zhang Y, Daignault S, Montie J, Lee CT. "A Comparison of Lymphovascular Invasion in Urothelial Cancer in Matched TURBT and Radical Cystectomy Specimens" J Urol. in 180(5): 1928-32, 2008.
  • Lo AC, Georgopoulos A, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Omar HG, Douglas JA, Merajver SD, Soliman AS: "Molecular Differences between Inflammatory and Non-Inflammatory Breast Cancers in Egyptian Patients." Breast Can Res Treat, 112:141-47, 2008.
  • Laxman, B, Morris, DS, Yu, J, Siddiqui, J, Cao, J, Mehra, R, Lonigro, RJ, Tsodikov, A, Wei, JT, Tomlins, SA, Chinnaiyan, AM: "A First Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer." Cancer Research, 68: 645-49, 2008.
  • Lee A, Shedden K, Rosania G, Crippen G: "Data Mining the NC160 to Predict Generalized Cytotoxicity." J Chem Inf Model, 48(7):1379-88, 2008.
  • Lee C, Johnson E, Daignault S. "Patterns of Hematuria Referral to Urologists: "Does A Gender Disparity Exist?" Urology, 72(3): 498-502, 2008.
  • Levine JE, Paczesny S, Mineishi S, Braun T, Choi SW, Hutchinson RJ, Jones D, Khaled Y, Kitko CL, Krijanovski O, Reddy P, Yanik G, Ferrara JLM: "Etanercept Plus Methlyprednisolone as Initial Therapy for Acute GVHD." Blood, (111): 2470-75, 2008.
  • Lin A, Abu-Isa E, Griffith KA, and Ben-Josef E: "Toxicity of Radiotherapy in Patients with Collagen Vascular Disease (CVD)." Cancer, 113(3):648-53. 2008
  • Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Douglas J, Hensley-Alford S, Merajver SD, Soliman AS: "Molecular Epidemiologic Features of Inflammatory Breast Cancer: A Comparison between Egyptian and U.S. Patients: "Breast Cancer Research and Treatment, 112(1): 141-7, 2008.
  • Long, Q, Little, RJ, and Lin, X: "Causal Inference in Hybrid Intervention Studies Involving Treatment Choice." JASA, 103, 474-485, 2008.
  • Madoz-Gurpide J, Kuick R, Wang H, Misek DE, Hanash SM: "Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response." Mol Cell Proteomics, 7(2):268-81, 2008.
  • Miller DC, Daignault S, Wolf JS Jr, Hafez KS, Kieran K, Dunn RL, Hollenbeck BK. "Hospital Characteristics and Use of Innovative Surgical Therapies Among Patients With Kidney Cancer." Med Care. 46(4):372-379, 2008.
  • Miller D, Saigal C.S., Banerjee M., Hanley J.,Litwin M.S: "Diffusion of surgical innovation among patients with kidney cancer." Cancer, 112(8):1708-17, 2008.
  • Mitra RS, Goto M, Lee JS, Maldonado D, Taylor JMG, Pan Q, Carey TE, Bradford CR, Prince ME, Cordell KG, Kirkwood KL, D’Silva NJ: "Rap1GAP Promotes Invasion via Induction of MMP-9 Secretion, Which is Associated with Poor Survival in Early N-Stage Squamous Cell Carcinoma." Cancer Research, 68(10): 3959-69, 2008.
  • Movva S., Noone A.M., Banerjee M., Patel D.A., Schwartz K., Simon M.S: "Racial Differences in Cervical Cancer Survival in the Detroit Metropolitan Area." Cancer. 112(6):1264-71, 2008.
  • Nair V, Strecher V, Fagerlin A, Ubel P, Resnicow K, Murphy S, Little R, Chakraborty B, Zhang A: "Screening Experiments and Fractional Factorial Designs in Behavioral Intervention Research." Am J Public Health, 98, 8, 1354-59, 2008.
  • Nease DE, Ruffin MT, Jimbo M, Klinkman MS, Braun TM, Underwood J: "Impact of a Generalizable Reminder System on Colorectal Cancer Screening in Diverse Primary Care Practices: A Report From the Prompting and Reminding at Encounters for Prevention Project." Medical Care (46): S68-S73, 2008.
  • Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek S: "Intregrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14." Cancer Res, 68(4): 1012-21, 2008.
  • Paczesny S, Levine J, Braun TM, Ferrara, JLM.: "Plasma Biomarkers in GVHD: A New Era?" Biology of Blood and Marrow Transplantation (15): 33-38, 2008.
  • Peres, E, Abidi MH, Mellon-Reppen S, Klein J, Braun T, Abella E, Dansey, R: "Reduced Intensity Transplantation for Metastatic Renal Cell Cancer With 2-year Follow-up." Journal of Immunotherapy (30): 562-566, 2008.
  • Picchio, M, Beck, R, Haubner, R, Seidl, S, Johnson, TD, Wester, H, Reischl, G, Schwaier,M, Piert, M: "Intratumoral spatial distribution on hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography." Journal of Nuclear Medicine 49:597-605, 2008
  • Proust-Lima, Taylor, JMG, Williams SG, Ankerst, DP, Liu, N, Kestin, LL, Bae, K, Sandler, H: "Determinants of Change in Prostate-Specific Antigen Over Time and Its Association with Recurrence After External Beam Radiation Therapy for Prostate Cancer in Five Large Cohorts." Intl J Radiat Oncol Biol Phys, 72(3): 782-791, 2008, PMCID: PMC2757130.
  • Qiu Y, Patwa T, Xu L, Shedden K, Misek D, Tuck M, Jin G, Ruffin M, Turgeon D, Synal S, Bresalier R, Marcon N, Brenner D, Lubman D: "Plasma Glycoprotein Profiling for Colorectal cancer Biomarker Identification by Lectin Clycoarray and Lectin Blot." J Proteome Res, 7(4):1693-703, 2008.
  • Quint LE, Cheng J, Schipper MJ, Chang A, Kalemkerian G: "Lung Lesion Doubling Times: Values and Variability Based on Method of Volume Determination." J Clin Radiol, 63(1): 41-8, 2008.
  • Redman BG, Chang AE, Whitfield J, Esper P, Jiang G, Braun T, Roessler B, Mule JJ: "Phase Ib Trial Assessing Autologous, Tumor-Pulsed Dendritic Cells as a Vaccine Administered With or Without IL-2 in Patients with Metastatic Melanoma." Journal of Immunotherapy (31): 591-598, 2008.
  • Rufener SL, Patel S, Kazerooni EA, Schipper MJ and Kelly AM. Comparison of on-call radiology resident and faculty interpretation of 4 and 16-row multidetector CT pulmonary angiography with indirect CT venography. Academic Radiology 2008: 15(1) 71-6.
  • Saddler C, Ouillette P, Kujawski L, Shangary S, Talpaz M, Kaminski M, Erba H, Shedden K, Wang S, Malek SN: "Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia." Blood, 111(3):1584-93, 2008.
  • Sangha N, Wu R, Kuick R, Powers S, Mu D, Fiander D, Yuen K, Katabuchi H, Tashiro H, Fearon ER, Cho KR: :"Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations." Neoplasia. 10(12):1362-72, 2008
  • Schipper, MJ, Taylor, JMG, Lin, X: "Generalized Monotonic Functional Mixed Models with Application to Modeling Normal Tissue Complications." Applied Statistics, 57(2), 149-163, 2008
  • Schulte R, Wood D, Daignault S, Shah R, Wei J. "Utility of Extended Pattern Prostate Biopsies for Tumor Localization: Pathologic Correlations following Radical Prostatectomy." Cancer, 113(7): 1559-65, 2008.
  • Shedden K, Taylor JMG, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG: "Gene Expression-Based Survival Prediction in Lung Adenocarcinoma: a Multi-Site, Blinded Validation Study." Nature Medicine 14, 822-827, 2008
  • Shen R, Ghosh, D, Taylor, JMG: "Modeling Intra-tumor Protein Expression Heterogeneity in Tissue Microarray Experiments." Statistics in Medicine, 27(11): 1944-59, 2008, PMCID: PMC2753194
  • Siddiqui MA, Griffith KA, Michael CW, and Pu RT: "Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration." Cancer Cytopathol. 114:27-33, 2008
  • Sinha S, Gruber SB, Mukherjee B, Rennert G: "Inference of the haplotype effect in a matched case-control study using unphased genotype data." Int J Biostat 4(1): article 6, 2008, PMCID: PMC2835450.
  • Siu W. Daignault S. Miller DC. Dunn RL. Gilbert S. Weizer AZ. Ye Z. Hollenbeck BK. "Understanding differences between high and low volume hospitals for radical prostatectomy." Urol Oncol, 26(3):260-5, 2008.
  • Smith DC, Mackler NJ, Dunn RL, Hussain M, Wood D, Lee CT, Sanda M, Vaishampayan U, Petrylak DP, Quinn DI, Beekman K, Montie JE: "Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder." J Urol, 180(6):2384-8: discussion 2388, 2008, PMID 18930256 PMCID PMC2716704
  • Soliman AS, Banerjee M, Ismail K, Hablas A, Seifeldin IA, Ramadan M, El-Hamzawy H, Fokuda A, Lo AC, Harford JB, Merajver SD: "High Proportion of Inflammatory Breast Cancer in the Population-Based Cancer Registry of Gharbiah, Egypt." The Breast Journal, in press, 2008.
  • Soto, DE, Andridge, R, Pan, CC, Williams, S, Taylor, JMG, Sandler, HM: "In Patients Experiencing Biochemical Failure after Radiation Therapy Pretreatment Risk Group and PSA Velocity Predict Differences in Overall Survival and Biochemical Failure Free Interval." Intl J Radiat Oncol Biol Phys, 71(5): 1295-301, 2008.
  • Soto, DE, Andridge, R, Taylor, JMG, Mclaughlin, PW, Sandler, HM, Pan, CC: "Predicting Biochemical Failure and Overall Survival Through Intra-therapy PSA Changes During Definitive External Beam Radiation." Intl J Radiat Oncol Biol Phys, 72(5): 1408-15, 2008.
  • Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaghulin PW, Ray ME, Sandler HM, Pan CC: "Impact of Common Iliac Nodal Treatment on Radiation Outcomes in Localized Prostate Cancer." Urology 71: 313-317, 2008.
  • Stoffel EM, Turgeon DK, Stockwell DH, Normolle DP, Tuck MK, Marcon NE, Baron JA, Bresalier RS, Arber N, Ruffin MT, Syngal S, Brenner DE: Great Lakes New England Clinical Epidemiology and Validation Center of the Early Detection Research Network. "Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying." Cancer Prevention Research 1(7): 507-13, 2008.
  • Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, Bresalier RS, Marcon NE, Baron JA, Ruffin MT, Brenner DE, Syngal S: Great Lakes-New England Clinical Epidemiology and Validation Center of the Early Detection Research Network. "Missed Adenomas During Colonoscopic Surveillance in Individuals with Lynch Syndrome (HNPCC). Cancer Prevention Research 1(6): 470-475, 2008, PMC2671076.
  • Strecher V, McClure J, Alexander G, Chakraborty B, Nair V, Konkel J, Greene S,
  • Collins L, Carlier C, Wiese C, Little R, Pomerleau C, Pomerleau O: "Web-Based Smoking Cessation Components and Tailoring Depth: Results of A Randomized Trial." Am J Prev Med, 34(5), 373-381, 2008.
  • Strecher V, McClure J, Alexander G, Chakraborty B, Nair V, Konkel J, Greene S, Couper M, Carlier C, Wiese C, Little R, Pomerleau C Pomerleau O: "The Role of Engagement in a Tailored Web-Based Smoking Cessation Program: Results of a Randomized Trial." Journal of Medical Internet Research, 10, 5, e36, 2008.
  • Sundaram B, Gross BH, Martinez FJ, Oh E, Müller NL, Schipper MJ and Kazerooni EA. Impact of the Predominant Findings on the Accuracy of High Resolution Computerized Tomography (HRCT) for the Diagnosis of Diffuse Lung Disease." Am J Radiol, 191(4):1032-9, 2008.
  • Tan HJ. Stoffel J. Daignault S. McGuire EJ. Latini JM. "Ileovesicostomy for adults with neurogenic bladders: complications and potential risk factors for adverse outcomes." Neurourology & Urodynamics. 27(3):238-43, 2008.
  • Taylor BS, Pal M, Yu J, Laxman B, Sundaram SK, Zhao R, Menon A, Wei JT, Nesvizhskii AI, Ghosh D, Omenn GS, Lubman DM, Chinnaiyan AM, Sreekumar A: "Humoral response profiling reveals pathways to prostate cancer progression." Mol Cell Proteomics 7(3): 600-11, 2008.
  • Taylor JMG, Ankerst DP, Andridge RR: "Validation of Biomarker-based Risk Prediction Models." Clin Can Res, 14(19): 5977-83, 2008.
  • Tomlins, SA, Rhodes, DR, Yu, J, Varambally, S, Mehra, R, Perner, S, Demichelis, F, Helgeson, BE, Laxman, B, Morris, DS, Cao, Q, Cao, X, Andrén, O, Fall, K, Johnson, L, Wei, JT, Shah, B, Al-Ahmadie, H, Eastham, JA, Eggener, SE, Fine, SW, Hotakainen, K, Stenman, UH, Tsodikov, A, Gerald, WL, Lilja, H, Reuter, VE, Kantoff, PW, Scardino, PT, Rubin, MA, Bjartell, AS, Chinnaiyan, AM: "The Role of SPINK1 in ETS Rearrangement Negative Prostate Cancers." Cancer Cell. 13(6): 519-528, 2008.
  • Tsodikov A, Chefo S: "Generalized Self-Consistence: Multinomial Logit Model and Poisson Likelihood." J Stat Planning and Inference, 138(8):2380-97, 2008.
  • Woods Ignatoski KM, Friedman J, Escara-Wilke J, Zhang X, Daignault S, Dunn RL, Smith DC, Keller ET. "Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to Therapy." J Interferon Cytokine Res, 2008.
  • Worden FP, Kumar B, Lee J, Wolf G, Cordell KG, Taylor JMG, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Tsien CI, D’Silva NJ, Yang K, Kurnit DM, Mason, HL, Miller T, Wallace N, Bradford CR, CareyTE: "Chemoselection as a Strategy for Organ Preservation in Advanced Oropharnyx Cancer: Response and Survival Positively Associated with HPV16 Copy Number." JCO, 26(19):3138-46, 2008, PMCID: PMC2742158
  • Yanik GA, Ho VT, Levine J, White ES, Braun T, Antin J, Whitfield J, Custer J, Jones D, Ferrara JLM, Cooke KR: "The Impact of Soluble Tumor Necrosis Factor Receptor: Etanercept on the Treatment of Idiopathic Pneumonia Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation." Blood (112): 3073-308, 2008.
  • Ye W, Lin X, Taylor JMG: "A Penalized Likelihood Approach to Joint Modeling of Longitudinal and Time-to-event Data. Statistics and Its Interface, 1:33-45, 2008 2008.
  • Ye W, Lin X, Taylor JMG: "Semiparametric Modeling of Longitudinal Measurements and Time-To-Event Data- A Two-Stage Regression Calibaration Approach." Biometrics, 64:1238-46, 2008.
  • Yu J, Yu J, Cordero KE, Johnson MD, Ghosh D, Chinnaiyan AM, Rae JM, Lippman ME: "A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival." Neoplasia 10, 79-88, 2008.
  • Yu, M, Taylor, JMG, Sandler, H: "Individualized Prediction In Prostate Cancer Studies Using a Joint Longitudinal-Survival-Cure Model." JASA, 103(481):178-187, 2008.
  • Yuan Z, Ghosh D: "Combining multiple biomarkers in logistic regression." Biometrics, 64(2): 431-9, 2008.
  • Zhang L, Mukherjee B, Ghosh M, Gruber S, Moreno V: "Misclassification of exposures in case-control studies of gene-environment interaction." Stats in Med, 27: 2756-2783, 2008.
  • Zhang X, Johnson TD, Little RJA, Cao Y: "Quantitative magnetic resonance imaging via the EM algorithm with stochastic variation." Annals of Applied Statistics (2): 736-755, 2008, PMCID: PMC2799942

 
  • Allen, A, Elshaikh, M, Worden, F, Bradford, C, Teknos, T, Chepeha, D, Hogikyan, N, Tsien, C, Dawson, L, Erba, S, Wolf, G, Normolle, D, Eisbruch, A: "Acceleration of a Hyperfractionated Chemoirradiation Regimen for Head and Neck Cancer Combined With Aggressive Nutritional Support." Head & Neck, 29: 137-42, 2007.
  • Banerjee M., George J., Yee C., Hryniuk W., Schwartz K: "Disentangling the Effects of Race on Breast Cancer Treatment." Cancer, 110:2169-2177, 2007.
  • Bauer JA, Kumar B, Cordell K, Prince ME, Tran HH, Wolf GT, Chepeha DB, Teknos TN, Wang S, Eisbruch A, Tsien C, Urba SG, Worden FP, Lee JS, Griffith KA, Taylor JMG, D'Silva NJ, Wang S, Wolter KG, Henson B, Fisher SG, Carey TE, Bradford CR: "Targeting Apoptosis to Overcome Cisplatin Resistance: A Translational Study in Head and Neck Cancer." Int J Rad Onc Biol Phys, 69(2): S106-8, 2007.
  • Beebe-Dimmer J, Dunn RL, Sarma A, montie JE, Cooney KA: "Features of the Metabolic Syndorme and Prostae Cancer in African-American Men." Cancer, 109(5): 875-881, 2007.
  • Ben-David MA, Sturtz DE, Griffith KA, Douglas KR, Hayman JA, Lichter AS, and Pierce LJ: "Long-term Results of Conservative Surgery and Radiotherapy for Ductal Carcinoma In-situ Using Lung Density Correction:" The University of Michigan Experience. The Breast Journal, 13(4):392-400, 2007
  • Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, MacDougald OA, Cho KR, Fearon ER. "p53-mediated activation of miRNA34 candidate tumor-suppressor genes." Curr Biol. 17(15):1298-307, 2007.
  • Boocock, D., Patel, K., Faust, G., Normolle, D., Marczylo, T., Brenner, D. Booth, T., Gescher, A., Steward, W: "Quantitation of Trans-Resveratrol and Detection of its Metabolites in Human Plasma and Urine by High Performance Liquid Chromatography." J Chromatography B,.848(2): 182-187, 2007
  • Bradley DA, Dunn R, Nanus D, Stadler W, Dreicer R, Rosenberg J, Smith DC, Hussain M: "Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design." Clin Genitourin Cancer, 5(7):460-3, 2007, PMID 18272031 PMCID
  • Braun TM: "A Mixed Model-Based Variance Estimator for Marginal Model Analysis of Cluster Randomized Trials." Biometrical Journal, 49(3): 394-405, 2007
  • Braun TM, Thall PF, Nguyen H, de Lima M: "Simultaneously Optimizing Dose and Schedule of a New Cytotoxic Agent." Clinical Trials (4): 113-124, 2007.
  • Brenner, D., Normolle, D: "Biomarkers for Cancer Risk, Early Detection, and Prognosis: The Validation Conundrum." Can Epid Biomarkers Prevention, 16:1918-1920, 2007.
  • Cao, Y., Platt, J., Francis, I., Balter, J., Pan, C., Normolle, D., Ben-Josef, E., Ten Haken, R., Lawrence, T: "The Prediction of Radiation-Induced Liver Dysfunction Using a Local Dose and Regional Venous Perfusion Model." Medical Physics 34(2): 604-612, 2007.
  • Chen G, Wang X, Yu J, Varambally S, Yu J, Thomas DG, Wang Z, Fielhauer J, Ghosh D, Giordano TJ, Giacherio D, Chang AC, Orringer MB, Bigsbee W, Beer, DG, Chinnaiyan AM: "Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma." Cancer Research, 67: 3461-67, 2007.
  • Choi H, Shen R, Chinnaiyan AM, Ghosh D: "A Latent Variable Approach for Meta-Analysis of Gene Expression Data from Multiple Microarray Experiments." BMC Bioinformatics, 27:8 (1):364, 2007.
  • Chugh R, Wagner T, Griffith KA, Taylor JMG, Thomas DG, Worden FP, Leu KM, Zalupski MM, Baker, LH: "Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma." Cancer 109(11) 2315-22, 2007.
  • Chun SY, Chen F, Washburn JG, Macdonald JW, Innes KL, Zhao R, Cruz-Correa MR, Dang LH, Dang DT: "CDX2 promotes anchorage-independent growth by transcriptional repression of IGFBP-3." Oncogene, 26: 4725-29, 2007
  • Davila M, Jhala D, Ghosh D, Grizzle WE, Chakrabarti R: "Expression of LIM kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer." Mol Cancer, 6:40, 2007.
  • Desai, S., Ben-Josef, E., Normolle, D., Francis, I., Greenson, J., Simeone, D., Chang, A., Colletti, L., Lawrence, T., Zalupski, M: "Phase I Study of Oxaliplatin, Full-dose Gemcitabine and Concurrent Radiation Therapy in Patients with Pancreatic Cancer." J Clin Oncol 25(29): 4587-4592, 2007.
  • Desai SP, El-Rayes BF, Ben-Josef E, Greenson JK, Knol JA, Huang EH, Griffith KA, Philip PA, McGinn CJ, and Zalupski MM: "A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer." Am J Clin Oncol, 30(4): 340-5, 2007.
  • Feng, F., Lopez, C., Normolle, D., Varambally, S., Li, X., Chun, P., Davis, M., Lawrence, T., Nyati, M: "Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo." Clin Can Res, 13(8): 2512-2518, 2007.
  • Feng M, Murphy J, Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME: "Long-term Outcomes after Radiation Therapy for Retroperitoneal and Deep Truncal Sarcoma." Int. J. Radiation Oncology Biol. Phys. 69(1): 103-110, 2007.
  • Ghosh D: "Incorporating monotonicity into the evaluation of a biomarker." Biostatistics, 8(2): 402-413, 2007.
  • Ghosh D, Chinnaiyan AM: "Empirical Bayes identification of tumor progressor genes from microarray data." Biometrical Journal, 49(1): 68-77, 2007.
  • Gilbert S, Wood D, Weizer A, Dunn R, Lee C, Montie J, Wei J. "Measuring Health-related Quality of Life Outcomes in Bladder Cancer Patients Using the Newly Validated Bladder Cancer Index (BCI)". Cancer, 109(9): 1756-62, 2007.
  • Gilbert, S, Dunn, RL, Wei, JT: "Zoledronic Acid Initiated During the First Year of Androgen Deprivation Therapy Increases Bone Mineral Density in Patients with Prostate Cancer." J Urol, 177(4):1584-1585, 2007.
  • Gossner G, Choi M, Tan L, Fogoros SK, Griffith KA, Kuenker M, Liu JR: "Genistein induces Apoptosis and Autophagocytosis in Ovarian Cancer Cells." Gyn Onc. 105: 23-30, 2007.
  • Gu, G., Bowden, T., Normolle, D., Sun, Y: "SAG/ROC2 E3 Ligase Regulates Skin Canrcinogenesis by Stage-Dependent Targeting of c-/AP1and Iκ-α/NF-κB." J Cell Biol 178(6): 1009-1023, 2007.
  • Henry N, Dunn R, Merjaver S, Pan Q, Pienta K, Brewer G, Smith D. "Phase II Trial of Copper Depletion with Tetrathiomolybdate as an Antiangiogenesis Strategy in Patients with Hormone Refractory Prostate Cancer". Oncology, 71(3): 168-75, 2007.
  • Hollenbeck B, Daignault S, Dunn R, Gilbert S, Weizer A, Miller D. "Getting ‘Under the Hood’ of the Volume-Outcome Relationship for Radical Cystectomy". Journal of Urology, 177(6): 2095-9, 2007.
  • Hollenbeck B, Dunn R, Miller D, Daignault S, Taub D, Wei J: "Volume-Based Referral for Cancer Surgery: Informing the Debate."J Clin Oncol, 25(1):91-6, 2007.
  • Hollingsworth JM. Miller DC. Daignault S. Hollenbeck BK. "Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis." Cancer, 109(9):1763-8, 2007.
  • Hollingsworth JM. Miller DC. Daignault S. Shah RB. Hollenbeck BK. "Variable penetrance of a consensus classification scheme for renal cell carcinoma." Urology, 69(3):452-6, 2007.
  • Hsu, C., Taylor, JMG, Murray, S: "Multiple Imputation For Interval Censored Data With Auxiliary Variables." Statistics in Medicine, 26: 769-781, 2007.
  • Hussain M, MacVicar G, Petrylak D, Dunn R, Vaishampayan U, Lara P, Chatta G, Nanus D, Glode L, Trump D, Chen H, Smith D. "Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced HER2-Positive Urothelial Carcinoma: Results of a Multi-Center Phase II NCI Trial". J Clin Oncol. 25(16): 2218-2224, 2007.
  • Jagsi R, Griffith KA, Koelling T, Roberts R, and Pierce LJ: "Rates of Myocardial Infarction and Coronary Artery Disease and Risk Factors in Patients Treated with Radiation Therapy for Early Stage Breast Cancer." Cancer. 109:650-656, 2007.
  • Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J, Kumar-Sinha C, Cao X, Dash A, Wang L, Ghosh D, Shedden K, Montie JE, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM: "Integrative analysis of genomic aberrations associated with prostate cancer Progression." Cancer Res, 67(17):8229-39, 2007.
  • Kong F, Hayman J, Ten Haken R, Normolle D, Kalemkerian G, Arenberg D, Lyons S, Turrisi A, Lichter A, Fraass B, Eisbruch A, Lawrence T: "A Pilot Study of [18F]Fluorodeoxyglucose Positron Emission Tomography Scans During and After Radiation-Based Therapy in Patients With Non–Small-Cell Lung Cancer." J Clin Oncol, 25(1):3116-23, 2007.
  • Kueck A, Opipari AW, Griffith KA, Tan L, Choi M, Huang J, Wahl H, and Liu JR: "Resveratrol Inhibits Glucose Metabolism in Human Ovarian Cancer Cells." Gyn Onc 107(3):450-7, 2007
  • Kuick R, Misek DE, Monsma DJ, Webb CP, Wang H, Peterson KJ, Pisano M, Omenn GS, Hanash SM: "Discovery of cancer biomarkers through the use of mouse models." Cancer Lett, 249(1):40-8, 2007.
  • Kumar B, Cordell KG, Lee JS, Prince ME , Tran HH, Wolf GT, Urba SG, Worden FP, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JMG, D’Silva NJ, Yang K, Kurnit DM, Bradford CR, Carey TE: "Response to Therapy and Outcomes in Oropharyngeal cancer are Associated with Biomarkers Including Human Papillomavirus, Epidermal Growth Factor Receptor, Gender and Smoking." Intl J Radiat Oncol Biol Phys, 69(2): S109-S111, 2007.
  • Layman RM, Thomas DG, Griffith KA, Smerage JB, Helvie MA, Roubidoux MA, Diehl KM, Newman LA, Sabel MS, Hayman JA, Pierce LJ, Hayes DF, Schott AF: "Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer." Clin Can Res,13: 4092-97, 2007.
  • Lee C, Dunn R, Ingold C, Montie J, Wood D. "Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion". Urology, 69(6): 1068-72, 2007.
  • Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM: "Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer." Intl J Radiat Oncol, Biol, Phys, 68: 1059-1064, 2007.
  • Li, Y, Taylor, JMG, Ten Haken, R, Eisbruch, A: "The Impact of Dose on Parotid Salivary Recovery in Head and Neck Cancer Patients Treated with Radiation Therapy." Intl J Rad Onc Biol Phys, 67(3):660-669, 2007, PMC2001308.
  • Liu D, Lin X, Ghosh D:"Semiparametric regression of multidimensional genetic pathway data: least-squares kernel machines and linear mixed models." Biometrics, 63(4):1079-88 2007.
  • Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF: "The prognostic role of a gene signature from tumorigenic breast-cancer cells." N Engl J Med, 356(3):217-26, 2007.
  • Mackler N, Pienta K, Dunn R, Cooney K, Redman B, Olsen K, Fardig J, Smith D. "Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Patients with Hormone Sensitive Adenocarcinoma of the Prostate". Clinical Genitourinary Cancer, 5(5): 318-22, 2007.
  • Madi R. Daignault S. Wood DP. "Extraperitoneal v intraperitoneal robotic prostatectomy: analysis of operative outcomes." J Endourology, 21(12):1553-7, 2007.
  • Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT, Pienta KJ, Ghosh D,
  • Rubin MA, Chinnaiyan AM, Shah RB: "Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer." Mod Pathol, 20(5):538-44, 2007.
  • Miller D, Spencer B, Shah R Ritchey J, Stewart A, Gay E, Dunn R, Wei J, Litwin M. "The Quality of Surgical Pathology Care for Men Treated with Radical Prostatectomy in the United States". Cancer. 109(12) 2445-53, 2007.
  • Miller D, Spencer B, Wei J, Ritchey J, Stewart A, Dunn R, Sandler H, Litwin M. "Treatment choice and quality of care for men with localized prostate cancer". Medical Care. 45(5):401-9, 2007.
  • Montgomery JS. Gayed BA. Daignault S. Latini JM. Wood DP. Montie JE. Wei JT. Schuster TG. "Early urinary retention after catheter removal following radical prostatectomy predicts for future symptomatic urethral stricture formation." Urology, 70(2):324-7, 2007.
  • Morgan D, Dunn R, Fenner D, Faerber G, DeLancey J, McGuire E, Wei J. "Comparitive Analysis of Urinary Incontinence Severity After Autologous Fascia Pubovaginal Sling, Pelvicol Pubovaginal Sling, and Tension Free Vaginal Tape". Journal of Urology, 177(2): 604-9, 2007.
  • Morris D, Miller D, Hollingsworth J, Dunn R, Roberts W, Wolf J, Hollenbeck B. "Differential Adoption of Laparoscopy by Treatment Indication". Journal of Urology, 178(5): 2109-13, 2007.
  • Murphy JD, Adusumilli S, Griffith KA, Zalupski MM, Lawrence TS, Ben-Josef E: "Full-dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer."  Int. J. Radiation Oncology Biol. Phys. 68: 801-8, 2007.
  • Nandalur KR, Hardie AD, Raghavan P, Schipper MJ, Baskurt E, Kramer CM. Composition of the Stable Carotid Plaque: Insights from a Multidetector computed tomography study of plaque volume. Stroke 2007: 38(3):935-40.
  • Paek SC, Griffith KA, Johnson TM, Sondak VK, Wong SL, Chang AE, Cimmino VM, Bradford CR, Rees RS, and Sabel MS: "Impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma." Cancer. 109:100-8, 2007.
  • Peng, Y., Taylor, J.M.G., Yu, B.: A Marginal Regression Model for Multivariate Failure Time Data with a Surviving Fraction. Lifetime Data Analysis, 13:351-369, 2007.
  • Poisson LM, Ghosh D: "Statistical issues and analyses of in vitro and in vivo genomic data in order to identify clinically relevant profiles." Cancer Informatics, 1: 231-243, 2007.
  • Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB,
  • Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM: "Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles." Neoplasia. 9(2):166-80, 2007.
  • Rhode J, Zick S, Fogoros S, Wahl H, Griffith KA, Huang J, and Liu JR: "Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells." BMC Complementary and Alternative Medicine, 7:44, 2007
  • Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally
  • R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM: "Molecular concepts analysis links tumors, pathways, mechanisms, and drugs." Neoplasia, 9(5):443-54, 2007.
  • Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN" Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis." Clin Cancer Res, 13(16):4777-85, 2007.
  • Sabel MS, Arora A, Griffith KA, Arora A, Shargorodsky J, Blazer DG, Rees R, Wong SL, Cimmino VM, and Chang AE: "Inguinal Node Dissection for Melanoma in the Era of Sentinel Lymph Node Biopsy." Surgery. 141:728-35, 2007.
  • Schipper, MJ, Taylor, JMG, Lin, X: "Bayesian Generalized Monotonic Functional Mixed Models for the Effects of Radiation Dose Histograms on Normal Tissue Complications." Statistics in Medicine, 26(25) 4643-56, 2007.
  • Schneider BJ, El-Rayes B, Muler J, Philip PA, Kalemkarian G, Griffith KA, Zalupski MM: "Phase II Trial of Carboplatin, Gemcitabine and Capecitabine in Patients with Carcinomas of Unknown Primary Site." Cancer., 110(4): 770-775, 2007.
  • Simeone D.M., JiB.,BanerjeeM., RamachandranV., Arumugam T., Anderson M., Bamberger A.M., Liu D., Greenson J.,LogsdonCD: "CEACAM1, a Novel Serum Biomarker in Pancreatic Cancer." Pancreas, 34:436-443, 2007.
  • Sleight BS, Chan KW, Braun TM, Serrano, A, Gilman AL: "Infliximab for GVHD Therapy in Children. Bone Marrow Transplantation (40): 473-480, 2007.
  • Soliman A.S., Lo A-C., Banerjee M., El-Ghawalby N., Khaled H.M., Bayoumi S., Seifeldin I., Abdel-Aziz A., Abbruzzese J.L., Greenson J.K., Hamilton S.R: "Differences in K-ras and P53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution." Carcinogenesis, 28, 1794-1799, 2007.
  • Stender RN, Engler, WJP, Braun TM, Hankenson, C: "Establishment of Blood Analyte Intervals for Laboratory Mice and Rats Using the i-STAT * Portable Clinical Analyzer." Journal of the American Association for Laboratory Animal Science, 46(3): 47-52, 2007.
  • Taylor, JMG: "Discussion of ''Analysis of longitudinal data with drop-out: objectives, assumptions and a proposal" by P. Diggle, D. Farewell and R. Henderson." Applied Statistics, 56(5): 544, 2007
  • Taylor, JMG, Liu, N: "Statistical Issues Involved with Extending Standard Models." In: Advances in Statistical Modeling and Inferences: Essays in Honor of Kjell A. Doksum, edited by Vijay Nair, World Scientific Publishing Company, Singapore, 2007, p. 299-311.
  • Taylor JMG, Wang, L, Li, Z: "Analysis on Binary Responses with Ordered Covariates and Missing Data." Statistics in Medicine, 26 (18):3443-58, 2007.
  • Tsien C, Gomez-Hassan D, Lawrence T, Chenevert T, Lee JS, Ten Haken R, Tatro D, Junck LR, Cao Y: "Quantitative Measurement of Regional Signal Intensity Changes of High Grade Gliomas Following Radiotherapy using T1-Weighted MR1 Imaging." Intl J Radiat Oncol Biol Phys 67(5):1476-83, 2007.
  • Vaishampayan U.,Hussain M., Banerjee M., Seren S., Sarkar F.H., Fontana J., Forman J., Cher M., Powell I.J., Pontes E., Kucuk O: "Lycopene and Soy Isoflavones in the Treatment of Prostate Cancer." Nutrition and Cancer, 59:1-7, 2007.
  • Wahl H, Tan L, Griffith K, Choi M, Liu JR: "Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells." Gyn Onc. 105: 104-112, 2007.
  • Wang SH, Van Antwerp M, Kuick R, Gauger PG, Doherty GM, Fan YY, Baker JR Jr: "Microarray analysis of cytokine activation of apoptosis pathways in the thyroid." Endocrinology 148(10):4844-52 2007.
  • Wasco MJ, Daignault S, Zhang Y, Kunju, LP, Kinnaman M, Braun T, Lee, CT, Shah RB: "Urothelial Carcinoma with Divergent Histological Differentiation (Mixed Histology) is an Independent Predictor of Presence of Extravesical Tumor when Detected at Transurethral Resection." Journal of Urology, 70(1): 69-74, 2007.
  • Wei S., Kryczek I., Edwards R.P., Zou L., Szeliga W., Banerjee M., Cost M., Cheng P., Chang A., Redman B., Herberman R.B., Zou W: "Interleukin 2 Administration Alters the CD4+FOXP3+ T Cell Pool and Tumor Trafficking in Patients with Ovarian Carcinoma." Can Res, 67:7487-7494, 2007.
  • Weizer A, Joshi D, Daignault S, Kinnaman M, Hussain M, Montie J, Zhang Y, Lee C: "Performance Status is a Predictor of Overall Survival of Elderly Patients with Muscle Invasive Bladder Cancer." Journal of Urology, 177(4): 1287, 1293, 2007.
  • Weizer A, Ye Z, Hollingsworth J, Dunn R, Shah R, Wolf J, Wei J, Montie J, Hollenbeck B. "Adoption of new technology and healthcare quality: surgical margins after robotic prostatectomy". Urology, 70(1): 96-100, 2007.
  • Williams, S, Taylor, JMG, Liu, N, Tra, Y, Duchesne, G, Kestin, L, Martinez, A, Pratt, G, Sandler, H: "Use of Individual Fraction Size from 3756 Patients to Directly Determine the  ratio of prostate cancer." Int J Rad Onc Biol Phys, 68(1): 24-33, 2007.
  • Wood D, Schulte R, Dunn R, Hollenbeck B, Saur R, Wolf J, Montie J. "Short-term Health Outcome Differences between Robotic and Conventional Radical Prostatectomy". Urology, 70(5): 945-9, 2007.
  • Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho KR: "Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/beta-Catenin and PI3K/Pten Signaling Pathways." Cancer Cell, 11(4):321-33, 2007.
  • Yu J, Cao Q, Mehra R, Laxman B, Yu J, Tomlins SA, Creighton CJ, Dhanasekaran
  • SM, Shen R, Chen G, Morris DS, Marquez VE, Shah RB, Ghosh D, Varambally S,
  • Chinnaiyan AM: "Integrative genomics analysis reveals silencing of beta-adrenergic signaling by
  • polycomb in prostate cancer." Cancer Cell, 12(5):419-31, 2007.
  • Yu J, Yu J, Almal AA, Dhanasekaran SM, Ghosh D, Worzel WP, Chinnaiyan AM: "Feature selection and molecular classification of cancer using genetic programming." Neoplasia, 9(4):292-303, 2007.
  • Yu J, Yu J, Rhodes DR, Tomlins SA, Cao X, Chen G, Mehra R, Wang X, Ghosh D, Shah RB, Sooryanarayana Varambally, Kenneth J. Pienta, and Arul M. Chinnaiyan: "A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome." Cancer Res 67: 10657-10663, 2007.
  • Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, Fearon ER, Cho KR: "Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion." Cancer Res. 67(21):10163-72, 2007.
  • Zhao J, Chang AC, Li C, Shedden KA, Thomas DG, Misek DE, Manoharan AP, Giordano TJ, Beer DG, Lubman DM: "Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping." Mol Cell Proteomics, 6(6):987-99, 2007.
  • Zhao J, Patwa TH, Qiu W, Shedden K, Hinderer R, Misek DE, Anderson MA, Simeone DM, Lubman DM: "Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera." J Proteome Res 6(5):1864-74, 2007.

  • Adusumilli S, Hussain HK, Caoili EM, Weadock WJ, Murray JP, Johnson TD, Chen Q, Desjardin B: "MR imaging of sonographically indeterminate adnexal masses." Am J Roentenology 187:732–740, 2006.
  • Beebe-Dimmer J, Drake E, Dunn R, Bock C, Montie J, Cooney K. "Association between Family History of Prostate and Breast Cancer among African American Men with Prostate Cancer." Urology, 68(5): 1072-6, 2006.
  • Beekman K, Colevas A, Cooney K, DiPaola R, Dunn R, Gross M, Keller E, Pienta K, Ryan C, Smith D, Hussain M. "Phase II Evaluations of Cilengitide in Asymptomatic Patients with Androgen Independent Prostate Cancer: Scientific Rational and Study Design". Clinical Genitourinary Cancer, 4(4): 299-302, 2006.
  • Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, and Ben-Josef E: "External-Beam Radiotherapy for Localized Extrahepatic Cholangiocarcinoma." Int. J. Radiat Oncol Biol. Phys. 66(3):772-779, 2006.
  • Ben-David MA, Kleer CG, Paramagul C, Griffith KA, Pierce LJ: "Is LCIS as a Component of Breast Cancer a Risk Factor for Local Failure? Results of a Matched-Pair Analysis." Cancer. 106:28-34, 2006.
  • Bhavani, S, Bichakjian,C, Johnson, T, Little, R, Peck, F, Schwartz, J, Strecher, V: "Strategy Hubs: Domain Portals to Help Find Comprehensive Information." Journal of the American Society for Information Science and Technology, 57(1): 4-24, 2006.
  • BlazarBR, WeisdorfDJ, DeForTE, GoldmanA, Braun T, Silver S, Ferrara JLM: "A Phase I/II Randomized, Placebo-Control Trial of Palifermin to Prevent Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)." Blood (108): 3216-3222, 2006.
  • Braun, T: "Generalizing the TITE-CRM to Adapt for Early & Late-Onset Toxicities." Stat in Med, 25(12):2071-83, 2006.
  • Braun, TM., Yuan Z: "Comparing the Small Sample Performance of Several Variance Estimators under Competing Risks." Statistics in Medicine (26): 1170-1180, 2006.
  • Davis J, Wojno K, Daignault S, Hofer M, Kuefer R, Rubin M, Day M. "Elevated E2F1 Expression in Metastatic Prostate Cancer." Cancer Res, 66(24):11897-906, 2006.
  • Djuric U, El-Maarri O, Lamb B, Kuick R, Seoud M, Coullin P, Oldenburg, J, Hanash S, Slim R. "Familial molar tissues due to mutations in the inflammatory gene, NALP7, have normal postzygotic DNA methylation." Hum Genet, 120 (3):390-5, 2006.
  • Elder JT, Ghosh D, Shah RB: "Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: correlation with androgen independence." Prostate, 66: 1437-1444, 2006.
  • Fu Z, Kitagawa Y Shen R, Shah R, Mehra R, Rhodes D, Mizokami A, Dunn R, Chinnaiyan A, Keller E. "The Metastasis Suppressor Gene Raf Kinase Inhibitor Protein is a Novel Prognostic Biomarker of Prostate Cancer Recurrence". Prostate, 66(3): 248-56, 2006.
  • Ghosh D: "Modelling tumor biology-progression relationships in screening trials." Stat in Med, 25: 1872-84, 2006.
  • Ghosh, D: "Random Projection-based Clustering for Finding Cancer Subtypes in Microarray Data." Neurocomputing, 69:2258-67, 2006.
  • Ghosh D: "Semiparametric global cross-ratio models for bivariate censored data." Scandinavian Journal of Statistics, 33: 609-619, 2006.
  • Ghosh D: "Semiparametric inferences for the association parameter with semi-competing risks data." Stat in Med, 25:2059-70, 2006.
  • Ghosh D: "Shrunken p-values for assessing differential expression, with applications to genomic data analysis." Biometrics, 62: 1099-1106, 2006.
  • Ghosh D, Chen W, Raghunathan TE: "The false discovery rate: a variable selection perspective." J Stat Planning and Inference, 136: 2668-84, 2006.
  • Giordano TJ, Au AY, Kuick R, Thomas DG, Rhodes DR, Wilhelm KG Jr, Vinco M, Misek DE, Sanders D, Zhu Z, Ciampi R, Hanash S, Chinnaiyan A, Clifton-Bligh RJ, Robinson BG, Nikiforov YE, Koenig RJ: "Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation." Clin Cancer Res 12(7):1983-93, 2006.
  • Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR: "Fibroblast growth factor 9 has oncogenic activity and is a downstream target of wnt signaling in ovarian endometrioid adenocarcinomas." Cancer Res 66(3):1354-62, 2006.
  • Henry NL, Dunn RL, Merajver S, Pan Q, Pienta KJ, Brewer G, Smith DC: "Phase II trial of Copper Depletion with Tetrathiomolybdata as an Antiangiogenesis Strategy in Patients with Hormone-Refreactory Prostate Cancer." Oncology 71: 168-175, 2006.
  • Hollenbeck B, Miller D, Taub D, Dunn R, Khuri S, Henderson W, Montie J, Underwood W, Wei J. "Risk factors for adverse outcomes after transurethral resection of bladder tumors". Cancer, 106(7): 1527-35, 2006.
  • Hollenbeck B, Taub D, Miller D, Dunn R, Wei J. "National utilization trends of partial nephrectomy for renal cell carcinoma: A case of underutilization?" Urology, 67(2): 254-9, 2006.
  • Hollenbeck B, Taub D, Miller D, Dunn R, Wei J. "Utilization of Nephrectomy at Select Medical Centers: A Case of Follow the Crowd?" Journal of Urology. 175(2): 670-4, 2006.
  • Hollingsworth J, Miller D, Daignault S, Hollenbeck B. "Rising Incidence of Small, Organ-Confined Renal Masses: A Case for Overtreatment?"J Natl Cancer Inst, 20:98(18):1331-4, 2006.
  • Hollingsworth J, Miller D, Dunn R, Montgomery J, Roberts W, Hafez K, Wolf J. "Surgical Management of Low Stage Renal Cell Carconoma: Technology Does Not Supersede Biology". Urology, 67(6): 1175-80, 2006.
  • Hollingsworth J, Miller D, Dunn R, Montgomery J, Wolf J. "Cost Trends for Oncologic Renal Surgery: Support for a Laparoscopic Standard of Care". Journal of Urology, 176(3): 1097-101, 2006.
  • Hollenbeck B, Miller D, Taub D, Dunn R, Khuri S, Henderson W, Montie J, Underwood W, Wei J. "The Effects of Adjusting for Case Mix on Mortality and Length of Stay Following Radical Cystectomy". Journal of Urology, 176(4): 1363-8, 2006.
  • Hsu, C., Taylor, JMG, Murray, S, Commenges, D: "Survival Analysis Using Auxiliary Variables Via Nonparametric Multiple Imputation." Statistics in Medicine, 25:3503-3517, 2006.
  • Huang E.H., Park J.C., Appelman H., Weinberg A.D., Banerjee M., Logsdon C.D., Schmidt A.M. Induction of Inflammatory Bowel Disease Accelerates Adenoma Formation in MIN +/- Mice. Surgery, 139:782-788, 2006.
  • Huang, C, Taylor, JMG, Beer, D, Kardia, S: "Hidden Markov Model for Defining Genomic Changes in Lung Cancer using Gene Expression Data." OMICS, 10(2): 276-88, 2006.
  • Jagsi R, Griffith KA, Koelling T, Roberts R, Pierce LJ: "Stroke Rates and Risk Factors in Patients Treated with Radiation Therapy for Early Stage Breast Cancer. JCO. 24(18):2779-2785, 2006.
  • Johnson, T, Johnson, V.: "A Bayesian Hierarchical Approach to Multirater Correlated ROC Analysis." Statistics in Medicine, 25: 1858-1871, 2006.
  • Johnston W, Kelel K, Hollenbeck B, Daignault S, Wolf J S: "Acute Integrity of Closure for Partial Nephrectomy: Comparison of 7 Agents in a Hypertensive Porcine Model." Journal of Urology, 175(6):2307-11, 2006.
  • Khan MK, Mamou F, Schipper MJ, Kwitney A, Warnat A, Nair B, Kariapper MS, Brewer G, Normolle D, Merajver S and Teknos T.: "The combination of Tetrathiomolybdate (TM) and radiation therapy in an in vivo mouse tumor model of head and neck squamous cell carcinoma (HNSCC)." Archives of Otolaryngology-Head and Neck Surgery, 132(3):333-8, 2006.
  • Kleer C, Teknos T, Islam M, Marcus B, Lee JS, Pan Q, Merajver S: "RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck." Clin Can Res 12, 4485-4490, 2006.
  • Kong FM, Hayman JA, Ten Haken RK, Griffith KA, Kalemkarian GP, Arenber D, Lyons S, Turrisi A, Lichter A, Frass B, Eisbruch A, and Lawrence TS: "Final Results of a Phase I Dose Escalation Study in Patients with Non-Small Cell Lung Cancer: Predictors for Radiation Pneumonitis and Fibrosis." Int. J. Radiat Oncol Biol. Phys. 65(4):1075-1086, 2006.
  • Kubisch CH, Gukovsky I, Lugea A, Pandol SJ, Kuick R, Misek DE, Hanash SM, Logsdon CD. "Long-term ethanol consumption alters pancreatic gene expression in rats: a possible connection to pancreatic injury." Pancreas, 33(1):68-76, 2006.
  • Lao CD. Ruffin MT, Normolle D. Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE: :Dose escalation of a curcuminoid formulation." BMC Complementary & Alternative Medicine. 6:10, 2006.
  • Lee C, Dunn R, Williams C, Underwood W. "Racial Disparity in Bladder Cancer: Trends in Tumor Presentation at Diagnosis". Journal of Urology, 176(3): 927-34, 2006.
  • Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE, and Wood, Jr DP: "Cystectomy Delay More Than 3 Months from Initial Bladder Cancer Diagnosis Results in Diminished Disease Specific and Overall Survival." Journal of Urology, 175(4): 1262-7, 2006.
  • Lee KC, Hall DE, Hoff BA, Moffat BA, Sharma S, Chenevert TL, Meyer CR, Leopold, WR, Johnson TD, Mazurchuk RV, Rehemtulla A, Ross BD: "Dynamic imaging of emerging resistance during cancer therapy." Cancer Research, 66(9):4687–4692,2006.
  • Loberg R, Day L, Dunn R, Kalikin L, Pienta K. "Inhibition of Decay-Accelerating Factor (CD55) Attenuates Prostate Cancer Growth and Survival In Vivo". Neoplasia, 8(1): 69-78, 2006.
  • Macdonald J, Ghosh D: "COPA - cancer outlier profile analysis." Bioinformatics, 22: 2950-51, 2006.
  • MacGregor, JN, Li Q, Chang AE, Braun TM, Hughes DPH, McDonagh KT: "Ex vivo Culture with IL-12 Improves CD8+ T Cell Adoptive Immunotherapy for Murine Leukemia Independent of IL-18 or IFN*, but Requires Perforin." Cancer Research (66): 4913-4921, 2006.
  • Mackler N, Dunn R, Hellerstedt B, Cooney K, Esper P, Fardig J, Olson K, Pienta K, Smith D. "Dose Escalation of Oral Vinorelbine in Combination with Estramustine in Hormone Refractory Adenocarcinoma of the Prostate." Cancer, 106(12): 2617-23, 2006.
  • Mamou, F., May, K., Schipper, M., Gill, N., Kariapper, M., Nair, B., Brewer, G., Normolle, D., Khan, M. "Tetrathiomolybdate Blocks bFGF- but not VEGF- induced Incipient Angiogenesis." In Vitro, Anticancer Research26: 1753-1758, 2006.
  • McCabe M, Low J, Daignault S, Imperiale M, Wojno K, Day M: "Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer." Cancer Research. Cancer Research, 66(1):385-92, 2006.
  • McHugh JL, Su K, Griffith KA, Schwartz JL, Wong SL, Cimmino V, Change AE, Johnson TM, and Sabel MS: "Significance of Multiple Lymphatic Basin Drainage in Truncal Melanoma Patients Undergoing Sentinel Lymph Node Biopsy." Ann Surg Oncol. 13(9):1216-1223, 2006.
  • McLaughlin J, Sarma A, Wallner L, Dunn R, Campbell D, Montie J, Wei J. "Preoperative and Intraoperative Risk Factors Associated with 30-day Morbidity Following Urological Surgery: The National Surgical Quality Improvement Program". Journal of Urology, 176(5): 2179-86, 2006.
  • Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C and Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiation Oncology Biology Physics 2006: 66(2): 445-53.
  • Meyer CR, Johnson TD, McLennan, G, Aberle DR, Kazerooni EA, MacMahon H, Mullan BF, Yankelevitz DF, Van Beek EJR, Armato III, SG, McNitt-Gray MF, Reeves AP, Henschke CI, Hoffman EA, Bland PH, Pais R, Englemann RM, Croft BY, Clarke LP, The Lung Image Database Consortium: "Evaluation of Lung CT Nodule Annotations across Radiologists and Methods." Academic Radiology 13:1254–1265, 2006.
  • Meyer CR, Moffat BA, Kuszpit K, Bland P, Mckeever P, Johnson TD, Chenevert T, Rehemtulla A, Ross B: "A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information." Molecular Imaging, 5(1)16–23, 2006.
  • Miller D, Hollingsworth J, Hafez K, Daignault S, Hollenbeck B: "Partial Nephrectomy for Small Renal Masses: Is It Used Too Sparingly?" Journal of Urology, 175:853-7, 2006.
  • Miller D, Taub D, Dunn R, Wei J, Hollenbeck B. "Laparoscopy for renal cell carcinoma: diffusion versus regionalization?" Journal of Urology, 176(3): 1102-7, 2006.
  • Miller D, Wei J, Dunn R, Hollenbeck B. "Trends in the Diffusion of Laparoscopic Nephrectomy". JAMA, 295(21): 2480-82, 2006.
  • Miller D, Wei J, Dunn R, Montie J, Pimentel H, Sandler H, McLaughlin W, Sanda M. "Use of Medications or Devices for Erectile Dysfunction Among Long-term Prostate Cancer Treatment Survivors: Potential Influence of Sexual Motivation and/or Indifference." Urology. 68(1): 166-71, 2006.
  • Moffat BA, Chen, M, Kariaapper, MST, Hamstra DA, Hall DE, Stojanovska J, Johnson, TD, Blaivas M, Kumar M, Chenevert TL, Rehemtulla, A, Ross BD: "Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and upregulation of VEGF-D." Clinical Cancer Research, 12(5):1525–1532, 2006
  • Moffat BA, Chenevert TL, Meyer CR, McKeever PE, Hall DE, Hoff B, Johnson TD, Rehemtulla A, Ross BD: "The Functional Diffusion Map: An Imaging Biomarker for Early Prediction of Cancer Treatment Outcome." Neoplasia 8(4):259–267, 2006.
  • Morris D, Taub D, Wei J, Dunn R, Wolf J, Hollenbeck B. "Regionalization of Percutaneous Nephrolithotomy: Evidence for the Increasing Burden of Care on Tertiary Centers". The Journal of Urology, 176(1): 242-6, 2006.
  • Montgomery J Gayed B, Hollenbeck B, Daignault S, Sanda M, Montie J, Wei J. "Obesity Adversely Affects Health Related Quality of Life Prior to and Following Radical Retropubic Prostatectomy." Journal of Urology, 176(1):257-61, 2006.
  • Newman LA, Griffith KA, Jatoi Ismail, Simon MS, Crowe JP, Albain KS, Colditz Ga: "Meta-Analysis of Survival in African American and White American Breast Cancer Patients: Effect of Ethnicity versus Socioeconomic Status." JCO. 24:1342-1349, 2006.
  • Normolle, D., Lawrence, T: "Designing Dose Escalation Trials with Late Onset Toxicities Using the Time-to-Event Continual Reassessment Method." J Clin Oncol24: 4426-4433, 2006.
  • Oh KS, Kong FM, Griffith KA, Yanke B, and Pierce LJ: "Planning the Breast Tumor Bed Boost: Changes in the Excision Cavity Volume and Surgical Scar Location Following Breast-Conserving Surgery and Whole Breast Irradiation." Int. J. Radiat Oncol Biol. Phys. 66(3):680-686, 2006.
  • Proust, C, Jacqmin-Gadda, H, Taylor, JMG, Ganiayre, J, Commenges, D: "A Nonlinear Model with Latent Process for Cognitive Evolution Using Multivariate Longitudinal Data." Biometrics, 62: 1014-24, 2006.
  • Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, and Michael CW: "Does Hurthle Cell Lesion/Neoplasm Predict Malignancy More Than Follicular Lesion/Neoplasm on Thyroid Fine Needle Aspiration?" Diagnostic Cytopathology. 34(5):330-334, 2006.
  • Raponi, M, Zhang, Y, Yu, J, Chen, G, Lee, G, Taylor, JMG, MacDonald, J, Thomas, D, Moskaluk, C, Wang, Y, Beer, D: "Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung." Cancer Research, 66(15): 7466-72, 2006
  • Ray M, Mehra R, Sandler H, Daignault S, Shah R. "E-Cadherin Protein Expression Predicts Salvage Radiotherapy Outcomes for Prostate Cancer." Journal of Urology, 76(4 Pt 1):1409-14, 2006.
  • Reddy GR, Bhojani MS, McConville, P, Moody J, Moffat BA, Hall DE, Kim G, Koo YE, Woolliscroft MJ, Sugai JV, Johnson TD, Philbert MA, Kopelman R, Rehemtulla A, Ross BD: "Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors." Clinical Cancer Research 12(22):6677–6686, 2006.
  • Reddy, P, Johnson, K, Uberti, J, Reynolds, C, Silver, S Ayash, L, Braun, T, Ratanatharathorn, V: "Nephrotic Syndrome Associated with Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation, 38(5): 351-7, 2006.
  • Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Luca PC, Newman LA: "Clinicopathologic Features Associated with Having Four or More Metastatic Axillary Nodes in Breast Cancer Patients with a Positive Sentinel Lymph Node. Annals of Surgical Oncology, 13(1): 36-44, 2006.
  • Sarma A, McLaughlin J, Wallner L, Dunn R, Cooney K, Schottenfeld D, Montie J, Wei J. "Sexual Behavior, Sexually Transmitted Diseases, and Prostatitis: The Risk of Prostate Cancer in African American Men". Journal of Urology, 176(3): 1108-13, 2006.
  • Schepkin VD, Chenevert TL, Kuszpit K, Lee KC, Meyer CR, Johnson TJ, Rehemtulla A, Ross BD: "Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors." Magnetic Resonance Imaging, 24(3):273–278, 2006.
  • Schepkin VD, Lee KC, Kuszpit K, Muthuswami M, Johnson TD, Chenevert TL, Rehemtulla A, Ross BD: "Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance." NMR in Biomedicine, 19:1035–1042, 2006.
  • Schott AF, Rae JM, Griffith KA, Hayes DF, Stearns V, Baker LH: "Combination Vinorelbine and Capecitabine for Metastatic Breast Cancer Using a Non-Body Surface Area Dosing Scheme. Cancer Chemother Pharmacol., 58: 129-135, 2006.
  • Shah NM, Soliman A.S., Banerjee M, Merajver S.D., Ismail K, Seifeldin I, Hablas A, Zarzour A, Abdel-Aziz A, Ben Ayed F, Chamberlain R.M: "Knowledge Gained after a Brief CME Module on Breast Cancer Diagnosis." Journal of Cancer Education, 21:169-174, 2006.
  • Shah RB, Ghosh D, Elder JT: "Epidermal Growth Factor Receptor (ErbB1) Expression in Prostate Cancer Progression: Correlation with Androgen Independence." The Prostate, 66(13): 1437-44, 2006.
  • Shen R, Ghosh D, Chinnaiyan AM, Meng Z: "Eigengene-based linear discriminant analysis for gene expression data." Bioinformatics, 22: 2635-2642, 2006.
  • Simon MS, Banerjee M, Crossley-May H, Vigneau F, Noone AM, Schwartz K: "Racial Differences in Breast Cancer Survival in the Detroit Metropolitan Area." Breast Cancer Research and Treatment, 97:149-155, 2006.
  • Symon Z, Daignault S, Symon R, Dunn R, Sanda M, Sandler H. "Measuring Patients’ Expectations Regarding HRQOL Outcomes Associated with Prostate Cancer Surgery or Radiotherapy". Urology. 68(6):1224-9, 2006.
  • Taub D, Dunn R, Miller D, Wei J, Hollenbeck B. "Discharge Practice Patterns Following Cystectomy for Bladder Cancer: Evidence for the Shifting of the Burden of Care". Journal of Urology, 176(6): 2612-8, 2006.
  • Taub, DA, Hollenbeck, BK, Cooper, KL, Dunn, RL, Miller, DC, Taylor, JMG, Wei, JT: "Racial Disparities in Resource Utilization for Cystectomy." Urology, 67(2): 288-93, 2006.
  • Taylor, JMG, Braun, T, Li, Z: "Comparing an Experimental Agent to a Standard Agent: Relative Merits of a One-Arm or Randomized Two-Arm Phase II Design." Clinical Trials, 3(4): 335-348, 2006.
  • Underwood W, Dunn R, Williams C, Lee C. "Gender and Geographic Influence on the Racial Disparity in Bladder Cancer Mortality in the United States". Journal of the American College of Surgeons, 202(2): 284-90, 2006.
  • Urba, S, Wolf, G, Eisbruch, A, Worden, F, Lee, J, Bradford, C, Teknos, T, Chepeha, D, Prince, M, Hogikyan, N, Taylor, JMG: "Single-Cycle Induction Chemotherapy Selects Patients with Advanced Laryngeal Cancer for Combined Chemoradiation: A New Treatment Paradigm." Journal of Clinical Oncology, 24(4):593-598, 2006.
  • Wang Y, Wu R, Cho KR, Shedden KA, Barder TJ, Lubman DM: "Classification of Cancer Cell Lines Using an Automated Two-Diminsional Liquid Mapping Method with Hierarchical Clustering Techniques." Mol Cell Proteomics, 5(1): 43-52, 2006.
  • Wolter KG, Wang SJ, Henson BS, Wang S, Griffith KA, Kumar B, Chen J, Carey TE, Bradford CR, and D’Silva NJ: "(-)-Gossypol inhibits growth of human head and neck squamous cell carcinoma in vivo. Neoplasia. 8(3):163-172, 2006.
  • Zhang Z, Mitra R, Henson B, Datta N, McCauley L, Kumar P, Lee J, Carey T, Dsilva Nisha NJ.: "Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma." Am J Path, 168 (2), 2006.
  • Zhu Y, Wu R, Sangha N, Yoo C, Cho KR, Shedden KA, Katabuchi H, Lubman DM: "Classifications of Ovarian Cancer Tissues by Proteomic Patterns." Proteomics, 6(21): 5846-56, 2006

  • Alexander, B, Wechsler, D, Herman, J, Braun, T, Yanik, G, Hutchinson, R, Levine, J, Pierce, L: "Utility of Cranial Boost in Addition to Total Body Irradiation in the Treatment of High Risk Acute Lymphoblastic Leukemia." International Journal of Radiation Oncology, Biology, Physics, 63(4): 1191-1196, 2005.
  • Allen, A, Prosnitz, R, Ten Haken, R, Yu, X, Zhou, S, Marsh, R, Normolle, D, Marks, L, Pierce, L: "Body Mass Index Predicts the Incidence of Radiation Pneumonitis in Breast Cancer Patients." International Journal of Radiation Oncology, Biology and Physics, 11(5): 390-8, 2005.
  • Bauer, J, Trask, D, Kumar, B, Los, G, Castro, J , Lee, J, Chen, J, Wang, S, Bradford, C, Carey, T: Reversal of Cisplatin Resistance with a BH3 Mimetic, (-)-Gossypol, in Head and Neck Cancer Cells: Role of Wild-Type p53 and Bcl-xL. Molecular Cancer Therapeutics, 4: 1096-1104, 2005.
  • Ben-Josef, E, Normolle, D, Pan, C, Tatro, D, Ten Haken, R, Knol, J, Walker, S, Dawson, L, Ensminger, W, Lawrence, T: "High-dose Conformal Radiation Therapy with Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies." J Clin Oncol 23(34): 8739-47, 2005.
  • Bradley SV, Oravecz-Wilson KI, Bougeard G, Mizukami I, Munaco AJ, Sreekumar A, Chinnaiyan AM, Li L, Corradetti MN, Normolle D, Sanda MG, Ross TS: "Autoantibodies to Huntingtin Interacting Protein-1: A new blood test for prostate cancer." Cancer Res, 65(10):4126-33, 2005.
  • Braun, T, Yuan, Z, Thall, P: "Determining a Maximum Tolerated Schedule of a Cytotoxic Agent." Biometrics, 61(2): 335-343, 2005.
  • Chao, M, Schwartz, J, Wechsler, D, Thornbury, C, Griffith, KA, Williams, J: "High-Risk Surgically Resected Pediatric Melanoma and Adjuvant Interferon Therapy." Pediatr Blood Cancer, 44(5):441-448, 2005.
  • Chapet, O, Kong, F, Lee, J, Hayman, J, Ten Haken, R: Normal Tissue Complication Probability Modeling for Acute Esophagitis in Patients Treated with Conformal Radiation Therapy for Non Small Cell Lung Cancer. Radiotherapy and Oncology 77: 176-181, 2005
  • Chen B, Loberg R, Olson K, Thakur M, Neeley C, O’Hara S, Qweitzig D, Gross S, Doyle G, Terstappen L, Dunn R, Kalikin L, Pienta K. "Preliminary Study of Immunomagnetic Quantification of Circulating Tumor Cells in Patients with Advanced Disease". Urology, 65(3): 616-21, 2005.
  • Chugh R, Dunn R, Zalupski M, Biermann J, Sondak V, Mace J, Leu K, Chandler W, Baker L. "Phase II study of 9-Nitro-Camptothecin in Patients with Advanced Chordoma or Soft Tissue Sarcoma". Journal of Clinical Oncology, 23(15): 3597-604, 2005.
  • Claeys G, Sarma A, Dunn R, Zuhlke K, Montie J, Wojno K, Schottenfeld D, Cooney K. "INS PstI Polymorphism and Prostate Cancer Diagnosis in African-American Men". The Prostate, 65(1): 83-7, 2005.
  • Dobbins, K, Beer, D, Meyerson, M, Yeatman, T, Gerald, W, Jacobson, J, Conley, B, Buetow, K, Heiskanen, M, Simon, R, Minna, J, Girard, L, Misek, D, Taylor, JMG, Hanash, S, Naoki, K, Hayes, D N, Ladd-Acosta, C, Enkemann, S, Viale, A, Giordano, T: "Inter-Laboratory Comparability Study of Cancer Gene Expression Analysis Using Oligonucleotide Microarrays." Clinical Cancer Research, 11: 565-572, 2005.
  • Douglas, J, Zuhlke, KA, Beebe-Dimmer, J, Levin, AM, Gruber, SB, Wood, DP, Cooney, KA.: "Identifying Susceptibility Genes for Prostate Cancer- A Family-Based Association Study of Polymorphisms in CYP17, CYP11A1, and LH. Cancer Epidemiology, Biomarkers and Prevention, 14: 2035-39, 2005.
  • Eisbruch, A, Normolle, D: "Testing new chemo-irradiation regimens for head and neck cancer (editorial)."Int J Radiat Oncol Biol Phys, 61(1): 5-6, 2005.
  • Feng, M, Jabbari, S, Lin, A, Schipper, M, Dawson, L, Tsien, C, Eisbruch, A: "Predictive Factors for Loco-Regional (LR) Failures After Intensity Modulated Radiotherapy (IMRT) for Head and Neck (HN) Cancers." Intl J Radiat Oncol Biol Phys, 77: 32-8, 2005.
  • Fung, K, Lyden, T, Lee, J, Urba, S, Worden, F, Eisbruch, A, Tsien, C, Bradford, C, Chepeha, D, Hogikyan, N, Prince, M, Teknos, T, Wolf, G: Voice and Swallowing Outcomes of an Organ-Preservation Trial for Advanced Laryngeal Cancer. Intl. J. Radiat Oncol, Biol, Phys, 63(5):1395-99, 2005
  • Ghosh D: "Nonparametric methods for identifying multiple replications of origins in genomewide data. Functional and Integrative Genomics 5, 28 – 31, 2005.
  • Ghosh, D, Chinnaiyan, A: "Classification and Selection of Biomarkers in Genomic Data Using LASSO." J Biomedicine and Biotechnology, 2: 147-154, 2005
  • Ghosh, D, Chinnaiyan, A: "Covariate Adjustment in the Analysis of Microarray Data from Clinical Studies." Functional and Integrative Genomics, 5: 18-27, 2005.
  • Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, Gauger P, Doherty G, Thompson NW, Hanash S, Koenig RJ, Nikiforov YE: "Molecular Classification of Papillary Thyroid Carcinoma: Distinct BRAF, RAS, and RET/PTC Mutation-Specific Gene Expression Profiles Discovered by DNA Microarray Analysis. Oncogene, 24(44): 6646-56, 2005
  • Gitlin, S, Yuan, Z, Little, R, Todd, R: "Factors that Influence Successful Training and Faculty Career Development in Hematology/Oncology Patient-Oriented Clinical Research." Journal of Cancer Education, 20, 71-78, 2005.
  • Hayman J, Kabeto M, Schipper M, Bennett J, Vicini F, Pierce L: "Assessing the Benefit of Radiation Therapy after Breast Conserving Surgery for Ductal Carcinoma In-Situ From Both Healthy Women and Former Patients." J Clin Oncol. 23(22): 5171-5177, 2005.
  • Hollenbeck B, Miller D, Dunn R, Montie J, Wei J. "The Effects of Stage Divergence on Survival Following Radical Cystectomy for Urothelial Cancer." Urologic Oncology: Seminars and Original Investigations, 23(2): 77-81, 2005.
  • Hollenbeck B, Miller D, Taub D, Dunn R, Khuri S, Henderson W, Montie J, Underwood W, Wei J. "Identifying Risk Factors for Potentially Avoidable Complications Following Radical Cystectomy". Journal of Urology. 174(4): 1231-7, 2005.
  • Hollenbeck B, Taub D, Dunn R, Wei J. "Quality of Care: Utilization of Partial Cystectomy for Bladder Cancer – A Case of Inappropriate Use?" Journal of Urology. 174(3): 1050-4, 2005.
  • Hollenbeck B, Taub D, Miller D, Dunn R, Montie J, Wei J. "The Regionalization of Radical Cystectomy to Specific Medical Centers". Journal of Urology. 174(4): 1385-9, 2005.
  • Holmes-Rovner M, Stableford S, Fagerlin A, Wei J, Dunn R, Ohene-Frempong J, Kelly-Blake K, Rovner D. "Evidence-based patient choice: A prostate cancer decision aid in plain language." BMC Medical Informatics and Decision Making, 5(1) 16, 2005.
  • Hughes, D, Baskar, D, Urban, F, Friedman, M, Braun, T, McDonagh, K: "Fate and Function of Dual-Activated T Cells Following Adoptive Transfer: IL-2 Promotes Development of Memory T Cells in Vivo". Cytotherapy, 7(5):396-407, 2005.
  • Johnson, TD, Taylor, JMG, Ten Haken, R, Eisbruch, A.: "A Bayesian Mixture Model Relating Dose to Critical Organs and Functional Complication in 3D Conformal Radiation Therapy." Biostatistics, 6(4): 615-632, 2005.
  • Kleer C, Griffith, KA, Sabel M, Gallagher G, Van Golen K, Wu Z, Merajver S: "RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast." Breast Cancer Research and Treatment, 93:101-110, 2005.
  • Kong FM, Ten Haken, R, Schipper, M, Sullivan, M, Chen, M, Lopez, C, Kalemkerian G, Hayman, J.: "High-Dose Radiation Improved Local Tumor Control and Overall Survival in Patients with Inoperable/Unresectable Non–Small-Cell Lung Cancer: Long-Term Results of a Radiation Dose Escalation Study." Intl J Radiat Oncol Biol Phys, 63(2): 324-33, 2005.
  • Levin AM, Ghosh D, Cho KR, Kardia SLR: "A model-based scan statistic for identifying extreme chromosomal regions of gene expression in human tumors." Bioinformatics 21: 2867–2874, 2005.
  • Lin A, Jabbari S, Worden FP, Bradford CR, Chepeha DB, Teknos TN, Liao JJ, Nyquist G, Tsien C,  Schipper MJ, Urba S, Wolf GT and Eisbruch A.: "Metabolic abnormalities associated with weight loss during chemo-irradiation of head and neck cancer." Int J Radiat Oncol Biol Phys, 63(5): 1413-1418, 2005.
  • Mallick B, Ghosh, D, Ghosh M: "Bayesian kernel-based classification of microarray data." J Royal Statistical Society Series B 2, 219–234, 2005.
  • Mehra R, Varambally S, Shen R, Hayes DF, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer, CG: "Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis." Cancer Research, 65: 11259-11264, 2005.
  • Miller D, Sanda M, Dunn R, Montie J, Pimentel H, Sandler H, McLaughlin W, Wei J. "Long-term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality of Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy". Journal of Clinical Oncology, 23(12): 2772-80, 2005.
  • Nelson C, Bloom D, Dunn R, Wei J. "Bladder Exstrophy in the Newborn: A Snapshot of Contemporary Practice Patterns." Urology. 66(2): 411-5, 2005.
  • Nelson C, Dunn R, Wan J, Wei J. "The Increasing Incidence of Newborn Circumcision: Data from the National Inpatient Sample". Journal of Urology, 173(3): 978-81, 2005.
  • Nelson C, Dunn R, Wei J. "Contemporary Epidemiology of Bladder Exstrophy in the United States". Journal of Urology, 173(5): 1728-31, 2005.
  • Nelson C, Dunn R, Wei J, Gearhart J. "Surgical repair of bladder exstrophy in the Modern Era: Contemporary Practice Patterns and the Role of Hospital Case Volume." Journal of Urology, 174(3): 1099-102, 2005.
  • Nelson C, Park J, Dunn R, Wei J. "Contemporary Trends in Surgical Correction of Pediatric Ureteropelvic Junction Obstruction: Data from the Nationwide Inpatient Sample." Journal of Urology, 173(1): 232-6, 2005.
  • Nelson C, Park J, Wan J, Bloom D, Dunn R, Wei J. "The increasing incidence of congenital penile anomalies in the United States." Journal of Urology, 174(4): 1573-6, 2005.
  • Normolle, D, Ruffin, M., Brenner, D: "Design of Early Validation Trials of Biomarkers." Cancer Informatics, 1(1): 25-31, 2005.
  • Pan C, Eisbruch A, Lee J, Snorrason R, Ten Haken R, Kileny P: "Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.: Intl J Radiat Oncol Biol Phys, 61 (5): 1393-1402, 2005
  • Pan, Q, Bao, L, Kleer, C, Sabel, M, Griffith, K, Teknos T, Merajver, S: "Protein Kinase Ce is a Maker of Aggressive Breast Cancer and a Validated Target for RNA Interference Anti-Cancer Therapy." Cancer Research, 65(18):8366-71, 2005.
  • Pierce, L, Griffith, KA, Hayman, J, Douglas, K, Lichter, A: "Conservative Surgery and Radiotherapy for Stage I/II Breast Cancer Using Lung Density Correction: 10- and 15-Year Results." Int. J. Radiation Oncology Biol. Phys., 61(5): 1317-1327, 2005.
  • Pu, R, Schott, A, Sturtz, D, Griffith KA, Kleer, C: "Pathologic Features of Breast Cancer Associated With Complete Response to Neoadjuvant Chemotherapy: Importance of Tumor Necrosis." Am. J. Surgical Pathology, 29(3):354-358, 2005.
  • Rhodes, DR, Kalyana-Sundaram, S, Mahavisno, V, Barrette, TR, Ghosh, D, Chinnaiyan, AM: "Mining for Regulatory Programs in the Cancer Transcriptome." Nature Genetics, Epub 26, 2005.
  • Rhodes DR, Tomlins SA, Varambally S, Mahavisno V, Barrette T, Kalyana-Sundaram S, Ghosh D, Pandey A, Chinnaiyan AM: "Probabilistic model of the human protein-protein interaction network. Nature Biotechnology 23, 951–959, 2005.
  • Rozek, L, Lipkin, S, Fearon, E, Hanash, S, Giordano, T, Greenson, J, Kuick, R, Misek, D, Taylor, JMG, Douglas, J, Rennert, G, Gruber, S: "CDX2 Polymorphisms, RNA Expression, and Risk of Colorectal Cancer." Cancer Research, 65(13): 5488-92, 2005.
  • Rubin MA, Bismar TA, Andren O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan, AM, Adami HO, Kantoff PW, Johansson JE: "Decreased Alpha-Methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer specific death." Cancer Epidemiology, Biomarkers and Prevention 14: 1424–1432, 2005.
  • Sabel, M, Griffith, KA, Sondak, V, Lowe, L, Commino, V, Chang, A, Johnson, T: "Predictors of Non-Sentinel Lymph Node Positivity in Patients with a Positive Sentinel Node for Melanoma." Annals of Surgical Oncology, J. Am Coll Surg 201:37-47, 2005.
  • Schott, A, Roubidoux, M, Helvie, M, Hayes, D, Kleer, C, Newman, L, Pierce, L, Griffith, KA, Murray, S, Hunt, K, Paramagul, C, Baker, L: "Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy." Breast Cancer Research & Treatment, 92:231-238, 2005.
  • Schneider, R, Ben-Josef, E, McGinn, C, Chang, A, Colletti, L, Normolle, D, Lawrence, T, Zalupski, M: "Capecitabine and Radiation Therapy Preceded and Followed by Combination Chemotherapy in Advanced Pancreatic Cancer." Journal of Clinical Oncology, 63(5): 1325-1330, 2005.
  • Shedden K, Chen, W, Kuick, R, Ghosh, D, Macdonald, J, Cho, K, Giordano, T, Gruber, S, Fearon, E, Taylor, JMG, Hanash, S: "Comparison of Seven Methods for Producing Affymetrix Expression Scores Based on False Discovery Rates in Disease Profiling Data." Bioinformatics, 6(26): 1471-2105, 2005.
  • Shedden, K, Kshirsagar, M, Schwartz, D Wu, R, Yu, H, Misek, D, Hanash, S, Katabuchi, H, Ellenson, L, Fearon, E, Cho, K: "Histological Type, Organ of Origin, and Wnt Pathway Status: Impact on Gene Expression in Ovarian and Uterine Carcinomas." Clinical Cancer Research, 11: 2123-2131, 2005.
  • Siu W, Dunn R, Shah R, Montie J, Wei J. "Use of Extended Pattern Technique for Initial Prostate Biopsy". Journal of Urology. 174(2): 505-9, 2005.
  • Taub D, Hollenbeck B, Wei J, Dunn RL, McGuire E, Latini J. "Complications following Surgical Intervention for Stress Urinary Incontinence: A National Perspective". Neurology and Urodynamics, 24(7): 659-65, 2005.
  • Taylor, JMG, Yu, M, Sandler, H: "Individualized Predictions of Disease Progression Following Radiation Therapy for Prostate Cancer." J Clin Oncol, 23(4): 816-825, 2005.
  • Taylor, JMG, Wang, Y, Thiébaut, R: "Counterfactual Links to the Proportion of Treatment Effect Explained by a Surrogate Marker." Biometrics, 64(4): 1102-1111, 2005.
  • Uberti, J, Ayash, L., Ratanatharathorn, V., Silver, S., Reynolds, C., Becker, M., Reddy, P., Cooke, K.R., Yanik G., Whitfield, J., Jones, D., Hutchinson, R., Braun, T., Ferrara, J.L.M., Levine, J.E. "Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-vs-Host Disease (aGVHD) Blood and Bone Marrow Transplantation." 11(9): 680-7, 2005.
  • Underwood W, Jackson J, Wei J, Dunn R, Baker E, DeMonner S, Wood D. "Racial Treatment Trends in Localized/Regional Prostate Cancer: 1992-1999." 103(3): 538-45, 2005.
  • Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Shah, R, Chandran, U, Monzon, FA, Becich, MJ, Wei, JT, Pienta, KG, Ghosh, D, Rubin, MA, Chinnaiyan, AM: "Integrative Molecular Analysis of Prostate Cancer Reveals Signatures of Metastatic Progression." Cancer Cell, 8: 393-406, 2005.
  • Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM: "Autoantibody Signatures in Prostate Cancer." NEJM, 353(12):1224-35, 2005.
  • Williams, J, Lucas, P, Griffith, KA, Choi, M, Fogoros, S, Hu, Y, Liu, J: "Expression of Bcl-xL in Ovarian Carcinoma is Associated with Chemoresistance and Recurrent Disease." Gynecologic Oncology, 96(2): 287-295, 2005.
  • Witkiewicz, AK, Varambally, S, Shen, R, Mehra, R, Sabel, M, Ghosh, D, Chinnaiyan, A, Rubin, M, Kleer, C: "α-Methylacyl-CoA Racemase (AMACR) Protein Expression is Associated with the Degree of Differentiation in Breast Cancer Using Quantitative Image Analysis." Cancer Epidemiology Biomarkers and Prevention, 14: 1418-1423, 2005.
  • Worden, F, Taylor, JMG, Biermann, J, Sondak, V, Leu, K, Chugh, R, McGinn, C, Zalupski, M, Baker, L: "Randomized Phase II Evaluation of 6 g/m2 of Ifosfamide Plus Doxorubicin and Granulocyte Colony-Stimulating Factor (G-CSF) Compared with 12 g/m2 of Ifosfamide Plus Doxorubicin and G-CSF in the Treatment of Poor-Prognosis Soft Tissue Sarcoma." J Clin Oncol 23(1): 105-112, 2005.
  • Zick SM, Blume A, Normolle D, Ruffin M: "Challenges in herbal research: a randomized clinical trial to assess blinding with ginger." Complementary Therapies in Medicine. 13(2):101-6, 2005

  • Alexander, B, Wechsler, D, Herman, J, Braun, T, Yanik, G, Hutchinson, R, Levine, J, Pierce, L: "Role of Cranial Boost in Addition to Total Body Irradiation in the Treatment of High Risk Acute Lymphoblastic Leukemia." International Journal of Radiation Oncology, Biology, Physics, 60(1): S564, 2004.
  • Allen, A, Zalupski, M, Robertson, J, Eckhauser, F, Simone, D, Brown, D, Hejna, G, Normolle, D, Lawrence, T, McGinn, C: "Adjuvant Therapy in Pancreatic Cancer: A Phase I Trial of Radiation Dose Escalation with Concurrent Full Dose Gemcitabine." Int J Radiat Oncol Biol Phys, 59(5): 1461-67, 2004.
  • Alonzo, T, Braun T, Moskowitz, C: "Small Sample Estimation of Relative Accuracy for Binary Screening Tests." Statistics in Medicine (23): 21-34, 2004.
  • Banerjee, M, George, J, Song, E, Roy, A, Hryniuk, W: "Tree-Based Model for Breast Cancer Prognostication." Journal of Clinical Oncology, 22:2567-2575, 2004.
  • Beebe-Dimmer, J., Wood, D., Gruber, S., Douglas, J., Bonner, J., Mohai, C., Zuhlke, K., Shepherd, C., Cooney, K.: "Use of complementary and alternative medicine in men with a family history of prostate cancer: A pilot study." Urology 63(2): 282-7, 2004.
  • Chen, V, Khersonsky, S, Shedden, K, Chang, Y, Rosania, G: "System Dynamics of Subcellular Transport." Molecular Pharmaceutics 1(6): 414-425, 2004.
  • Dash A, Dunn R, Resh J, Wei, J, Montie J, Sanda M. "Preoperative Parameters Associated with Homologous Blood Transfusion Requirement During Radical Retropubic Prostatectomy: A Multivariate Nomogram to Assist Patient Counceling". Urology, 64(1): 117-22, 2004.
  • Dawson L, Saito N, Ratanatharathorn V, Uberti J, Adams P, Ayash L, Reynolds C, Silver S, Schipper M, Lichter A, Eisbruch A: "Phase I Study of Involved-Field Radiotherapy Preceding Autologous Stem Cell Transplantation for Patients with High-Risk Lymphoma or Hodgkin's Disease." Int J Radiation Oncology Biology Physics, 59(1): 208-218, 2004.
  • Eisbruch, A, Marsh, L, Dawson, L, Bradford, C, Teknos, T, Chepeha, D, Worden, F, Urba, S, Lin, A, Schipper, M, Wolf, G: "Recurrences near base of Skull After IMRT of Head and Neck Cancer: Implications for Target Delineation in High Neck and for Parotid Sparing." Int J Rad Onc Biol Phys, 59: 28-42, 2004.
  • Ergen, B, Hussain, H, Caoili, E, Korobkin, M, Carols, R, Weadock, W, Johnson, TD, Shah, R, Hayasaka, S, Francis, I: "MR for Preoperative Staging of Renal Cell Carcinoma Using the 1977 TNM Classification: Comparison with Surgical and Pathologic Staging." American Journal of Roentgenology, 182: 217-225, 2004.
  • Ghosh D: "Accelerated rates regression models for recurrent failure time data." Lifetime Data Analysis 10, 247–261, 2004.
  • Ghosh D: "Identification of shared components and sparse networks in gene expression data." Journal of Virtual Learning Signal Integration and Signal Processing 38, 277–286, 2004.
  • Ghosh, D: "Mixture Models for Assessing Differential Expression in Complex Tissues Using Microarray Data." Bioinformatics, 20: 1663-1669, 2004.
  • Ghosh, D: "Model Checking Techniques for Regression Models in Cancer Screening." The University of Michigan Department of Biostatistics Working Paper Series. Working Paper 37, 2004.
  • Hall, D, Moffatt, B, Stojanovska, J, Johnson, T, Li, Z, Hamstra, D, Rehemtulla, A, Chenevert, T, Carter, J, Pietronigro, Ross, B.: "Therapeutic Efficacy of DTI-015 using Diffusion MRI as an Early Surrogate Marker", Clinical Cancer Research, 10: 7852-7859, 2004.
  • Herman, J, Smith, D, Montie, J, Hayman, J, Sullivan, M, Kent, E, Griffith, KA, Esper, P, Sandler, H: "Prospective Quality of Life Assessment in Patients Receiving Concurrent Gemcitabine and Radiotherapy as a Bladder Preservation Strategy." Urology, 64(1):69-73, 2004.
  • Hofer, M, Fecko, A, Shen, R, Setlur, S, Pienta, K, Tomlins, S, Chinnaiyan, A, Rubin, M: "Expression of the Platelet-Derived Growth Factor Receptor in Prostate Cancer and Treatment Implications with Tyrosine Kinase Inhibitors." Neoplasia 6(5):503-12, 2004.
  • Hollenbeck B, Dunn R, Wei J, Sandler H, Sanda M. "Sexual Health Recovery After Prostatectomy, External Radiation, or Brachytherapy for Early Stage Prostate Cancer". Current Urology Reports, 5(3): 212-9, 2004.
  • Hollenbeck B, Miller D, Dunn R, Underwood W, Montie J, Wei J. "Aggressive Treatment for Bladder Cancer is Associated with Overall Survival Among Patients 80 Years and Older". Urology, 64(2): 292-7, 2004.
  • Hollenbeck B, Wei J, Sandler H, Dunn R, Sanda M. "Neoadjuvant Hormone Therapy Impairs Long-Term Sexual Outcome Among Younger Men that Undergo External Beam Radiotherapy for Localized Prostate Cancer." Urology, 63(5): 946-950, 2004.
  • Hussain, H, Syed, I, Nghiem, H, Johnson, T, Carlos, R, Weadock, W, Francis, I: "T2-weighted Imaging in the Assessment of Cirrhotic Liver." Radiology, 230: 637-644, 2004.
  • Krishnan, K, Aoki, T, Ruffin, M, Normolle, D, Boland, C, Brenner, D: "Effects of Low Dose Aspirin (81 mg) on Proliferating Cell Nuclear Antigen and Amaranthus Caudatus Labeling in Normal-Risk and High-Risk Human Subjects for Colorectal Cancer." Cancer Detection and Prevention28: 107-113, 2004.
  • Krueger E, Schipper M, Koelling T, Marsh R, Butler J, Pierce L: "Cardiac Chamber and Coronary Artery Doses Associated with Postmastectomy Radiotherapy Techniques to the Chest Wall and Regional Nodes." Int J Radiation Oncology Biology Physics, 60(4): 1195-203, 2004.
  • Kuefer, R, Volkmer, B, Loeffler, M, Shen, R, Kempf, L, Merseburger, A, Gschwend, J, Hautmann, R, Sandler, H, Rubin, M: "Comparison of External Radiation Therapy vs. Radical Prostatectomy in Lymph Node Positive Prostate Cancer Patients." Prostate Cancer Prostatic Disease 7(4):343-9, 2004.
  • Lao, C, Simmons, M, Fortlage, L, Syngal, S, Bresalier, R, Normolle, D, Griffith, K, Appelman, H, Brenner, D: "Dysplasia in Barrett's Esophagus: Implications for Chemoprevention." Cancer, 100(8): 1622-7, 2004.
  • Lee C, Dunn R, Chen B, Joshi D, Sheffield J, Montie J. "Impact of Body Mass Index on Radical Cystectomy". Journal of Urology, 172: 1281-5, 2004.
  • Leu, K, Ostruszka, L, Shewach, D, Zalupski, M, Sondak, V, Biermann, J, Lee, J, Couwlier, C, Palazzolo, K, Baker, L: "Labortaory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treatment with Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma." Journal of Clinical Oncology: 22(9): 1706-1712, 2004.
  • Lin, J, Lin, L, Thomas, D, Greenson, J, Giordano, T, Robinson, G, Barve, R, Weishaar, F, Taylor, JMG, Orringer, M, Beer, D: "Melaonma-associated Antigens in Esophageal Adenocarcinoma: Identification of Novel MAGE-A10 Splice Variants." Clinical Cancer Research, 10: 5708-5716, 2004.
  • Marcus, B, Arenberg, D, Lee, J, Kleer, C, Chepeha, D, Schalbach, C, Islam, M, SupritiPaul, Pan, Q, Hanash, S, Kuick, R, Merajver, S, Teknos, T: "Prognostic Factors in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: The Impact of Tumor-Associated macrophages." Cancer, 101(12): 2779-87, 2004.
  • Macoska J., Paris P., Collins C., Andaya A., Beheshti B., Chaib H., Kant R., Begley L., MacDonald JW. and Squire JA.: "Evolution of 8p loss in transformed human prostate epithelial cells. Cancer Genetics and Cytogenetics." 154(1): 36-43, 2004.
  • Meirovitz A, Ben-Josef E, Ensminger WD, Walker S, Brown D, Normolle D, Lawrence T: "Phase I Whole-Liver Radiation Dose Escalation Trial Using Amifostine as a Radioprotector." Int J Radiat Oncol Biol Phys, 60(1):S427, 2004.
  • Miller D, Rumohr J, Dunn R, Bloom D, Park J. "What is the Fate of the Refluxing Contralateral Kidney in Children with Unilateral Multicystic Dysplastic Kidney?" Journal of Urology, 172:1630-4, 2004.
  • Moni, J, Graves-Ditman, M, Cederna, P, Griffith, KA, Krueger, E, Fraass B, Pierce L: "Dosimetry Around Metallic Ports in Tissue Expanders in Patients Receiving Postmastectomy Radiation Therapy: An Ex Vivo Evaluation." Medical Dosimetry, 29: 49-54, 2004.
  • Muler, J, McGinn, C, Normolle, D, Lawrence, T, Brown, D, Hejna, G, Zalupski, M: "A Phase I Trial Using the Time-to-Event Continual Reassessment Strategy to Escalate Cisplatin with Gemacitabine and Radiation Therapy for Pancreatic Cancer." Journal of Clinical Oncology, 22: 238-243, 2004.
  • Park, P, Chandler, W, Barkan, A, Orrego, J, Cowan, J, Griffith, KA, Tsien, C: "The Role of Radiation Therapy after Surgical Resection of Nonfunctional Pituitary Macroadenomas." Neurosurgery. 55:100-107, 2004.
  • Powell I.J., Banerjee M., Bianco F.J., Wood D.P. Jr, Dey J., Lai Z., Heath M., Pontes E.J. The Effect of Race/Ethnicity on Prostate Cancer Treatment Outcome is Conditional: A Review of Wayne State University Data. Journal of Urology, 171:1508-1512, 2004.
  • Rhodes D, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandy A, Chinnaiyan A: "Large-Scale Meta-Analysis of Cancer Microarray Data Identifies Common Transcriptional Profiles of Neoplastic Transformation and Progression." Proc Natl Acad Sci USA, 101: 9309-9314, 2004.
  • Rhodes, D, Yu, J, Shanker, K, Deshpande, N, Varambally, R, Ghosh, D, Barrette, T, Pandy, A, Chinnaiyan, A: "ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform." Neoplasia, 6(1): 1-6, 2004.
  • Ruffin, M, Bailey, J, Normolle, D, Michael, C, Bieniasz, M, Kmak, D, Unger, E, Brenner, D: "Low Dose Topical Delivery of All-Trans Retinoic Acid for CIN II and III." Cancer Epidemiology, Biomarkers and Prevention 13: 2148-2152, 2004.
  • Sarma A, McLaughlin J, Jacobsen S, Blumentals W, Dolin P, Dunn R, Cooney K, Montie J, Schottenfeld D, Wei J. "Longitudinal Changes in Lower Urinary Tract Symptoms Among a Cohort of African-American Men: The Flint Men's Health Study." Urology, 64(5): 959-65, 2004.
  • Shah, R, Kunju, L, Shen, R, LeBlanc, M, Zhou, M, Rubin, M: "Usefulness of Basal Cell Cocktail (p63+34bE12) in the Diagnosis of Atypical Prostate Glandular Proliferations." American Journal of Clinical Pathology 122(4):517-23, 2004.
  • Shah, R, Mehra, R, Chinnaiyan, A, Shen, R, Ghosh, D, Zhou, M, MacVicar, G, Varambally, S, Harwood, J, Bismar, T, Kim, R, Rubin, M, Pienta, K: "Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program." Cancer Research 64(24):9209-16, 2004.
  • Shedden K: "Confidence Levels for the Comparison of Microarray Experiments." Statistical Applications in Genetics and Molecular Biology, 3(1): , 2004.
  • Shedden K, Rosania G: "Exploratory Chemoinformatic analysis of cell-type selective anticancer drug targeting." Molecular Pharmaceutics 1(4): 267-280, 2004.
  • Shedden K, Taylor JMG: "Differential Correlation Detects Complex Associations Between Gene Expression and Clinical Outcomes in Lung Adenocarcinomas." Methods of Microarray Data Analysis IV (Jennifer Shoemaker ed.), Kluwer, 2004.
  • Shen, R, Ghosh, D, Chinnaiyan, A: "Prognostic Meta-Signature of Breast Cancer Developed by Two-Stage Mixture Modeling of Microarray data." BMC Genomics 5: 94, 2004.
  • Sondak, V, Taylor, JMG, Wang, Y, Sabel, M, Lowe, L, Grover, A, Chang, A, Yahanda, A, Moon, J, Johnson, T: "Mitotic Rate and Younger Age are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From The Generation Of A Probabilistic Model." Annals of Surgical Oncology, 11(3):247-58, 2004.
  • Sreekumar, A, Laxman, B, Rhodes, D, Bhagavathula, S, Harwood, J, Giacherio, D, Ghosh, D, Sanda M, Rubin M, Chinnaiyan, A: "Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer." Journal of the National Cancer Institute 96(11):834-43, 2004.
  • Suh W, Schott A, Hayman J, Schipper M, Shewach D, Pierce L: "A phase I Dose Escalation Trial of Gemcitabine with Radiotherapy for Breast Cancer in the Treatment of Unresectable Chest Wall Recurrences." The Breast Journal, 10: 204-210, 2004.
  • Swain J, Dunn R, McConnell D, Gonzalez-Martinez J, Smith G. "Direct Effects of Leptin on Mouse Reproductive Function: Regulation of Follicular, Oocyte, and Embryo Development". Biology of Reproduction, 71(5): 1446-52, 2004.
  • Thatai L., Banerjee M., Lai Z., Vaishampayan U. Racial Disparity in Clinical Course and Outcome of Metastatic Androgen Independent Prostate Cancer. Urology, 64:738-743, 2004.
  • Trask, P, Griffith, KA: "The Identification of Empirically-Derived Cancer Patient Subgroups Using Psychosocial Variables." Journal of Psychosomatic Research, 57: 287-295, 2004.
  • Uberti, J, Ayash, L, Braun, T, Reynolds, C, Silver, S, Ratanatharathorn, V: "Tacrolimus as Monotherapy or Combined with Minidose Methotrexate for Graft-versus-Host Disease Prophylaxis After Allogeneic Blood Stem Cell Transplantation: Long-Term Outcomes." Bone Marrow Transplantation (34): 425-431, 2004.
  • Yu, M, Law, J, Taylor, JMG, Sandler, H: "Joint Longitudinal-Survival-Cure Models and Their Application to Prostate Cancer." Statistica Sinica, 14: 835-862, 2004.

  • Braun, T: "A Mixed Model Formulation for Designing Cluster Randomized Trials with Binary Outcomes." Statistical Modelling (3): 233-249, 2003.
  • Braun T, Levine J, Ferrara J: "Determining a Maximum Tolerated Cumulative Dose: Dose Reassignment Within the TITE-CRM." Controlled Clinical Trials 24(6):669-81, 2003.
  • Chaib H, MacDonald JW, Vessella R, Washburn J, Quinn J, Odman A, Rubin M, Macoska J: "Haploinsufficiency and Reduced Expression of Genes Localized to the 8p Chromosomal Region in Human Prostate Tumors." Genes Chromosomes Cancer 37(3):306-13, 2003.
  • Chang, A, Li Q, Jiang G, Sayre, D, Braun T, Redman, B: "A Phase II Trial of Autologous Tumor Vaccination, Anti-CD3 Activated Vaccine-Primed Lymphocytes Plus IL-2 in Stage IV Renal Cell Cancer." Journal of Clinical Oncology, 21 (5) 884-90, 2003.
  • Chen, G, Gharib, T, Wang, H, Huang, C, Kuick, R, Thomas, D, Shedden, K, Misek, D, Taylor, JMG, Giordano, T, Kardia, S, Iannettoni, M, Yee, J, Hogg, P, Orringer, M, Hanash, S, Beer, D: "Protein Profiles Associated with Poor Survival in Lung Adenocarcinoma." Proceedings of the National Academy of Science, 100(23): 13537-42, 2003.
  • Chen, G, Wang, H, Gharib, T, Huang, C, Thomas, D, Shedden, K, Kuick, R, Taylor, JMG, Kardia, S, Misek, D, Giordano, T, Iannettoni, M, Orringer, M, Hanash, S, Beer, D: "Overexpression of Oncoprotein 18 Correlates With Poor Differentiation in Lung Adenocarcinomas." Mol Cell Proteomics, 2 (2): 107-16, 2003.
  • Cox, C, Merajver, S, Yoo, S, Dick, R, Brewer, G, Lee J, Teknos, T: "Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine Model." Archives of Otolaryngology - Head and NeckSurgery, 129:781-785, 2003.
  • Dayananda, P, Taylor, JMG, Whiting, D: "Prostate Cancer: Progression of Prostate-Specific Antigen after External Beam Irradiation." Mathematical Biosciences, 182: 127-134, 2003.
  • Degnim A, Griffith K, Sabel M, Hayes D, Cimmino V, Diehl K, Lucas P, Snyder M, Chang A, and Newman L: "Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients: A meta-analysis." Cancer. 98 (11): 2307-2315, 2003.
  • Dhaini, H, Thomas, D, Giordano, T, Johnson, T, Biermann, J, Leu, K, Hollenberg, P, Baker, L: "Delineation of Cytochrome P450 CYP3A4/5 Expression as a Biomarker of Therapeutic Response in Osteosarcoma." Journal of Clinical Oncology, 21 (13): 2481-2485, 2003
  • Fu, Z, Smith, P, Zhang, L, Rubin, M, Dunn, R, Dong, Z, Cher, M, Yao, Z, Keller, E: "Raf Kinase Inhibitor Protein (RKIP) is a Prostate Cancer Metastasis Suppressor Gene That Inhibits MEK-Induced TIMP Expression." Journal of the National Cancer Institute, 95(12): 878-89, 2003.
  • Ghosh, D: "Goodness of fit methods for the additive risk model in tumorigenicity experiments" Biometrics 59, 721-726, 2003.
  • Ghosh, D: "Penalized discriminant methods for the classification of tumors from microarray experiments." Biometrics 59, 992-1000, 2003.
  • Ghosh, D, Barrette, T, Rhodes, D, Chinnaiyan, A: "Statistical issues and procedures for meta-analysis of microarray data: a case study in prostate cancer, Functional and Integrative Genomics 3, 180-188, 2003.
  • Ghosh D, Lin DY: "Semiparametric analysis of recurrent events in the presence of dependent censoring." Biometrics 59, 877–885, 2003.
  • Giordano, T, Thomas, D, Kuick, R, Lizyness, M, Misek, D, Smith, A, Sanders, D, Gauger, P, Thompson, N, Taylor, JMG, Hanash, S: "Distinct Molecular Profiles of Adrenocortical Tumors Uncovered by DNA Microarray Analysis." American J. Pathology, 162: 521-531, 2003.
  • Hellerstedt B, Pienta K, Esper P, Dunn R, Fardig J, Olson K, Smith D. "Phase II Trial of Oral Cyclophosphamide, Prednisone and Diethylstilbestrol for Androgen-Independent Prostate Cancer." Cancer, 98(8): 1603-10, 2003.
  • Hollenbeck B, Dunn R, Wei J, Montie J, Sanda M. "Determinants of Long-Term Sexual HRQOL After Radical Prostatectomy Measured by a Validated Instrument." Urology, 169: (4): 1453-7, 2003.
  • Hussain, M., Banerjee, M., Sarkar, F., Djuric, Z., Pollak, M., Doerge, D., Fontana, J., Chinni, S., Davis, J., Forman, J., Wood, D., Kucuk, O.: "Soy Isoflavones in the Treatment of Prostate Cancer." Nutrition and Cancer. 47: 111-117, 2003.
  • Joseph, M, Harlow, S, Wei, J, Sarma, A, Dunn, R, Taylor, JMG, James, S, Cooney, K, Doerr, K, Montie, J, Schottenfeld, D: "Risk Factors for Lower-Urinary Tract Symptoms in a Community-Based Population of African-American Men." Am J of Epidemiology, 157: (10): 906-914, 2003.
  • Kalikin L, Schneider A, Thakur M, Fridman Y, Griffin L, Dunn R, Rosol T, Shah R, Rehemtulla A, McCauley L, Pienta K. "In Vivo Visualization of Metastatic Prostate Cancer and Quantitation of Disease Progression in Immunocompromised Mice." Cancer Biology & Therapy, 2(6): 656-660, 2003.
  • Kleer, C, Cao, Q, Varambally, S, Shen, R, Ota, I, Tomlins, S, Ghosh, D, Sewalt, R, Otte, A, Hayes, D, Sabel, M, Livant, D, Weiss, S, Rubin, M, Chinnaiyan, A: "EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100: 11606–11611, 2003.
  • Lee, K, Montie, J, Dunn, R, Lee, C: "Hautmann and Studer Orthotopic Neobladders: A Contemporary Experience." J of Urology, 169: 2188-2191, 2003.
  • Levine, J, Uberti J, Ayash A, Reynolds C, Ferrara J, Silver, S, Braun, T, Yanik G, Hutchinson R, Ratanatharathorn, V: "Lowered Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation Delays Acute GVHD But Does Not Improve Outcome for Advanced Hematologic Malignancy." Biology of Blood and Marrow Transplantation 9(3): 189-97, 2003.
  • Marshall, J, Griffith, KA, Haffty, B, Slin, L, Vicini, F, McMormick, B, Wazer, D, Recht, A, Pierce, L: "Conservative Management of Paget Disease of the Breast with Radiotherapy: 10- and 15-Year Results." Cancer,97:2142-9, 2003.
  • Michailidis, G, Shedden, K: The application of rule based methods to class prediction problems in genomics. Journal of Computational Biology: 10(5):689-98, 2003.
  • Miller, C, Lin, L, Moy, J, Schipper, M, Normolle, D, Brenner, D, Iannettoni, M, Orringer, M,Beer, D: "Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade
  • Dysplasia." Clinical Cancer Research, 9: 4819-4825, 2003.
  • Miller D, Litwin, M, Sanda, M, Montie, J, Dunn R, Resh J, Sandler H, Wei J. "Use of Quality Indicators to Evaluate Localized Prostate Cancer Care." Cancer, 97: 1428-35, 2003.
  • Miller, D, Taub, D, Dunn, R, Montie, J, Wei, J: "The Impact of Co-morbid Disease on Cancer Control and Survival Following Radical Cystectomy." Journal of Urology, 169: (1) 105-9, 2003.
  • Miller, D, Zheng, S, Dunn, R, Sarma, A, Montie, J, Lange, E, Meyers, D, Xu J, Cooney, K. "Germline Mutations of the Macrophage Scavenger Receptor 1 Gene: Association with Prostate Cancer Risk in African-American Men". Cancer Research, 63(13): 3486-9, 2003.
  • Nelson, C, Dunn R, Wei J, Rubin, M, Montie, J, Sanda, M: "Contemporary Pre-operative Parameters Predict Cancer-free Survival after Radical Prostatectomy: A Tool to Facilitate Treatment Decisions". Urologic Oncology: Seminars and Original Investigations. 21(3): 213-8, 2003.
  • Pan, C, Lee, J, Chan, J, Sandler, H, Underwood, W, McLaughlin, P: "The Association Between Presentation PSA and Race in Two Sequential Time Periods in Prostate Cancer Patients Seen at a University Hospital and its Community Affiliates." Intl J Radiation Oncology, Biology Physics, 57(5): 1292-1296, 2003.
  • Ray, M, Dunn, R, Cooney, K, Sandler, H. "Family History of Prostate Cancer and Relapse after Definitive External Beam Radiation Therapy." International Journal of Radiation Oncology, Biology, and Physics, 57(2): 371-6, 2003.
  • Redman, B, Esper, P, Pan, Q, Dunn, R, Hussain, H, Chenevert, T, Brewer, G, Merajver, S: "Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kindey Cancer". Clinical Cancer Research, 9(5): 1666-72, 2003.
  • Ross, B, Moffat, B, Lawrence T, Mukherji, S, Gebarski, S, Quint, D, Johnson, T, Junck, L, Robertson, P, Muraszko, K, Dong, Q, Meyer, C, Bland, P, McConville, P, Geng, H, Rehemtulla, A, Chenevert, T: "Evaluation of Cancer Therapy Using Diffusion Magnetic Resonance Imaging." Molecular Cancer Therapeutics, 2: 581-587, 2003
  • Roubidoux, M, Kaur, J, Griffith, KA, Sloan, J, Wilson, C, Novotny, P, Lobell, M: "Correlates of Mammogram Density in Southwestern Native-American Women." Cancer Epidemiology, Biomarkers & Prevention. 12:552-558, 2003.
  • Roubidoux MA, Kaur JS, Griffith KA, Stillwater B, Novotny P, Sloan J: "Relationship of Mammographic Parenchymal Patterns to Breast Cancer Risk Factors and Smoking in Alaska Native Women." Cancer Epidemiology, Biomarkers & Prevention. 12:1081-1086, 2003.
  • Sarma A, Wei J, Jacobsen D, Dunn R, Roberts R, Lieber M, Cooney K, Schottenfeld D, Montie J, Jacobsen S: "Comparison of Lower Urinary Tract Symptom Severity and Associated Bother between Community-Dwelling Black and White Men: The Olmsted County Study of Urinary Symptoms and Health Status and The Flint Men’s Health Study." Urology, 61(6): 1086-91, 2003.
  • Scheiman, J, Greenson, J, Lee J, Cryer, B: "Impact of COX-2 Specific Inhibition on Human Helicobacter pylori (HP) Gastritis: Implications for Ulcerogenesis and Carcinogenesis." Alimentary Pharmacology and Therapeutics17: 1535-1544, 2003.
  • Schwartz, D, Wu, R, Kardia, S, Levin, A, Huang, C, Shedden, K, Kuick, R, Misek, D, Hanash, S, Taylor, JMG, Reed, H, Hendrix, N, Zhai, Y, Fearon, E, Cho, K: "Novel Candidate Targets of -catenin/TCF Signaling Identified by Gene Expression Profiling of Ovarian Endometrioid Adenocarcinomas." Cancer Research, 63:2913-2922, 2003.
  • Schwartz K.L., Crossley-May H., Vigneau F., Brown K., and Banerjee M. Race, Socioeconomic Status, and Stage at Diagnosis for Five Common Malignancies. Cancer Causes & Control, 14: 761-766, 2003.
  • Seifman B, Dunn R, Wolf J. "Laparoscopy into the Previously Operated Abdomen: Effect on Operative Time, Length of Stay, and Complications." Journal of Urology, 169: (1) 36-40, 2003.
  • Shedden, K, Taylor, JMG, Giordano, T, Kuick, R, Misek, D, Rennert, G, Schwartz, D, Gruber, S, Logsdon, C, Simeone, D, Kardia, S, Greenson, J, Cho, K, Beer, D, Fearon, E, Hanash, S: Accurate Molecular Classification of Human Cancers Based on Gene Expression using a Simple Classifier with a Pathologic Tree-Based Framework. American Journal of Pathology, 163(5):1985-95, 2003.
  • Shedden, K, Brumer, J, Chang, Y, Rosania, G: "Chemoinformatic analysis of a supertargeted combinatorial library of styryl molecules." Journal of Chemical Information and Computer Sciences, 43(6):2068-2080, 2003.
  • Shedden, K, Townsend, L, Drach, J, Rosania, G: A rational approach to personalized anticancer therapy: chemoinformatic analysis reveals mechanistic gene-drug associations. Pharmaceutical Research 6:843-847, 2003.
  • Shedden, K, Xie, X, Chandaroy, P, Chang, Y, Rosania, G: Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Research, 63(15):4331-7, 2003.
  • Smith D, Chay C, Dunn R, Fardig J, Esper P, Olson K, Pienta K,: "Phase II Trial of Paclitaxel, Estramustine, Etoposide and Carboplatin (TEEC) in the Treatment of Hormone Refractory Prostate Cancer". Cancer, 98(2): 269-76, 2003.
  • Smolkin, M, Ghosh, D: "Cluster Stability Scores for Cancer Subtypes in Microarray Experiments." BMC Bioinformatics, 3: 180-188, 2003.
  • Swain J, Wang X, Saunders T, Dunn R, Smith G. "Specific Inhibition of Mouse Oocyte Nuclear Protein Phosphatase-1 Stimulates Germinal Vesicle Breakdown." Molecular Reproduction and Development. 65(1): 96-103, 2003.
  • Thomas, C, Bradshaw, P, Pollock, B, Montie, J, Taylor, JMG, Thames, H, McLaughlin, P, DeBiose, D, Hussey, D, Wahl, R: "In-111-Labeled Capromab Pendetide adioimmunoscintigraphy and Prognosis for Durable Biochemical Response to Salvage Radiation Therapy in Men after Failed Prostatectomy." Journal Clinical Oncology, 21: (9) 1715-1721, 2003.
  • Trask P, Paterson A, Griffith K, Riba M, and Schwartz J. "Cognitive-Behavioural Intervention for Distress in Patients with Melanoma: Comparison with Standard Medical Care and Impact on Quality of Life." Cancer. 98: 854-864, 2003.
  • Tsien, C, Griffith, KA, Sandler, H, McLaughlin, P, Sanda, M, Montie, J, Reddy, S, Hayman, J: "Long-term Results of 3-D Conformal Radiotherapy following Radical Prostatectomy." Urology, 62(1):93-98, 2003.
  • Symon Z, Griffith KA, McLaughlin PW, Sandler HM: "Dose Escalation for Localized Prostate Cancer: Substantial Benefit Observed with 3D-Conformal Therapy." Int. Journal Radiation, Biology, and Physics, 57 (2): 384-390, 2003.
  • Urba, S., Orringer, M., Ianettonni, M., Hayman, J., Hayasaka, S.: "Concurrent Cisplatin, Paclitaxel and Radiation Therapy as Pre-operative Treatment for Patients with Loco-Regional Esophageal Carcinoma." Cancer, 98(10): 2177-83, 2003.
  • Zhou, M, Shah, R, Shen, R, Rubin, M: "Basal Cell Cocktail (34_E12 + p63) Improves the Detection of Prostate Basal Cells." The American Journal of Surgical Pathology 27(3): 365-371, 2003.

 
  • Beer, D, Kardia, S, Huang, C, Taylor, JMG, Misek, D, Lin, L, Chen, G, Gharib, T, Giordiano, T, Thomas, D, Kuick, R, Orringer, M, Iannettoni, M, Hanash, S: "Gene Expression Profiles Define a High-Risk Group among Patients with Early Stage Lung Adenocarcinoma." Nature Medicine, 8: 816-824, 2002.
  • Braun, T: "The Bivariate CRM: Extending the CRM to Phase I Trials of Two Competing Outcomes." Controlled Clinical Trials (23): 240-255, 2002.
  • Chan, J., Lee, S., Fraass, B., Normolle, D., Greenberg, H., Junck, L., Gebarski, S., Sandler, H.
  • "Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy." Journal of Clinical Oncology20: 1635-1642, 2002.
  • Chang, A, Redman, B, Whitfield, J, Nickoloff, B, Braun, T, et al.: "A Phase I Trial of Tumor Lysate Pulsed Dendritic Cells in the Treatment of Advanced Cancer". Clinical Cancer Research (8): 1021-1032, 2002.
  • Chenevert, T, Meyer, C, Moffat, B, Rehemtulla, A, Mukherji, S, Gebarski, S, Quint, D, Robertson, P, Lawrence, T, Junck, L, Taylor, JMG, Johnson, T, Dong, Q, Muraszko, K, Brunberg, J, Ross, B: "Diffusion MRI: A New Strategy for Assessment of Cancer Therapeutic Efficacy." Molecular Imaging, 1: (4) 336-343, 2002.
  • Chen, G, Gharib, T, Prescott, M, Huang, C, Shedden, K, Kardia, S, Thomas, D, Giordano, T, Kuick, R, Krause, M, Wood, C, Taylor, JMG, Iannettoni, M, Orringer, M, Hanash, S, Beer, D: "Proteomic Analysis of Lung Adenocarcinomas: Identification of Proteins Predictive of Patient Survival". Clinical Cancer Research, 8: (7) 2298-2305, 2002.
  • Cooper, K, Bhatia, J, Muenchen, H, McLean, L, Hayasaka, S, Taylor, JMG, Poncza, P, Pienta, K: "The Regulation of Prostate Cancer Cell Adhesion to Human Bone Marrow Endothelial Cell Monolayers by Androgen Dihydrotestosterone and Cytokines." Clin Experimental Metastasis, 19: (1) 25-33, 2002.
  • Dash, A, Maine, I, Varambally, S, Shen, R, Chinnaiyan. A, Rubin, M: "Changes in Differential Gene Expression because of Warm Ischemia Time of Radical Prostatectomy Specimens. American Journal of Pathology. 61:1743-1748, 2002.
  • Dash, A, Sanda, M, Yu, M, Taylor, JMG, Fecko, A, Rubin, M: "Prostate Cancer Involving the Bladder Neck: Recurrence-Free Survival and Implications for AJCC Staging Modification". Urology, 60: (2) 276-280, 2002.
  • Dawson, L, Normolle, D, Balter, J, McGinn, C, Lawrence, T, Ten Haken, R: "Analysis of Radiation Induced Liver Disease using the Lyman NTCP Model". Int. J. Radiation, Biology and Physics, 53: 810-821, 2002.
  • Dawson LA, Biersack MP, Schipper MJ and Ten Haken RT.: "A novel approach to evaluate partial volume-dose-complication relationships." ABSTRACT, Int J Radiat Oncol Biol Phys, 54(2), Supplement 1, 127-128, 2002.
  • Faucett, C, Schenker, N, Taylor, JMG: "Survival Analysis Using Auxiliary Variables via Multiple Imputation, with Application to AIDS Clinical Trial Data". Biometrics,58:37-47, 2002.
  • Gharib, T, Chen, G, Wang, H, Huang, C, Prescott, M, Shedden, K, Misek, D, Thomas, D, Giordano, T, Taylor, JMG, Kardia, S, Yee, J, Orringer, M, Hanash, S, Beer, D: "Proteomic Analysis of Cytokeratin Isofroms Uncovers Association with Survival in Lung Adenocarcinoma". Neoplasia, 4 (5) 440-448, 2002.
  • Ghosh, D: "Resampling methods for variance estimation of singular value decomposition analyses from microarray experiments". Functional and Integrative Genomics 2: 92–97, 2002.
  • Ghosh, D.: "Singular Value Decomposition Regression Models for the classification of Tumors from Microarray Experiments." Proceedings of the 2002 Pacific Symposium on Biocomputing, Eds. Altman, R. et al., 18-29, 2002.
  • Ghosh, D, Chinnaiyan, AM: "Mixture Modelling of Gene Expression Data From Microarray Experiments." Bioinformatics, 18:275-286, 2002.
  • Ghosh D, Lin DY: "Marginal regression models for recurrent and terminal events." Statistica Sinica 12, 663-688, 2002.
  • Gillard, M, Wang, T, Boyd, C, Dunn, R, Fader, D, Johnson, T: "A Comparison Study of Conventional Diamond Fraise vs. Manual Spot Dermabrasion using Medium Grade Drywall Sanding Screen on Surgical Scars Resulting from Skin Cancer Surgery." Archives of Dermatology, 138 (8): 1035-9, 2002.
  • Goldstein, D, Ghosh, D, Conlon, E.: "Statistical Issues in the Clustering of Gene Expression Data." Statistica Sinica, 12: 219-241, 2002.
  • Hollenbeck B, Dunn R, Wei J, McLaughlin P, Han M, Sanda M. "Neoadjuvant Hormonal Therapy and Older Age are Associated with Adverse Sexual HRQOL Outcome after Prostate Brachytherapy." Urology, 59(4): 480-4, 2002.
  • Joseph M, Wei J, Harlow S, Cooney K, Dunn R, Jaffe C, Montie J, Schottenfeld D: "Relationship of Serum Sex-Steroid Hormones and Prostate Volume in African-American Men". The Prostate, 53 (4): 322-9, 2002.
  • Khan, M, Miller, M, Taylor, JMG, Gill, N, Dick, R, Van Golen, K, Brewer, G, Merajver, S: "Radiotherapy and Antiangiogenic TM in Lung Cancer." Neoplasia 4:(2) 164-170, 2002.
  • Krueger E, Koelling T, Marsh R, Schipper M, Butler J, Pierce L: "Cardiac Substructure (CS) and Coronary Artery (CA) Doses Associated with Post-mastectomy Radiotherapy (pmrt) Techniques to the Chest Wall (cw) and Regional Nodes." Int J Radiation Oncology Biology Physics, 54(2): S165, 2002.
  • Kuefer R, Varambally S, Zhou M, Lucas P, Appelman H, Loeffler M, Wolter H, Mattfeldt T,Hautmann R, Gschwend J, Pienta K, Barrette T, Dunn R, Chinnaiyan A, Rubin M. "Alpha-Methylacyl-CoA Racemase: Expression levels of this novel cancer biomarker depend on tumor differentiation". Am J Pathology, 161 (3): 841-8, 2002.
  • Law, NJ, Taylor, JMG, Sandler, H: "The Joint Modelling of a Longitudinal Disease Progression Marker and the Failure Time Process in the Presence of Cure." Biostatistics, 3: 547-563, 2002.
  • Levine, J, Braun, T, Penza, S, Beatty, P, Cornetta, K, Martino, R, Barrett, A, Leis, J, Holmes, H, Johnson, M, Giralt, S, Porter, D, Drobyski, W, Horowitz, M, Collins, R: "A Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies Following Allogeneic Stem Cell Transplantation." Journal of Clinical Oncology, 20: (2) 405-412, 2002.
  • Li, Chin-Shang, Taylor, JMG: "A Semiparametric Accelerated Failure Time Cure Model." Statistics in Medicine, 21: 3235-3247, 2002.
  • Li, C-S, Taylor, JMG: "Smoothing Covariate Effects in Cure Models". Communications in Statistics, Theory and Methods, 31: (3) 477-493, 2002.
  • Lu, Q, Dunn, R, Angeles, R, Smith, G: "Regulation of Spindle Formation by Active Mitogen Activated Protein Kinase and Protein Phosphatase 2A during Mouse Oocyte Meiosis 1." Biology of Reproduction, 66: (1) 29-37, 2002.
  • Maheshwari, D, Wygoda, W, Schipper, MJ, McGinn, C, Lawrence TS, Dawson, LA: "Outcome of Unresectable Primary Hepatobiliary and Colorectal Metastatic Liver Cancer Treated with Conformal Radiation Therapy." Int J. Radiat Oncol Biol Phys, 54(2): S4, 251, 2002.
  • Moran, C, Arenberg, D, Huang, C, Giordano, T, Thomas, D, Misek, D, Chen, G, Iannettoni, M, Orringer, M, Hanash, S, Beer, D: "RANTES Expression is a predictor of survival in Stage I Lung Adenocarcinoma." Clinical Cancer Research 8: 3803-3812, 2002.
  • Ordemann, R, Hutchinson, R, Friedman, J, Burakoff, S, Reddy, P, Duffner, U, Braun, T, Liu, C, Teshima, T, Ferrara, J: "Enhanced Allostimulatory Activity of Host Antigen-Presenting Cells in Old Mice Intensifies Acute Graft-versus-Host Disease." Journal of Clinical Investigation 109: 1249-1256, 2002.
  • Pan, C, Kim K, Taylor, JMG, McLaughlin, P, Sandler H: "Influence of 3D-CRT Pelvic Irradiation on Outcome in Prostate Cancer Treated with External Beam Radiotherapy." Int J Radiat Oncol Biol Phys, 53(5):1139-45, 2002.
  • Pierce, L, Butler, J, Martel, M, Normolle, D, Koelling, T, Marsh, R, Lichter, A, Fraass, B: "Post-Mastectomy Radiotherapy of the Chest Wall: Dosimetric Comparison of Common Techniques." International Journal of Radiation, Biology and Physics 52: 1220-1230, 2002.
  • Rhodes, D, Barrette, T, Rubin, M, Ghosh, D, Chinnaiyan, A: "Meta-Analysis of Microarrays: interstudy validation of Gene Expression Profiles Reveals Pathway Dysregulation in Prostate Cancer." Cancer Research, 62: 4427-4433, 2002.
  • Rubin, M, Dunn, R, Strawderman, M, Pienta, K: "Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis." American Journal of Surgical Pathology, 26(3) 312-9, 2002.
  • Rubin, M, Zhou, M, Dhanasekaran, S, Varambally, S, Barrette, T, Sanda, M, Pienta, K, Ghosh, D, Chinnaiyan, A: "-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer." JAMA, 287: 1662-1670, 2002.
  • Sarma, A, Jaffe, C, Schottenfeld, D, Dunn, R, Montie, J, Cooney, K, Wei ,J: "Insulin-like Growth Factor-1, Insulin-Like Growth Factor Binding Protein-3 and Body Mass Index: Clinical Determinants of Prostate Growth among African-American Men". Urology, 59: (3) 362-7, 2002.
  • Schwartz, D, Kardia, S, Shedden, K, Kuick, R, Michailidis, G, Taylor, JMG, Misek, D, Wu, R, Zhai, Y, Darrah, D, Reed, H, Elleson, L, Giordano, T, Fearon, E, Hanash, S, Cho, K: "Gene Expression in Ovarian Cancer Reflects Both Morphology and Biological Behavior, Distinguishing Clear Cell from Other Poor-Prognosis Ovarian carcinomas". Cancer Research, 62: 4722-4729, 2002.
  • Shedden, K: Modeling the influence of disease processes on gene expression. Statistica Sinica 12(1):263-272, 2002.
  • Song, J, Tata, D Li, L, Taylor, JMG, Bao, S, Miller, D: "Combined Shockwave and
  • Immuno-gene Therapy of Mouse Melanoma and Renal Carcinoma Tumors".
  • Ultrasound in Medicine and Biology, 28: (7) 957-964, 2002.
  • Suh, W, Hayman, JA, Schott, A, Schipper, MJ, Shewach, DS, Lawrence, TS, Pierce, LJ: "A Phase 1 Dose Escalation Trial of Concurrent Gemcitabine With Standard Irradiation for Unresectable Chest Wall Recurrences After Mastectomy." Int J Radiat Oncol Biol Phys, 54(2):S1, 5-6, 2002.
  • Taylor, JMG, Cooper, K, Wei, J, Sarma, A, Raghunathan, T, Heeringa, S: "Use of Multiple Imputation to Correct for Nonresponse Bias in a Survey of Urologic Symptoms among African-American Men". American J. Epidemiology, 156: (8) 774-782, 2002.
  • Taylor, JMG, Murray, S, Hsu, C: "Survival Estimation and Testing Via Multiple
  • Imputation". Statistics and Probability Letters, 58: (3) 221-232, 2002.
  • Taylor, JMG, Wang, Y: "Joint Modelling and Surrogate Markers". Controlled Clinical Trials, 23: 626-634, 2002.
  • Taylor, JMG, Yu, M: "Bias and Efficiency Loss Due to Categorizing an Explanatory Variable." Journal of Multivariate Analysis, 83: (1) 248-263, 2002.
  • Trask, PC, Paterson, A, Riba, M, Brines, B, Griffith, K, Parker, P, Weick, J, Stelle, P, Kyro, K, Ferrara, J: "Assessment of Psychological Distress in Prospective Bone Marrow Transplant Patients." Bone Marrow Transplantation, 29: 917-925, 2002.
  • Varambally, S, Dhanasekaran, S, Zhou, M, Barrett, T, Kumar-Sinha, C, Sanda, M, Ghosh, D, Pienta, K, Sewalt, R, Otte, A, Rubin, M, Chinnaiyan, A: "The Polycomb Group Protein EZH2 is Involved in Progression of Prostate Cancer." Nature, 419: 624-629, 2002.
  • Wang, Y, Taylor, JMG: "A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker". Biometrics, 58: 803-812, 2002.
  • Wei, J, Dunn, R, Sandler, H, Nyquist, L, Montie, J, McLaughlin, P, Sanda, M: "A Comprehensive Comparison of Health Related Quality of Life Following Contemporary Therapies for Localized Prostate Cancer." Journal of Clinical Oncology, 20: (2) 557-66, 2002.
  • Winer, I, Normolle, D, Shureiqi, I, Sondak, V, Johnson, T, Su, L, Brenner, D: "Expression of 12-Lipoxygenase as a Biomarker for Melanoma Carcinogenesis." Melanoma Research, 12: 429-434, 2002.
  • Yanik, G, Matthay, K, Levine, J, Sisson, J, Shulkin, B, Shapiro, B, Hubers, D, Spalding, S, Braun, T, Ferrara, J, Hutchinson, R: "I-Meta-iodobenzylguanidine in Combination with Myeloablative Chemotherapy and Autologous Stem Cell Support for the Treatment of Neuroblastoma". Journal of Clinical Oncology (20): 2142-2149, 2002.

 
  • Ayash, L, Clarke, M, Silver, S, Braun, T, Uberti, J, Ratanatharathorn, V, Reynolds, C, Ferrara, J, Broun, R, Adams, P: "Double Dose-Intensive Chemotherapy with Autologous Stem Cell Support for Relapsed and Refractory Testicular Cancer: The University of Michigan Experience and Literature Review". Bone Marrow Transplant 27(9)939-47, 2001.
  • Braun, T, Feng, Z: "Optimal Permutation Tests for the Analysis of Group Randomized Trials." Journal of the American Statistical Association, 96 (456): 1424-1432, 2001.
  • Chaib, H, Rubin, M, Mucci, N, Li, L, Taylor, JMG, Day, M, Rhim, J, Macoska, J: "Activated in Prostate Cancer: A PDZ Domain-containing Protein Highly Expressed in Human Primary Prostate Tumors." Cancer Research 61: 2390-2394, 2001.
  • Cooney, K, Strawderman, M, Doerr, K, Alcser, K, Heeringa, S, Taylor, JMG, Montie, J, Schottenfeld, D: "Age-Specific Distribution of Serum Prostate-Specific Antigen in a Community-based Study of African-American Men." Urology, 57:91-96, 2001.
  • Dhanasekaran, S, Barrette, T, Ghosh, D, Shah, R, Varambally, S, Kurachi, K, Pienta, K, Rubin, MA, Chinnaiyan, AM: "Delineation of Prognostic Biomarkers in Prostate Cancer." Nature, 412: 822-826, 2001.
  • Geiger, J, Hutchinson, R, Hohenkirk, L, McKenna, E, Yanik, G, Levine, J, Chang, A, Braun, T, Mulé, J: "Vaccination of Pediatric Solid Tumors with Tumor Lysate-Pulsed Dendritic Cells Expand Specific T Cells and Mediates Tumor Regression." Cancer Research, 61(23)8513-19, 2001.
  • Ghosh D: " Efficiency considerations in the additive hazards model with current status data." Statistica Neerlandica 55, 367–376, 2001.
  • Giordano, T, Shedden, K, Schwartz, D, Kuick, R, Taylor, JMG, Lee, N, Misek, D, Greenson, J, Kardia, S, Beer, D, Rennert, G, Cho, K, Gruber, S, Fearon, E, Hanash, S: "Organ-Specific Molecular Classification of Primary Lung, Colon and Ovarian Adenocarcinomas Using Gene Expression Profiles." American Journal of Pathology, 159(4)1231-8, 2001.
  • Greenberg, H, Chamberlain, M, Glantz, M, Wang, S: "Adult medulloblastoma: Multiagent Chemotherapy." Neuro-Oncology, 3:29-34, 2001.
  • Harris, RB, Griffith, KA, Moon, TE: "Trends in the Incidence of Nonmelanoma Skin Cancers in Southeastern Arizona, 1985-1996." J. American Academy of Dermatology. 45(4):528-536, 2001.
  • Hasan A, Schmaier A, Warnock M, Normolle D, Driscoll E, Lucchesi B, Werns S:
  • "Thrombostatin Inhibits Cyclic Flow Variations in Stenosed Canine Coronary Arteries."
  • Thrombosis and Haemostasis, 86(5) 1296-1304, 2001.
  • Hayman, J, Martel, M, Ten Haken, R, Normolle, D, Todd, R, Littles, J, Sullivan, M, Possert, P, Turrisi, A, Lichter, A: "Dose escalation in non-small cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial." Journal of Clinical Oncology 19: 127-136, 2001.
  • Heeringa, S, Alcser, K, Doerr, K, Strawderman, M, Cooney, K, Medbery, B, Schottenfeld, D: "Potential Selection Bias in a Community-Based Study of PSA Levels in African-American Men." Journal of Clinical Epidemiology 54:142-8, 2001.
  • Hinoi T, Tani M, Lucas P, Caca K, Dunn R, Macri E, Loda M, Appelman H, Cho K, Fearon E. "Loss of CDX2 Expression and Microsatellite Instability are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the Colon". American Journal of Pathology, 159(6): 2239-48, 2001.
  • Kielb, S, Dunn R, Rashid, M, Murray, S, Sanda, M, Montie, J, Wei, J: "Assessment of Early Continence Recovery Following Radical Prostatectomy: Patient-Reported Symptoms and Impairment." Journal of Urology 166:958-61, 2001
  • Kleer, C, Van Golen, K, Braun, T, Merajver, S: "Persistent E-Cadherin Expression in Inflammatory Breast Cancer." Modern Pathology, 14:458-64, 2001.
  • Kleer, C, Giordano, T, Braun, T, Oberman, H: "Pathologic, Immunohistochemical, and Molecular Features of Benign and Malignant Phyllodes Tumors of the Breast." Modern Pathology. (3): 185-190, 2001.
  • Krishnan, K, Ruffin, M, Normolle, D, Shureiqi, I, Burney, K, Bailey, J, Peters-Golden, M, Rock, C, Boland, C, Brenner, D: "Colonic Mucosal Prostaglandin E2 and Cyclooxygenase Expression Before and After Low Aspirin Doses in Subjects at High Risk or at Normal Risk for Colorectal Cancer." Cancer Epidemiology, Biomarkers & Prevention, 10: 447-53, 2001.
  • Krueger, E, Wilkins, E, Strawderman, M, Cederna, P, Goldfarb, S, Vicini, F, Pierce, L: "Complications and Patient Satisfaction Following Expander/Implant Breast Reconstruction With and Without Radiotherapy." Int. J. Radiation Oncology, Biology, Physics 49:713-21, 2001.
  • Madu, C, Quint, D, Normolle, D, Marsh, R, Wanf, E, Pierce, L: "Radiographic Definition of the Supraclavicular and Infraclavicular Nodes: Implications for Three-Dimensional CT-Based Conformal Radiotherapy." Radiology, 221:333-339, 2001.
  • McGinn,C, Zalupski, M, Shureiqi, I, Robertson, J, Eckhauser, F, Smith, D, Decker, D, Neumann, K, Brown, D, Hejna, G, Strawderman, M, Normolle, D, Lawrence, T: "A phase I trial of radiation dose escalation with concurrent weekly full dose Gemcitabine in patients with advanced pancreatic cancer." Journal of Clinical Oncology, 19(22) 4202-8, 2001.
  • McKeever, P, Junck, L, Strawderman, M, Blaivas, M, Tkaczyk, A, Cates, M, Yan, M, Li, L: "Proliferation Index is Related to Patient Age in Glioblastoma." Neurology 56:1216-8, 2001.
  • Murray, S, Tsiatis, A: "Using Auxiliary Time-Dependent Covariates to Recover Information in Nonparametric Testing With Censored Data." Lifetime Data Analysis, 7: 125-141, 2001.
  • Reynolds, C., Ratanatharathorn, V., Adams, P., Braun, T., et. al., "Allogeneic Stem Cell Transplantation Reduces Disease Progression Compared to Autologous Transplantation in Patients with Multiple Myeloma." Bone Marrow Transplantation 27: 801-807, 2001.
  • Rickman, D, Bobek, M, Misek, D, Kuick, R, Blaivas, M, Kurnit, D, Taylor, JMG, Hanash, S: "Distinctive Molecular Profiles of High-Grade and Low-Grade Gliomas Based on Oligonucleotide Microarray Analysis." Cancer Research 61: 6885-6891, 2001.
  • Rubin, M, Mucci, N, Manley, S, Cushenberry, E, Strawderman, M, Sanda, M, Montie, J, Bassily, N: "Predictors of Gleason Pattern 4/5 Prostate Cancer on Radical Prostatectomy: Can High Grade Tumor be Predicted Preoperatively?" J. Urology 165:114-8, 2001.
  • Schmaier, A, Srikanth, S, Elghetany, M, Normolle, D, Gokhale, S, Feng, H, Walker: "Hemostatic/fibrinolytic protein changes in C3H/HeN mice infected with Rickettsia conorii - A model for Rocky Mountain Spotted Fever." Thrombosis and Haemostasis, 86: 871-879, 2001.
  • Sreekumar, A, Nyati, M, Barrette, TR, Ghosh, D, Lawrence, T, Chinnaiyan, AM: "Profiling Cancer Cells using Protein Microarrays: Discovery of Novel Radiation-Regulated Proteins." Cancer Research, 61: 7585-7593, 2001.
  • Sy, J, Taylor, JMG: "Standard errors for the Cox proportional hazards cure model." Mathematical and Computer Modelling, 33:1237-1251, 2001.
  • Taylor, JMG, Griffith, K, Sandler, H: "Definitions of Biochemical Failure in Prostate Cancer Following Radiation Therapy." Int. J. Radiation Oncology Biology Physics, 50:1212-9, 2001.
  • Taylor, JMG, Weiss, R, Li, W, Hsu, C, Suwinski, R: "Estimation for Paired Binomial Data with Application to Radiation Therapy." Statistics in Medicine, 20:3375-3390, 2001.
  • Trask, P, Paterson, A, Hayasaka, S, Dunn, R, Riba, M, Johnson, T: "Psychosocial Characteristics of Individuals with Non-Stage IV Melanoma." Journal of Clinical Oncology 19:2844-50, 2001.
  • Trask, P, Paterson, A, Hayasaka, S, Wang, C, Milliron, K, Blumberg, L, Gonzalez, R, Murray, S, Merajver, S: "Worry Interference in Women at High Risk for Breast and Ovarian Cancer: Impact on Functioning and Health Behaviors." Psycho-Oncology, 10(5)349-60, 2001.
  • Urba, S, Orringer, M, Iannetoni, M, Turrisi, A, Forastiere, A, Strawderman, M: "A randomized trial of preoperative chemoradiation before surgery versus surgery alone in patients with local-regional esophageal carcinoma." J Clin Oncol. 305-13, 2001.
  • Wei, J, Schottenfeld, D, Cooper, K, Taylor, JMG, Faerber, G, Velarde, M, Bree, R, Montie, J, Cooney, K: "The Natural History of Lower Urinary Tract Symptoms Among African-American Men: Relationships with Aging, Prostate Size, Flow Rate and Bother." Journal of Urology, 165:1521-25, 2001.
  • Zhou, M, Hayasaka, S, Taylor, JMG, Shah, R, Proverbs-Singh, T, Manley, S, Rubin, M: "Lack of Association Between Prostate Carcinoma Nuclear Grading and Prostate Specific Antigen Recurrence Following Radical Prostatectomy." Journal of Urology, 166: (6) 2193-7, 2001.

  • Bavikatty, N, Killeen, A, Akel, N, Normolle, D, Schmaier, A: "Association of the Prothrombin G20210A Mutation with Factor V Leiden in a Midwestern American Population." American Journal of Clinical Pathology 114: 272-275, 2000.
  • Brewer, J, Dick, R, Grover, D, LeClaire, V, Tseng, M, Wicha, M, Pienta, K, Redman, B, Jahan, T, Sondak, V, Strawderman, M, LeCarpentier, G, Merajver, S: "Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent." Clinical Cancer Research 6:1-10, 2000.
  • Chang, A, Bishop, D, Nickoloff, B, Redman, B, Normolle, D, Li, Q: "Immunogenetic Therapy of Human Melanoma Utilizing Autologous Tumor Cells Transduced to Secrete GM-CSF." Human Gene Therapy, 11:839-50, 2000.
  • Chenevert, T, Stegman, L, Taylor, JMG, Robertson, P, Greenberg, H, Rehemtulla, A, Ross, B: "Diffusion MRI- A Surrogate Marker of Therapeutic Efficacy in Experimental and Human Brain Tumors." Journal of the National Cancer Institute, 92:2029-2036, 2000.
  • Connolly, D, Greenspan, D, Wu, R, Ren, X, Dunn, R, Shah, K, Jones, R, Bosch, F, Munoz, N, Cho, K: "Loss of Fhit Expression in Invasive Cervical Carcinomas and Intraepithelial Lesions Associated with Invasive Disease." Clinical Cancer Research. 6: 3505-10, 2000.
  • Cooper, K, Walsh, M, Taylor, JMG, Hayasaka, S, Pienta, K: "Preferential Adhesion of Prostate Cancer Cells to Bone is mediated by binding to Bone Marrow Endothelial Cells as compared to Extracellular Matrix Components in Vitro." Clinical Cancer Research, 6:4839-4847, 2000.
  • Dawson, L, McGinn, C, Normolle, D, Ten Haken, R, Walker, S, Ensminger, W, Lawrence, T: "Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies." Journal of Clinical Oncology,18: 2210-18, 2000.
  • Fields, M, Eisbruch, A, Normolle, D, Orfali, A, Davis, M, Pu, A, Lawrence, T: "Radiosensitization Produced by Once- vs. Twice-Weekly 2'2'-difluoro-2'-deoxycytidine (Gemcitabine)." Int. Journal of Radiation, Biology and Physics 47(3): 785-791, 2000.
  • Fiveash, J, Hanks, G, Roach, M, Wang, S, Vigneault, E, McLaughlin, P, Sandler, H: "3D conformal radiation therapy (3DCRT) for high grade prostate cancer: A multi-institutional review." Int J Radiat Oncol Biol Phys., 47:335-42, 2000.
  • Ghosh D, Deisher TA, Ellsworth, JE: "Methods for the analysis of repeated measures." Journal of Pharmacological and Toxicological Methods, 42, 157–162, 2000.
  • Ghosh D: "Methods for the analysis of multiple events and death." Controlled Clinical Trials, 21, 115–126, 2000.
  • Ghosh D, Lin, DY: "Nonparametric analysis of recurrent events and death." Biometrics, 56, 554–562, 2000.
  • Hald, J, Eldevik, O, Dunn, R, Bakke, S, Pedersen, H, Nakstad, P: "Improving Postoperative MR Imaging of Pituitary Macroadenomas." European Radiology 10:1068-72, 2000.
  • Hirth, J, Watkins, P, Strawderman, M, Schott, A, Bruno, R, Baker, L: "The effect of an individual’s cytochrome CYP3A4 activity on docetaxel clearance." Clinical Cancer Research 6:1255-8, 2000.
  • Hollenbeck, B, Bassily, N, Wei, J, Montie, J, Hayasaka, S, Taylor, JMG, Rubin, M: "Whole-Mounted Radical Prostatectomy Specimens Do Not Increase Detection of Adverse Pathologic Features." Journal of Urology, 164:1583-86, 2000.
  • Li, Q, Normolle, D, Sayre, D, Zeng, X, Sun, R, Jiang, G, Redman, B, Chang, A: "Immunological Effects of BCG as an Adjuvant in Autologous Tumor Vaccines." Clinical Immunology  94: 64-72, 2000.
  • Mucci, N, Rubin, M, Strawderman, M, Montie, J, Smith, D, Pienta, K: "Expression of Nuclear Antigen Ki-67 in Prostate Cancer Needle Biopsies and Radical Prostatectomy Specimens." J Natl. Cancer Inst. 92:1941-2, 2000.
  • Nelson, C, Rubin, M, Strawderman, M, Montie, J, Sanda, M: "Pre-operative parameters for predicting early prostate cancer recurrence following radical prostatectomy." Urology, 59:(5) 740-5, 2000.
  • Perrone, E, Theoharis, C, Mucci, N, Hayasaka, S, Taylor, JMG, Cooney, K, Rubin, M: "Matched Case Study to Assess Prostate Cancer Tumor Proliferation in African American and Caucasian Men using High-Density Tissue Microarray Technology." Journal National Cancer Institute, 92:937-939, 2000.
  • Pierce, L, Strawderman, M, Narod, S, et. al: "Effect of radiotherapy following breast conserving treatment in women with breast cancer with germline BRCA1/2 mutations." J Clin Oncol. 18:3360-9, 2000.
  • Rao, G, Murray, S, Ethier, S: "Radiosensitization of Human Breast Cancer Cells by a Novel ErbB Family Receptor TyrosineKinase Inhibitor." Int. J. Rad. Onc. Biol. & Phys., 48: 1519-28, 2000.
  • Rubin, M, Bassily, N, Sanda, M, Montie, J, Strawderman, M, Wojno, K: "Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma." Amer. J. Surgical Pathology 24(2): 183-189, 2000.
  • Rubin, M, Dunn, R, Kambham, N, Misick, C, O'Toole, K: "Should a Gleason Score be Assigned to a Minute Focus of Carcinoma on Prostate Biopsy?" Am J. Surg Pathl. 24:1634-40, 2000.
  • Sandler, H, Dunn, R, McLaughlin, P, Hayman, J, Sullivan, M, Taylor, JMG: "Overall Survival After PSA-detected Recurrence Following Conformal Radiation Therapy." Int. J. Radiation Oncology, Biology Physics, 48: 629-633, 2000.
  • Sandler, H, Dunn, R, Wei, J, McLaughlin, P, Henning, G, Sanda, M: "Health related quality of life following 3D conformal external beam radiotherapy: treatment factors influence patient-reported outcome." International Journal of Radiation Oncology, Biology and Physics. 48(3): 249, 2000.
  • Sisk, E, Bradford, C, Jacob, A, Yian, C, Tang, G, Harris, M, Carey, T, Lancaster, W, Gregoire, L.: "Human Papillomavirus Infection in "Young" versus "Old" Patients with Squamous Cell Carcinoma of the Head and Neck." Head and Neck :22 (7) 649-657, 2000.
  • Sisson, J, Thompson, N, Giordano, T, Normolle, D: "Serum thyroglobulin levels in patients with low-risk papillary thyroid cancer." Thyroid, 10: 165-169, 2000.
  • Sumantran, V, Lee, D, Baker, V, Murray, S, Strawderman, M, Wicha, M: "A bcl-xs adenovirus demonstrates therapeutic efficacy in an ascites model of human breast cancer." J. Soc. of Gynecol. Investigation 7:184-189, 2000.
  • Urba, S, Wolf, G, Bradford, C, Thornton, A, Eisbruch, A, Carpenter, V, Tang, G, Strawderman, M: "Neoadjuvant Therapy for Organ Preservation in Head and Neck Cancer." Laryngoscope, 110:2074-2080, 2000.
  • Wei, J, Dunn, R, Litwin, M, Sandler, H, Sanda, M.: "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC)." Urology. 56: 899-905, 2000.
  • Wei, J, Dunn, R, Marcovich, R, Montie, J, Sanda, M: "Prospective Assessment of Patient-reported Urinary Continence Following Radical Prostatectomy." Journal of Urology 164: 744-8, 2000.
  • Wu, R, Connolly, D, Dunn, R, Cho, K: "Restored Expression of Fragile Histidine Triad Protein and Tumorigenicity of Cervical Carcinoma Cells." Journal of the National Cancer Institute 92: 338-44, 2000.
  • Yang, T, Jisong, C, Taylor, JMG, Yang, A, Ginsburg, A: "Rescue of fatal neonatal hemmorrhage in factor V deficient mice by low level transgene expression." Thrombosis & Haemostasis 83: 70-7, 2000.
  • Yanik, G, Levine, J, Ratanatharathorn, V, Dunn, R, Ferrara, J, Hutchinson, R: "Tacrolimus (FK506) and Methotrexate as Prophylaxis for Acute Graft Versus Host Disease in Pediatric Allogeneic Stem Cell Transplantation." Bone Marrow Transplantation 26:161-7, 2000.
  • Zellars, R, Roberson, P, Strawderman, M, Zhang, D, Sandler, H, TenHaken, R, Osher, D, McLaughlin, W: "Prostate position late in the course of external beam therapy": patterns and predictors." Int. J. Rad. Biol. and Physics, 47: 655-60, 2000.
  • Zhuang, D, Schenker, N, Taylor, JMG, Dubray B, Mosseri, V: "Analyzing the Effects of Anemia on local recurrence of Head and Neck Cancer when Covariates values are missing." Statistics in Medicine. 19:1237-1249, 2000.

  • Hasan, A, Rebello, S, Smith, E, Srikanth, S, Werns, S, Driscoll, E, Faul, J, Brenner, D, Normolle, D, Lucchesi, B, Schmaier, A: "Thrombostatin Pharmacokinetics, Pharmacodynamics, and Inhibition of Canine Coronary Thrombosis." Circulation 82: 1182-1187, 1999.
  • Hochster, H, Strawderman, M, Harris, J, Atkins, M, Oken, M, Skeel, R, Jubelirer, S, Parkinson, D: "Conventional Dose Melphalan is Inactive in Metastatic Melanoma: Results of an Eastern Cooperative Oncology Group Study (E1687)." Anti-Cancer Drugs 10:245-8, 1999.
  • Martel, M, Ten Haken, R, Hazuka, M, Kessler, M, Strawderman, M, Turrisi, A, Lawrence, T, Fraass, B, Lichter, A: "Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients." Lung Cancer 24 (1): 31-7, 1999.
  • Shureiqi, I, Wojno, K, Poore, J, Reddy, R, Moussalli, M, Spindler, S, Greenson, J, Normolle, D, Hasan, A, Brenner, D: "Decreased 13-S-hydroxyoctadecadienoic Acid Levels and 15-lipoxygenase Expression in Human Colon Cancer Tissues." Carcinogenesis20:1985-1995, 1999.
  • Smith, D, Esper, P, Strawderman, M, Redman, B, Pienta, K: "A phase II trial of oral estramustine, oral etoposide and intravenous paclitaxel in hormone refractory prostate cancer." J. Clin Oncol 17(6): 1664-71, 1999.
  • Strome, S, To, W, Strawderman, M, Gersten, K, Devaney, K, Bradford, C, Esclamado, R: "Squamous cell carcinoma of the buccal mucosa." Otolaryngol Head Neck Surg 120 (3): 375-9, 1999.
  • Van Golen, K, Davies, S, Wu, Z, Wang, Y, Bucana, C, Root, H, Chandrasekharappa, S, Strawderman, M, Ethier, S, Merajver, S: "A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and rhoC GTPase correlate with the inflammatory breast cancer phenotype." Clin Cancer Res 5 (9): 2511-9, 1999.

  • Carson, P, Fowkles, J, Roubidoux, M, Moskalik, A, Govil, A, Normolle, D, LeCarpientier, G, Nattakom, S, Helvie, M, Rubin, J: "3D Doppler Image Quantification of Breast Masses." Ultrasound in Medicine & Biology, 24:945-952. 1998.
  • Cascade, P, Gross, B, Kazarooni, E, Quint, L, Francis, I, Strawderman, M, Korobkin, M: "Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast enhanced and unenhanced CT." Am J Radiol 170:927-931, 1998.
  • Fader, D, Wise, C, Normolle, D, Johnson, T: "The Multidisciplinary Melanoma Clinic: A Cost Outcomes Analysis of Specialty." Journal of the American Academy of Dermatology, 38:742-751, 1998.
  • Field, L, Wilson,T, Strawderman, M, Gabriel, H, Helvie, M: "Mammographic screening in women more than 64 years old: a comparison of 1 and 2 year intervals." Am J Roentgenology 170 (4): 961-5, 1998.
  • Long, M, Ashcraft, E, Normolle, D, Mann, K: "Age-Related Phenotypic Alterations in Populations of Purified Human Bone Precursor Cells." Journal of Gerontology: Biological Sciences54: B54-62. 1998.
  • McGinn, C, Ten Haken, R, Ensminger, W, Walker, S, Wang, S, Lawrence T: "The treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model." J Clin Oncol 16:2246-2252,1998.
  • McKeever, P, Strawderman, M, Yamini, B, Mikhail, B, Blaivas, M: "MIB-1 Proliferation index predicts survival among patients with grade II astrocytoma." J Neuropathology and Experimental Neurology, 57: 931-936, 1998.
  • Patterson, S, Helvie, M, Joynt, L, Roubidoux, M, Strawderman, M: "Mammographic appearance of breast cancer in african-american women: report of 100 consecutive cases." Acad Radiol 5:2-8, 1998.
  • Ross, D, Kish, P, Muraszko, K, Blaivas, M, Strawderman, M: "Chemoprevention of ethylnitrosourea-induced rat gliomas by retenoic acid." J Neurooncology 40 (1): 29-38, 1998.
  • Schwab, E, Normolle, D, Pacis, R, Cho, S, Pienta, K: "High-Fat Diet Does Not Influence the Growth of the Dunning R3327-H Transplantable Prostate Adenocarcinoma." Anticancer Research, 18:3603-3607. 1998.
  • Smith, D, Dunn, R, Strawderman, M, Pienta. K: "Change in serum prostate specific antigen as a marker of response to cytotoxic therapy for hormone refractory cancer." J Clin Oncol 16(5): 1835-1843, 1998.
  • Smith, D, Redman, B, Flaherty, L, Li, L, Strawderman, M, Pienta, K: "A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer." Urology 52 (2): 257-60, 1998.

  • Carson, P, Moskalik, A, Govil, A, Roubidoux, M, Fowlkes, J, Normolle, D, Adler, D, Rubin, J, Helvie, M: "The 3D and 2D Color Flow Display of Breast Masses." Ultrasound Medical Biology, 23: 837-849. 1997.
  • Chang, A, Aruga, A, Cameron, M, Sondak, V, Normolle, D, Fox, B, Shu, S: "Adoptive Immunotherapy with Vaccine-Primed Lymph Node Cells Secondarily Activated with Anti-CD3 and IL-2." Journal of Clinical Oncology, 15:796-807. 1997.
  • Fukunaga-Johnson N, Sandler, H, McLaughlin, P, Strawderman, M, et al: "Results of 3D conformal radiotherapy in the treatment of localized prostate cancer." Int J Radiat Oncol Biol Phys 38:311-317, 1997.
  • Goh, M, Kleer, C, Kielczewski, P, Wojno, K, Kim, K, Oesterling, J: "Autologous Blood Donation Prior to Anatomical Radical Retropubic Prostatectomy: Is it Necessary?" Oncology 49:569-574, 1997.
  • Janz, N, Schottenfeld, D, Doerr, K, Selig, S, Dunn, R, Strawderman, M, Levine, P: "A Two-Stepped Intervention to Increase Mammography Among Women 65 and Older." American Journal of Public Health. 87(10): 1683-1686, 1997.
  • Martel, M, Strawderman, M, Hazuka, M, et al: "Volume and dose parameters for survival of non-small cell lung cancer patients." Radiotherapy and Oncology44:23-29, 1997.
  • McKeever, P, Ross, D, Strawderman, M, et al: "A comparison of the predictive power for survival in gliomas provided MB-1, bromodeoxyuridine, and proliferating cell nuclear antigen with histopathologic and clinical parameters," J Neuropathol Exp Neurol 56(7): 798-805, 1997.
  • Merajver, S, Weber, B, Cody, R, Zhang, D, Strawderman, M, et al: "Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the Michigan experience." J Clin Oncol 15 (8): 2873-81, 1997.
  • Ohno, T, Yang, Z, Ling, X, Jaffe, M, Normolle, D, Nabel, G: "Combination Gene Transfer to Potentiate Anti-Tumor Immunity." Gene Therapy, 4: 361-366. 1997.
  • Pienta, K, Redman, B, Bandekar, R, Strawderman, M, et al: "A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer." Urology 50 (3): 401-6, 1997.
  • Pierce, L, McCormick, B, Haffty, B, Solin, L, Vicini, F, Wazer, D, Recht, A, Strawderman, M, Lichter, A: "The conservative management of Paget’s disease of breast with radiotherapy." Cancer 80:1065-72, 1997.
  • Pierce, L, Strawderman, M, Douglas, K, Lichter, A: "Conservative surgery and radiotherapy for early stage breast cancer using lung correction: the University of Michigan experience." Int J. Radiat Oncol Biol Phys39(4): 921-928, 1997.
  • Roberts, J, Jenison, E, Kim, K, Clarke-Pearson, D, Langleben, A: "A Randomized, Multicenter, Double-Blind, Placebo-Controled, Dose-Finding Study of ORG 2766 in the Prevention or Delay of Cisplatin-Induced Neuropathies in Women with Ovarian Cancer." Gynecologic Oncology 67:172-177, 1997.
  • Ruffin, M, Krishnan, K, Rock, C, Normolle, D, Vaerten, M, Peters-Golden, M, Crowell, J, Kelloff, G, Boland, C, Brenner, D: "Suppression of Human Colorectal Mucosal Prostaglandins: Determining the Lowest Effective Aspirin Dose." Journal of the National Cancer Institute, 89: 1152-1160. 1997.
  • Sartor, C, Strawderman, M, Lin, X, et al: "Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy." Int J Radiat Oncol Biol Phys 38 (5): 941-7, 1997.
  • Wolber, F, Curtis, J, Milik, A, Fields, T, Seitzman, G, Kim, K, Kim, S, Sonstein, J, Stoolman, L: "Lymphocyte Recruitment and the Kinetics of Adhesion Receptor Expression during the Pulmonary Immune Response to Particulate Antigen." Am J Pathology 151:1715-1727, 1997.

  • Eisbruch A, Thornton, A, Urba, S, Esclamado, R, Carroll, W, Bradford, C, Hazuka, M, Littles, F, Strawderman, M, Wolf, G: "Chemotherapy flowed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer." J Clin Oncol14(8): 2322-2330, 1996.
  • Kirkwood, J, Strawderman, M, Ernstoff, M, et al: "Interferon Alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684." J Clin Oncol 14(1): 7-17, 1996.
  • Tchetgen, M, Song, J, Strawderman, M, Jacobsen, S, Oesterling, J: "Ejaculation increases the serum PSA concentration: Potential economic implications for our health care system." Urology 47(4): 511-6, 1996.